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I INTRODUCTION 
 
1. The phenomenon of cell proliferation 
 
1.1 Biological importance of cell proliferation 
 
In a normal adult organism many varied cell types die by 
programmed cell death every day in order to provide the 
homeostasis. All organs have remarkable capacity for 
regeneration and repair, even those traditionally thought to 
be postmitotic, like pancreas or brain. Lost cells must be 
constantly replaced by new ones and the rate of cell loss 
must be matched with the rate of renewal. If in an organ 
the cells are dying off with accelerated pace comparing to 
the proliferation level a decline in organ function is 
inevitable and it could result in a chronic degenerative 
disease. But if this imbalance is generalized to the whole 
organism, then it could lead to accelerated aging and 
death. 
The maintenance of normal cell function and tissue 
homeostasis requires the precise regulation of multiple 
signalling pathways that define cell commitment to 
proliferation, differentiation, growth arrest or programmed 
cell death. Proper duplication, maintenance, and repair of 
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the genome are necessary to guarantee the genomic 
stability. 
 
 
 
1.2. Cell cycle 
 
…Double or nothing. With few exceptions a living cell 
either reproduces or dies; the principle is so simple that 
no one has bothered to call it a principle. A cell is born in 
the division of a parent cell. It then doubles in every 
respect: in every part, in every kind of molecule, even in 
the amount of water it contains. Thereafter it divides with 
such equal justice that each new daughter cell is an 
identical copy of the parent. This doubling and halving, 
the cycle of growth and division, is known generally as 
the cell cycle…Daniel Mazia, 1974 [1] 
During the evolution of the cell, the size of the 
genome increased and multiple origins of the replication 
and the chromatin compactation into chromosomes 
became necessary. During eukaryotic cell cycle the 
enormous amount of DNA is accurately duplicated and 
segregated within chromosomes into two daughter cells. 
The inevitable separation of S phase and mitosis required 
the development of new controls to ensure that S phase 
can be initiated only when mitosis is completed and that 
mitosis proceeds only when the replication of DNA is 
finished. 
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1.2.1 Phases of the cell cycle 
 
The eukaryotic cell cycle has been divided into 4 
phases that make possible the correct formation of two 
fully functional daughter cells. Mitosis (M phase) was first 
to be described more than hundred years ago thanks to 
distinctive morphological stages, but it was not until 1951 
and the work of Alma Howard and Steve Pelc when the 
very concept of cell cycle emerged [2]. Mitosis was 
followed by a long interval before the DNA was 
synthesized again, and after DNA synthesis was 
completed there was short interval before the mitosis 
occurred. These intervals or brakes were called gap1 
(G1) and gap2 (G2), respectively, and the period of DNA 
synthesis is called S phase. The time when the cell is not 
dividing, namely G1, S and G2 phase are denominated 
interphase, the phase between two mitosis. In a normal 
tissue, not all cells are cycling; the concept of growth 
fraction was introduced by Mendelsohn et al [3], who laid 
the bases of the delineation between temporarily inactive 
cells, in G0 phase, which upon adequate stimulation 
could re-enter cell cycle, and terminally differentiated 
cells, which are dying by apoptosis without ever dividing 
again. The work of Lieberman et al. in 1963 [4] 
suggested that the interval of cell cycle defined as G0, G1 
and G2 phases which, comparing to dramatic mitosis 
seemed uneventful was actually hiding the sophisticated 
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biochemical machinery. It is now generally accepted that 
G1 cells are biochemically different from G0 cells, 
although the dilemma weather the Go phase is just a 
long G1 phase has puzzled the researchers for many 
years. 
 
 
1.2.2 The duration of the cell cycle 
 
  The length of each phase was determined in various 
cell lines by different methodologies. For example, Essers 
et al. [5] used GFP-hPCNA translocation during cell cycle 
followed by the time-lapse imaging to measure the time 
spans of the cell cycle phases in CHO9 cells. They found 
that G1 phase lasted 380±250min, early S phase 
266±26min, mid-S phase 323±53min, the late S phase 
141±39min, and the G2 phase 77±19min. It is apparent 
that the time individual cell needs to pass trough one cell 
cycle is variable and that the largest variations exist in 
the duration of G1 phase. This is true not only when 
individual cells of the same type are compared, but also 
in the case of the cells originating from different tissues. 
Proliferation rates in the adult body differ in the time that 
cells pass between G1 checkpoint and mitosis or in G0 
phase; neuronal cells almost never divide, liver cells 
normally divide once in every year or two, although 
stimulated by an acute liver damage could reduce their 
cycle time to a day or two, and some epithelial cells of 
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small intestine divide twice a day. On the contrary, the 
period from the beginning of S phase to the end of 
mitosis is usually brief, from 12 to 24h in mammals, and 
constant, regardless of the period between two divisions.  
 
 
1.2.3 The control of the cell cycle.  
 
1.2.3.1 Cyclins, Cyclin dependent kinases and 
checkpoints 
The sequence of cell cycle events is strictly controlled by 
successive activation of different types of complexes of 
cyclin and cyclin dependent kinase. Several checkpoint 
mechanisms have been identified that insures the proper 
timing and order of various processes fundamental for 
cell duplication.  
 
 
 
 
 
 
 
 
 
 
 
 Figure I 1. Checkpoints and inputs of regulatory information to the 
cell cycle control system. Alberts, B. Molecular Biology of the Cell
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Each step in the cell cycle is conditioned by the correct 
development of the previous one, and it could not be 
initiated until the previous event is completed. This 
dependence is not the consequence of the characteristics 
of the process itself, but of the function of the check point 
mechanisms (Fig I 1.).  
According to Hartwell, LH, Weinert, TA [6], ordering of 
the cell cycle events may be accomplished by two 
alternative mechanisms: firstly, the product of an early 
event is a substrate for a later event (the so-called 
substrate-product relationship) and secondly, regulatory 
mechanisms, termed checkpoints, may delay later events 
until earlier events are complete. Thus, checkpoints are 
biochemical pathways that ensure dependence of one 
process on another process that is otherwise 
biochemically unrelated [6]. For example, G1/S check 
point prevents the premature entry into S phase [7, 8]. 
Mitosis can not begin until the DNA replication is 
completed, which is confirmed at the G2/M check point. 
DNA has to be replicated only once per cell cycle and 
there are mechanisms that prevent re-replication until 
the cell has passed mitosis. However, if re-replication is 
initiated, checkpoint proteins would cause G2/M arrest. 
Several cell cycle transitions rely on the activity of cyclin-
dependent kinases (CDKs) and they are inhibited by 
some check point pathways in cell cycle arrest involving 
cyclin dependent kinase inhibitors (CKIs) [9]. These 
enzymes are composed of a serine-threonine kinase 
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subunit, the CDK, and an activating subunite, the cyclin 
[10], which have to reach a critical concentration to be 
able to activate CDKs. The concentration of CDKs is 
relatively stable, while the concentrationc of different 
cyclins oscillate throughout the cell cycle. The CDKs once 
activated, phopshorylate other proteins, enabling them to 
carry out their particular role in the correct moment of 
the cell cycle.  
  
1.2.3.2 At the crossroad between initiation of cell 
proliferation and differentiation 
The start of cell proliferation is often dependent on the 
stimulation by specific growth factors or hormones, which 
bound to the receptor present on the cell surface and 
initiates the signal for replication. This process affects the 
concentration of G1 cyclins: cyclin D and cyclin E. These 
cyclins form a complex with CDKs, enabling them to 
phoshorylate retinoblastoma gene product, pRb. This 
protein is present in early G1 phase in 
hypophosphorilated form and binds to E2F transcription 
factors inhibiting them in their role of preparing the 
nucleus for the DNA replication. The phosporylation of 
pRb causes release of E2F and subsequent onset of DNA 
replication [11]. The concentration of cyclin A increases 
gradually during G1 phase and its binding to CDK2 is 
necessary for the progress to S phase. A-CDK2 complex 
contributes to the maintainance of the DNA replication by 
activating the proteins at the DNA replication origins 
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[12]. On the other hand, towards the end of S phase A-
CDK1 complex prevails which is a signal for G2 phase. 
During this interval that precedes mitosis cell cycle could 
be stopped if the DNA replication had not been complete 
and accurate. The mitosis is initiated and controlled by 
the cyclin B-CDK1 complex. The B cyclins take over form 
cyclin A as activators of CDK1. The proper activation of 
this kinase is controlled at various steps of 
phosphorylation and dephosphorylation [10], which 
guarantees that mitotic division does not occur until the 
DNA has been replicated. The complex that activates 
mitosis is also called M-phase-promoting factor, MPF. Its 
activation is followed by a strong positive feedback which 
causes the concentration of MPF to increase “at an 
accelerating pace until the critical flashpoint is reached, 
whereupon a flood of active MPF triggers downstream 
events that propel the cell into mitosis” [13]. When 
activated, CDK1 phosphorylates structural nuclear 
proteins, nucleolin and lamins which makes possible the 
progress through mitosis and finally cell division.  
Weather the cell is going to continue to divide and 
enter the cell cycle or undergo differentiation and cell 
cycle exit is decided by a member of Id protein family, 
Id2. This protein coordinates inhibition of differentiation 
and stimulation of proliferation by the capacity to disrupt 
the antiproliferative effect of Rb family, thus allowing the 
cell cycle progression [14]. The Id2 expression rapidly 
increases following mitogenic stimulation, and shows 
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another peak as cell advances into the S phase, which 
indicates a possible dual role of this protein in the cell 
cycle progression [15]. Firstly, it could influence the 
activity of p140/E2F4/5 complexes which have inhibitory 
effect on cell proliferation during G0 phase [16], and 
secondly, during late G1 phase where it releases the 
E2F1-3 from the inhibitory complex with pRb/p107 and 
thus facilitate the gene expression required for the onset 
of S phase [17]. It has been shown that the loss of Id2 
siginifcantly reduces the rate of proliferation of primary 
and immortalized embryonic fibroblasts, and that Id2 
expression determines the rate of proliferation in 
primary, immortalized and tumour cell lines [18]. In 
general, expression level of Id genes is high in 
proliferating cells, and is low or absent in differentiated 
cells [19]. 
 
1.2.3.3 The inhibition of the cell cycle 
The cell in G0 or early G1 phase is characterized by a 
high concentration of cyclin kinase inhibitors, CKIs 
divided in two families: p21 family, which includes p21, 
p27 and p57 and INK4 family which consists of p15, p16, 
p18, and p19. P27 is one of the most important inhibitors 
of the CDKs phosphorilation and consequently, the cell 
cycle progression. Upon the mitogenic stimuli, the 
concentration of p27 decreases, CDKs are activated and 
pRb could be phosphorilated. pRb itself is an inhibitor of 
the cell cycle and it has been termed “gateway” for the 
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proliferation, because its inactivation is necessary for the 
cell cycle to begin [11]. If mitogenic stimulation is 
stopped, the p27 concentration increases and the cell is 
halted in G1. However, if the mitogenic stimuli are 
removed some time in late G1 phase, the cell will already 
be committed to proliferation and would be immune to 
external factors. This means that the cell has passed the 
“restriction point”. Both p15 ad p16 have been identified 
as tumor suppressors under the control of pRb. P21 is a 
cell cycle inhibitor that contributes to the cell cycle arrest 
in G1 or early S phase if the DNA damage has been 
detected. P53 protein, also called “the guardian of human 
genome” recognizes the damage in the DNA and induces 
the transcription of p21 [20] which then inhibits the 
activation of CDK2. This delay in the cell cycle 
progression permits the DNA repair, or if the damage is 
too extensive, the initiation of apoptosis. 
 This mechanism also operates in G2 to M transition, just 
before the beginning of mitosis. In this case, 
p21expression, induced by p53, leads to the inhibition of 
the CDK1 activation by cyclin B.  
The different stages of mitosis are also under rigorous 
control which assures the correct and timely development 
of each cell division phase. 
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2. The Implication of Cellular Redox Balance in Cell 
Proliferation.  
 
The oxidizing environment, shared by all aerobic 
organisms and crucial for their survival, poses a 
continuous treat to cellular structures all the living beings 
are made of. Structural proteins and lipids, and cellular 
membranes they compose, nucleic acids and enzymes 
that govern vital cellular processes are all susceptible to 
oxidative damage. Dealing with this inevitable and 
constant danger is one of the greatest challenges the 
living being with aerobic metabolism has to meet.  
 
2.1 Reactive Oxidative Species in Cell Proliferation 
 
Classical work of Kelvin Davies [21], almost ten years 
ago, showed that the cells show a whole range of responses 
to oxidative stress that depends on the intensity of the 
stress. Low level of hydrogen peroxide induced mitogenic 
responses and growth stimulation; this observation was 
firstly reported by Oberly et al [22] who have described that 
oxidative stimuli, such as superoxide and hydrogen 
peroxide, could activate signalling pathways that lead to 
proliferation. Davies et al. further assert that considerable 
increase in the oxidant concentrations caused temporary 
growth arrest which became permanent with a progressive 
increase. When high H2O2 concentrations were used, 
apoptosis took place and at very high oxidant levels the cells 
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were killed by necrosis. A year later, Pani et al [23] 
demonstrate a causal link between redox changes and 
growth control by cell density: they show that low level of 
oxygen species in the environment of proliferating cells was 
not only stimulating but necessary for the correct mitogenic 
signalling. This study was immediately followed by the work 
of Menon et al [24] who suggested that an oxidation event 
early in G1 phase may be a critical regulatory step in the 
progression of the cells into S phase. This lead to the 
development of the model of the “redox cycle within a cell 
cycle” proposed by the same group several years later [25]. 
 
 
 
 
 
 
 
 
 
 
 
 Menon, SG and Goswami, PC, 2007
 
According to this model, the transient change in ROS 
could modify the redox state of cell cycle regulatory 
proteins, at their critical cysteine residues, and thus 
determine progression or arrest in the proliferation. 
 12  
                                                                    I Introduction 
Antioxidant mechanism could scavenge ROS and reverse the 
process. In accordance to these reports, Barry Halliwell [26] 
draw a complete view of the present knowledge of the role 
of oxidative stress in promoting cancer, its damaging effects 
to DNA, and its action on cell proliferation and apoptosis. 
Malignant cells produce more radical species and, although 
antioxidant defence could also be induced in these cells, they 
display a pro-oxidant state. However, apparently the 
oxidative stress generated in these high proliferative cells 
does not exceed the level where oxidative damage becomes 
so severe that cell function is impaired. This finding is in line 
with previously cited and many others that support the role 
of reactive oxidative species mediated signalling in the 
promotion of cell growth. 
Thus, a clear picture emerges where oxidative stress 
is able to modulate cell growth suggesting its importance in 
cancer therapy. However, little information has been 
provided on the active role of glutathione and other powerful 
antioxidant cellular defence mechanisms during the cell 
cycle.  
 
 
2.2 The bridge between the oxidative stress and 
cell proliferation. Glutathione 
 
Glutathione (GSH) is the most abundant non-protein thiol in 
mammalian cells [27]. It is considered essential for survival 
in mammalian cells [28] and yeast [27, 29], but not in 
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prokaryotic cells. The exact nature of this important 
difference has not been elucidated. 
Glutathione was discovered in 1888 by Rey Pailhade as 
“organic hydrogenate of sulphur” [30] and “rediscovered” 
and fully described by Sir Frederic Gowland Hopkins in the 
1920s [31] ([30] and [31] quoted in [32])  
Glutathione has attracted the scientific interest with variable 
intensity along the century since its discovery and many 
important cellular functions of this tripeptide were revealed 
along the years.  
Glutathione shows a widespread localization within 
cells and considerably high concentration in cells and tissues 
(up to 10 mM) [33]. Examples of normal physiological 
functions of glutathione known for a long time include 
regulation of the transport of certain amino acids [34] 
control of cytoskeleton assembly [35] and regulation of 
enzymatic activity [36, 37]. During 1960s, GSH was 
demonstrated to be a co-substrate for a number of 
important enzymatic reactions: GSH-S-transferase was 
described (Booth 1961) and its role in a first–line defence 
against electrophilic insult, obviously dependent on 
glutathione, was suggested (Boyland, E 1969). These 
pioneer works became the bases for many studies that lead 
to the development of concepts such as drug and foreign 
compound detoxification, and multidrug resistance (Smith, 
1977) of crucial importance in the modern cancer therapy. 
Glutathione, as it lacks toxicity linked to cysteine [38], is 
considered perfect as a cellular thiol “redox buffer” with a 
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purpose to maintain a given thiol/disulfide redox potential 
[32]. Therefore, the redox properties and abundance that 
characterise this molecule grant it a major role in protecting 
the cell against oxidants and electrophiles, and during 1980s 
this particular role of glutathione is central in many research 
efforts.  
Association of redox regulation with toxicity events 
lead to the introduction of the concept of “oxidative stress” 
at biochemical and cellular level [39]. Oxidative stress is 
generally defined as an imbalance between prooxidants and 
antioxidants with a considerable effect on other cellular 
components, including redox sensitive functional groups of 
proteins. Nowadays, with the increasing awareness of the 
importance of ROS and glutathione in cellular signalling, and 
the cellular redox environment in fundamental physiological 
processes, a new definition of oxidative stress is proposed. 
Acording to Jones, DP [40], oxidative stress may be better 
defined as a disruption of redox signaling and control.  
Interestingly, more than 10 years ago, searching for a 
molecular link between oxidative stress and cell proliferation, 
Cotgrave IA and Gerdes RG recommended similar term: 
“oxidant mediated regulation” [41]. 
 
 
2.3 Glutathione in cell proliferation 
 
It seems that, traditionally, the attempts to elucidate the 
behaviour of highly proliferating cells in the light of its redox 
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status relayed mainly on the increased production of ROS, 
while little insight was devoted to the potential role of the 
antioxidant system. 
Several studies from more than 20 years ago have 
suggested that changes in low molecular weight thiols are 
associated with regulation of cell growth. Harris and Patt 
published in 1969 [42] that nonproliferating mouse tumour 
cells contained less LMWT than proliferating cells and in 
early eighties various authors report similar results: human 
lung and ovarian tumour cells during the exponential growth 
demonstrate higher GSH levels than during nondividing state 
[42-44]). In accordance to these findings, Kosower and 
Kosower [45] have demonstrated that decrease of GSH 
biosynthesis in vivo inhibits tumour growth rate. Moreover, it 
was suggested that cellular GSH may have to reach certain 
critical levels before proliferation can be initiated and that 
variations in the protein sulfhydril redox status may directly 
relate to regulation of cell growth [46].  
Defining the intrinsic cellular redox environment by 
estimation of glutathione (GSH)/glutathione disulfide (GSSG) 
redox state, the group of Dean P. Jones [47] concluded that 
each phase in the life of the cell is characterized by the 
certain redox state.  
Proliferating cells are in the most reduced state, with the 
values of Eh between -260mV and -230mV [48]. Upon a 
growth arrest caused by differentiation [47] or contact 
inhibition [48] cells are 40 mV more oxidised (-220mV to -
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190mV) while the apoptotic process is accompanied by 
further oxidation up to -165mV [49]. 
 
  
Cellular redox changes in assotiation with the growth state.
Nkabio, YS et al. 2002
 
 
 
 
 
 
 
 
 
Therefore, while the cell progresses from proliferation, 
through contact inhibition, differentiation, and finally 
apoptosis, there is an intrinsic and natural progression from 
more reduced to more oxidised cellular redox environment.  
The universality of this model which applies to various cells 
from different organisms (reviewed in [48]) inspired a daring 
hypothesis of Schafer and Buettner on the implication and 
function of thiols and disulfides as nano-switches.  
 
Schafer, FQ and Buettner, GR, 2001
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The GSSG/2GSH couple is imagined as a switchboard that 
move the cell from proliferation through differentiation 
towards programmed cell death, if the redox environment 
could not be maintained, or necrosis when the oxidative 
insult is to severe. 
 
 
2.4 Glutathiolation of regulatory proteins as a 
link between a stimulating oxidative event and 
reduced cell environment in cell proliferation 
 
During last two decades the increasing body of 
evidence reveals that several transcription factors undergo 
oxidant modification necessary for their activation. For 
instance, the property of binding DNA and thus regulate 
gene expression of AP1, Nfkb, p53, and SP1 depends on the 
redox status of cysteinyl thiols in their structures [49]. 
Thus, the idea of protein glutathionation as a 
regulatory mechanism of importance in cell proliferation 
came into sight.  
Glutathiolation is a protein modification which consists 
in the covalent union of the tripeptide glutathione to the SH 
group of the cysteine residue. For a long time this reaction 
was considered to be a consequence of the equilibrium 
between protein thiols and GSSG inevitably related to 
oxidative stress. From this point of view, glutathiolation 
flufills two important functions. Firstly, its reversibility 
enables the preservation of glutathione in the cell and serve 
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as a buffer for the reduction potential; otherwise, GSSG 
efflux would cause the loss of GSH from the cell, decreasing 
the reducing capacity which could be recovered only by the 
synthesis of new GSH [48]. Secondly, it provides protection 
for protein-SH against irreversible modifications and protein 
damage in response to higher levels of oxidative stress [50]. 
Interestingly, it was demonstrated that glutathiolation as a 
posttranslational modification occurs not only during 
oxidative stress, but also under basal conditions and is 
involved in regulating distinct transcription factors, such as 
NF-kB [51], its inhibitor factor IKK [52] and c-Jun [53]. 
Apparently, the binding capacity of these proteins for DNA or 
other proteins is modulated by glutathiolation. This relatively 
recent focus on the implication of glutathiolation modulatory 
effects on protein function yielded important breakthrough in 
elucidation of the implication of this modification in various 
physiological and pathological situations [54] and raises 
interesting questions about its possible implications in cell 
proliferation.  
 
 
2.3.1 The Role of Glutathione in DNA Synthesis 
 
Among the important roles that GSH plays in cellular 
physiology, and among the first to be described, was its role 
in DNA synthesis. 
 The pentose phosphate pathway is a cellular source of 
NADPH that is involved in reductive biosynthesis. In this 
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process, ribose-5-phosphate is formed and subsequently 
used for the synthesis of RNA, DNA and nucleotide 
coenzymes. Apart from the synthesis of nucleotides, NADPH 
is also required for the formation of amino acids, fatty acids, 
cholesterol, neurotransmitters and nitric oxide (NO). 
Furthermore, NADPH is the source of electrons in the 
process of reduction of ribonucleotides to 
deoxyribonucleotides catalyzed by the ribonucleotide 
reductase [55]. 
The rout is initialized by two distinct but complemented 
systems, the thioredoxin system and the glutaredoxin 
system. Thioredoxin operates by transferring the electrons 
to ribonucleotide reductase, and they are supplied by the 
thioredoxin reductase and NADPH.  The glutaredoxin system 
is initialised by the glutathione reductase, which reduces the 
GSSG to GSH using the NADPH as source of electrons. GSH 
is used by the glutaredoxin to provide the reducing power to 
the ribonucleotide reductase. 
The crucial role of glutathione in DNA synthesis has been 
extensively documented [55, 56]. For instance, Dethlefsen 
and co-workers [57] showed that glutathione depletion 
inhibits DNA synthesis in mammary carcinoma cells. In 
addition, the vital importance of GSH in this process has also 
been demonstrated in human T lymphocytes [58]. As 
mentioned above GSH is an indispensable requirement in 
eukaryotes. In contrast, it does not demonstrate the same 
importance in prokariotes. It has been shown that E. Coli 
lacking gshA, the rate limiting enzyme in the synthesis of 
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GSH, can grow without GSH supplementation [59, 60]. On 
the contrary, in yeast, the depletion of GSH does affect cell 
proliferation on the level different from DNA synthesis: 
mutants deficient in GCS after GSH withdrawal arrest cells in 
G1, whereas a strain with a defect in ribonucleotide 
reduction arrest cells in S phase [61]. Since other possible 
explanations, such as protection against oxidative stress or 
protection against non-native protein disulfides, have been 
discarded [62], it appears that the essential function of GSH 
in yeast is related to the redox properties of its thiol group. 
Consequently, glutathione can be replaced by dithiothreitol, 
but not with a GSH analog where a thiol group has been 
substituted by a methyl group [63]. Since GSH is the 
reductant for glutaredoxin as explained previously, and 
glutaredoxin is also essential [64] presumably their vital 
importance may be interdependent. 
 
2.3.2 Regulation of Telomerase Activity by Glutathione 
 
  The eukaryotic chromosomes are capped by 
telomeres, which consist of telomeric DNA repeated in 
tandem, associated with several proteins. These structures 
play an important role in the stability and the complete 
replication of the chromosomes. Conventional DNA 
polymerases cannot fully replicate the 3’-end of the lagging 
strand of linear molecules, and therefore in every cell 
division telomeric sequences are lost [65]. Telomerase is an 
important enzyme that ensures the maintenance of normal 
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telomere length. This activity is high in human cancers [66], 
but virtually absent in normal human tissues, except 
germinal cells [67]. Telomerase regulation is not completely 
understood, but its changes are related to both cancer and 
aging [68]. Studies carried out by Jady et al. show that 
human telomeres are more accessible during the S-phase 
[69] and that the telomerase assembly with telomeres takes 
place at this specific moment of the cell cycle [69, 70]. 
Telomerase plays a key role in cellular homeostasis, because 
it maintains the length of the telomeres. This especially 
important in germinal cells in which it is necessary to keep a 
normal telomeric length after many cellular divisions. 
Recently, Maria Blasco has suggested that telomeres are 
under epigenetic control [71]. Mammalian telomeres and 
subtelomeric regions are enriched in epigenetic markers that 
are characteristic of heterochromatin.  
There are evidence that point to a role of redox 
environment in a short term regulation of the activity of this 
important enzyme. Minamino et al. [72] using vascular 
smooth muscle cells, reported that hypoxia up-regulates 
telomerase activity. Hypoxia is known to lower oxidative 
stress and thus to increase levels of glutathione. A specific 
inhibitor of telomerase, 2-[3-(trifluoromethyl) 
phenyl]isothiazolin-3-one, reacts with a key cysteine 
residue, which is essential for telomerase activity and must 
be kept reduced. Consequently, it has been reported that 
dithiothreitol reverses this inhibition [73]. Furthermore, 
antioxidants have been shown to inhibit nuclear export of 
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telomerase reverse transcriptase and thus delay replicative 
senescence of endothelial cells [74]. In conclusion, a critical 
cysteine residue must be kept reduced in order to maintain 
full telomerase activity. It is likely that the glutathione redox 
potential may be important in this process. 
Previous findings of our group demonstrated that 
telomerase is regulated by the shift in glutathione redox 
potential within values similar to those found in vivo and 
alterations in telomerase activity are coordinated with 
changes in critical cell cycle proteins, particularly Id2 and 
E2F4 [75]. Thus, physiological variations in glutathione level 
induce changes in telomerase activities that are in 
concordance with changes in cell cycle regulatory proteins. A 
number of reports have shown similar results. Brown et al. 
[76] demonstrated for the first time in vivo that high hepatic 
glutathione levels correlate with increased telomerase 
activity. Also, the importance of glutathione regulation in 
telomerase activity has been proved in endothelial 
progenitor cells (EPC): impairment of antioxidant defences in 
EPC promoted oxidant mediated apoptosis and telomerase 
inactivation which subsequently lead to development and/or 
progression of atherothrombosis [77]. 
Recent data suggest that telomerase activity is regulated 
and ordered by telomere structure and telomerase 
assembly. Although not proven, the telomere structure may 
change in a cell cycle-dependent manner to restrict 
telomerase activity to S phase [78]. For this to happen, the 
precise control of the changes not only in telomerase 
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conformation, but in chromatin structure (i.e. in its 
compactation level) as well, is of vital importance. This 
finding that telomere length, and, therefore, telomere 
structure, is tightly regulated in telomerase proficient cells 
invokes a connection between cell cycle, telomerase and 
telomere structure [79]. In other words, the mechanism that 
lies beneath telomerase regulation might be related with the 
mechanism that control cell proliferation. This opens a highly 
significant area for exploratory study and the diversity of 
processes and control mechanisms that could be involved in 
this phenomenon remain to be elucidated. 
 
 
3. Compartmentalization of Glutathione 
 
3.1. The physiological importance of 
compartmentalization of glutathione 
 
Pioneer work from Alton [27] correlated GSH 
synthesis and its degradation throughout the so-called γ-
glutamyl cycle, and defined it as a cytosolic processes. The 
importance of cellular compartmentalization of GSH is two 
fold, first because it plays an important role in fighting 
against radical oxygen species (ROS). It is well known that 
these molecules have a very short half life and exert their 
action close to the place they were produced. Thus, the 
presence or absence of GSH could determine the 
development of localized oxidative damage for the cell 
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structure or metabolic function developed in the vicinity. 
Secondly, GSH compartmentalization is of vital importance 
because of its role as a cellular detoxifying agent; it is 
known that tumours that have high glutathione levels are 
more resistant to chemotherapy, and the importance of 
nuclear [80] and mitochondrial [81] compartimentalization 
of GSH has been pointed out. 
The overview of compartmentalization of glutathione 
in mammal cells is a complicated matter. This is due to the 
presence in the literature of a number of contradictory 
reports. The reason for the controversy is mainly 
methodological. Until very recently most reports were mainly 
based on cell-fractionation techniques. Those techniques 
appear to be reliable for mitochondrial studies; however 
their usefulness in nuclear or even endoplasmic reticulum 
measurements is at least controversial. 
However, although knowledge on cellular GSH distribution is 
not completely established, a considerable number of studies 
describe a reliable picture, which we present in the 
continuation.  
 
 
3.2. Glutathione content in cells 
 
3.2.1 Whole cells 
 
Glutathione concentration in some cells could be as high as 
10 mM. Cellular glutathione status suffer significant changes 
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under both physiological and pathological conditions. 
Lowering the concentration of the reduced form of 
glutathione (GSH) may or may not be accompanied by an 
increase in the levels of the oxidized form (GSSG), 
depending on whether it is caused by oxidative stress or by 
eflux. Accurate determination of glutathione in biological 
samples is of critical importance and is largely dependent on 
a proper sample treatment. The GSSG concentration is 
usually very low compared to the GSH concentration [29, 
82]. Pioneer work by Tateishi and co-workers and Akerboom 
and Sies [82, 83] showed that rat liver GSH ranges from 2.0 
to 7.0 µmols/g of tissue and GSSG from 0.007 to 0.084 
µmols/g of tissue. In isolated rat hepatocytes GSH 
concentration is 4 μmoles/g of wet weight [29]. 
Most of the glutathione is maintained in its reduced 
form by glutathione reductase. As mentioned above, 
glutathione synthesis and its degradation are linked by the 
γ-glutamyl cycle which involves cytosolic steps and one 
membrane bound enzyme, γ-glutamyl transferase.  
The main cellular localizations that have been 
described for glutathione are the cytosol, mitochondria, the 
endoplasmic reticulum (ER), and the cell nucleus. 
 
3.2.2. Cytosol 
 
As pointed out above, GSH synthesis occurs by two 
sequential, ATP-dependent reactions in the cytoplasm, 
catalyzed by glutamate cysteine ligase (formerly known as γ-
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glutamylcysteine synthase) and GSH synthetase. Almost all 
cellular GSH is synthesized in the cytosol with little if any 
production in other organelles, including mitochondria [84, 
85]. The capacity for GSH synthesis is present in almost all 
mammalians cells. Degradation of GSH is mediated by a 
different pathway. However, not all mammalian cell types 
can degrade GSH [86]. Cleavage of the γ-glutamyl-peptide 
bond by γ-glutamyl transferase (γ-GT) takes place mainly in 
epithelial cells but its expression is very low in parenchymal 
cells. The cytosolic concentration of GSH depends not only 
on the rate of synthesis and degradation but also its efflux 
through the plasma membrane. Recently a number of 
plasma membrane proteins capable of exporting GSH out of 
the cell have been described in tumour cells. These are ATP- 
binding cassette C1 (ABCC1) and cystic fibrosis 
transmembrane conductance regulator (CFTR) [87, 88]. 
ABCC1 is a member of the ABC transmembrane proteins that 
function as efflux pumps with diverse substrate specificity. It 
is involved in the extrusion of several endogenous cell 
metabolites, including leukotriene C4 (LTC4) and GSH. CFTR 
forms an ion channel that is permeable both to Cl- and to 
larger organic anions, among them GSH. In airway epithelial 
cells CFTR exports GSH to the airway surface fluid. Thus, a 
new direction of research on the regulation of cytosolic GSH 
has been opened by different families of membrane 
transporters. 
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3.2.3 Mitochondria 
 
Mitochondria are major sources of ROS, thus it is a 
cellular priority to maintain high glutathione levels within 
mitochondria. In fact, their function is closely linked to 
maintenance of the redox balance since mitochondria are the 
main consumers of oxygen within the cell. The generation of 
ROS as a by-product of mitochondrial physiological 
metabolism is due to the partial reduction reactions that 
take place during the four-electron reduction of molecular 
oxygen (O2) to water. 
Increased ROS production by mitochondria could induce a 
chronic oxidative stress, impaired mitochondrial function, 
and further production of ROS. This inevitably leads to 
mitochondrial damage and even to lesions in other cellular 
structures [89-91]. Not only oxygen-derived free radicals, 
but also reactive nitrogen species (RNS) like nitric oxide 
(NO) and peroxynitrite (ONOO) are produced inside 
mitochondria. Thus, formations of S-nitrosoglutathione 
(GSNO) takes place during normal mitochondrial 
metabolism. The formation of GSNO has been reported to 
play a regulatory role in mitochondrial homeostasis. 
In hepatocytes, 15 % of all cellular glutathione is in 
mitochondria [92]. 
 Initial studies on mitochondrial GSH transport were 
performed by Kurosawa et al [93] in the early nineties. 
These authors found higher GSH levels in mitochondria than 
in the cytosol and described the presence of mitochondrial 
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transport activity that was dependent on the respiratory 
state of mitochondria. The highest transport activity was 
found under state 4 conditions. Martensson [94] and co-
workers  found a two-kinetic component when studying 
isolated mitochondria form rat liver. Similar results, using 
different approaches, where reported by Garcia-Ruiz et al. in 
1995 [95] and Schnellman et al. [96]. 
Nowadays a clear picture emerges, where at least two 
anion carrier proteins, the dicarboxylate carrier (DIC) and 
the 2-oxoglutarate carrier (OGC), play a major role in the 
transport of GSH to mitochondria (for a review see [89]). 
According to Lash and co-workers [97] approximately 60% 
of the total amount of GSH transport in renal cortical 
mitochondria is mediated by DIC and around 40% is 
mediated by OGC. The authors do not exclude the presence 
of other unidentified carriers. It is known that DIC is 
responsible for the transport of dicarboxilates from the 
cytoplasm to mitochondria, thereby supplying substrates for 
the Krebs cycle [98, 99]. Thus, GSH would compete for the 
carrier and could explain the reported correlation between 
GSH transport and the mitochondrial state. 
 
3.2.4. Endoplasmic reticulum 
 
The endoplasmic reticulum (ER) plays a major role in 
the folding of native proteins. By contrast to the cytosol the 
ER contains a relatively higher concentration of oxidized 
glutathione (GSSG) [100]. This allows the formation of 
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native disulphide-bonds in the ER. The folding of many 
proteins depends upon the formation of disulphide bonds. 
Despite the vital importance of redox regulation in the ER, 
we have little knowledge about the mechanisms responsible 
for the ER redox balance. This process is catalyzed by 
protein disulphide isomerases and GSSG is believed to be 
involved in the oxidation of protein disulphide isomerases 
[101]. It has also been shown, however, that ER flavoprotein 
Erol catalyses the oxidation of protein disulphide isomerases 
in vivo and in vitro [102, 103]. 
Recent advances in genetics and cell biology have outlined a 
core pathway for disulphide bond formation in the ER of 
eukaryotic cells. In this pathway, oxidizing equivalents flow 
from the recently identified ER membrane protein Ero1p to 
secretory proteins. The reaction is catalyzed by the protein 
disulphide isomerase (PDI) [104]. 
Furthermore, very little information is available on the 
effects of different pathological conditions on the thiol 
metabolism and redox folding in the ER. For instance, when 
Nardai et al. [105] were examining the role of molecular 
chaperones in the cellular pathology of diabetes mellitus, 
they found that the ER redox environment moved to a more 
reducing state. This could be of major importance in the 
pathophysiology of the late-onset complications of the 
disease. 
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3.2.5 Nucleus 
 
Although the role of nuclear GSH in the synthesis of DNA 
[55] and in protection against oxidative damage or ionizing 
radiation [106] is well established, little is known about the 
concentration of GSH in the nucleus and its regulation. This 
is due to two main factors. The first is methodological: it is 
impossible to determine the nuclear concentration of GSH 
using standard cell fractionation and analytical approaches 
(for a review see Söderdahl et al. [107]) In view of this 
problem, in the present thesis we used confocal microscopy 
(see Material and Methods). 
The second factor is that most, if not all, of the reports share 
the common view of nuclear GSH distribution in a static 
situation. Cells are usually studied under steady state 
conditions i.e. when they are confluent (G0/G1 phase of the 
cell cycle). The nuclear membrane dissolves during mitosis 
and is formed again around newly replicated DNA packed in 
chromosomes; this spectacular change involves a variety of 
regulatory mechanisms. Therefore, if the nuclear GSH 
distribution is studied, the cell cycle physiology should be 
carefully considered.  
A number of reports underscore the important role that GSH 
plays in cell proliferation but it is not clear which is the exact 
nature of its intervention further from its contribution in DNA 
and protein synthesis.  
 The role of GSH in cell cycle regulation has been addressed 
mainly from the point of view of its overall cellular content. 
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This is surprising since it is in the nucleus where most cell 
cycle progression events take place. The nucleus changes 
dramatically during the different phases of cell cycle, and 
failing to consider the corresponding changes in its redox 
environment could confer an important disadvantage in 
elucidating the actual importance of glutathione in the 
control of cell proliferation.  
To our knowledge there is a lack of information about the 
cellular distribution of glutathione during the different 
phases of the cell cycle and the possible correlation between 
cellular growth and nuclear GSH levels.  
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II OBJECTIVES 
The main objective of the present thesis was to 
elucidate the importance of glutathione and its nuclear pool 
in the proliferation of cell lines with different inherent 
proliferative capacity, origin and differentiation level. 
Specific goals: 
1. Elucidation of the role of glutathione as a driving force for 
cell cycle progression., with an emphasis on the 
implication of the relationship between glutathione and 
telomerase activity 
2. Revealing the changes in the cellular/nuclear distribution 
of the glutathione along the cell cycle 
3. Disclosing the consequences of the depletion of the 
nuclear glutathione on the cell cycle progression. 
4. Exploring the possible mechanism involved in the 
sequestration of the glutathione to the nucleus and the 
potential implication of the Bcl-2 in this process. 
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1. MATERIALS 
1.1. Experimental model 
This work was entirely performed in cellular model 
that included: 
• established cell lines (a gift from Mr. Rene Fisher, ETH, 
Zurich, originally purchased from ATCC, USA) 
1. 3T3 fibroblasts 
2. MCF7 WT 
3. MCF7 Bcl-2, transfected with Bcl-2 oncogene 
• embryonic neural cell culture 
3T3 fibroblasts were previously used by our group in 
the study of the relationship between cellular glutathione 
levels and telomerase activity [1], so it was the cell type of 
choice in this work.  
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Cancer cell line, MCF7 (bcl2 wild type), allowed us to 
study the implication of the GSH and its 
compartmentalization in the highly proliferating cellular 
model. In addition, it has been demonstrated that 
overexpression of Bcl-2 induces higher cellular levels of GSH 
and its nuclear compartmentalization [2-4]. Therefore, an 
analogue that over expresses Bcl-2, MCF7 (bcl2+/+), was 
included in this study.  
Embryonic neural cell culture gave us the insight in 
the significance of our findings in non proliferative model. 
Moreover, this election of cellular models permitted us to 
challenge our hypothesis in three different species: mouse, 
human and rat.  
1.1.1. 3T3 fibroblasts 
The 3T3 Swiss is adherent cell line of embryonic 
fibroblasts. It was established by G. Todaro and H. Green in 
1962 from disaggregated Swiss mouse embryos. The cells 
are contact inhibited. 
3T3 fibroblasts were maintained and subcultured 
according to ATCC recommendations (available at 
www.atcc.com). Briefly, cells were maintained in Dulbecco's 
modified Eagle's medium (DMEM) (Gibco Invitrogen) 
supplemented with 10% foetal calf serum (Gibco Invitrogen) 
and antibiotics (25 U/ml penicillin, 25 µg/ml streptomycin), 
and 0.3 µg/ml amphotericin B (Sigma-Aldrich) in 5% CO2 in 
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air at 37°C. Cells were subcultured before they reach 
confluence in 1:5 ratio, and medium was changed 2 times 
per week. For experiments, cells were plated in 25 or 75 cm2 
flasks (Nunc, TPP), or, for confocal microscopy, in 2cm
2
 LAB-
TEK II chambered cover glass (Nunc) at the density of 20 
000 cells/cm2.  
1.1.2. MCF7 
MCF7 are adherent epithelial cells obtained by pleural 
effusion of mammary gland of a 69 year old caucasic female 
patient with metastatic adenocarcinoma. The MCF7 line 
retains several characteristics of differentiated mammary 
epithelium including ability to process estradiol via 
cytoplasmic estrogen receptors and the capability of forming 
domes. 
Transfection of MCF7 with human oncogen Bcl-2 
resulted in an analogue cell line over expressing Bcl-2: MCF7 
bcl2.  
MCF7 cell lines were maintained and subcultured 
according to ATCC recommendations (available at 
www.atcc.org). Briefly, cells were maintained in Iscove’s 
modified Dulbeco’s medium (IMDM) (Gibco Invitrogen) 
supplemented with 10% foetal calf serum (Gibco 
Invitrogen), antibiotics (25 U/ml penicillin, 25 µg/ml 
streptomycin) and in 5% CO2 in air at 37°C. Medium was 
renewed 2-3 times per week and cells were subcultured in 
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1:10 ratio. For experiments, cells were plated in 25 or 75 
cm2 flasks (Nunc, TPP), or, for confocal microscopy, in 2cm
2
 
LAB-TEK II chambered cover glass (Nunc) at the density of 
10 000 cells/cm2.  
1.1.3. Embryonic neural cell cultures 
The Wistar rats were sacrificed at 14th day of 
gestation, and foetal neurons were isolated as described by 
Valles et al. [5] 
Briefly, the homogenate of the foetal brain obtained 
by the careful disagreggation in DMEM (Gibco Invitrogen) 
supplemented with 10% FBS (Gibco Invitrogen) and 1% 
penicillin-streptomycin (Sigma-Aldrich), was filtered through 
a nylon mesh (pore size of 90 µm). The suspension obtained 
was plated in poly-L-Lysine (Sigma-Aldrich) pre-coated 
flasks at a density of 5x104 cells/mm2, and cells were grown 
in a humidified atmosphere of 5% CO2 and 95% air at 37ºC.  
The medium was changed after 1h to discard dead cells and 
tissue particles. To prevent non-neural proliferation cytosine-
β-D-arabinofuranoside [5µM] was added on the 4th day of 
culture, and 24h afterwards half of the culture medium was 
changed. The level of glial contamination was defined by 
immunocitochemistry with anti-GFAP (glial fibrillary acidic 
protein) and anti-MAP2 (microtubule associated protein 2) 
and was less than 3%.  
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1.2. EQUIPMENT 
Centrifuges 
SORVALL, model GLC-1 and 
HERAEUS, model Sepatech megafuge 1.0 R, for low speed 
centrifugations 
HERAEUS, model Sepatech Biofuge 17RS for high speed 
centrifugations 
Spectrophotometer: KONTRON, model Uvikon 810 
 Autoclave: SELECTA, model Autester-G. Owen: HERAEUS 
Instruments 
Magnetic stirrer: SELECTA, model Agimatic-S 
pH-meter: CRISON, model Microph 2001, electrode: 
INGLOD. 
Fluorimeter: PERKIN ELMER, model LS 50B. 
Precision scales: SALTER, model HA-120M, SARTORIUS, 
model PT 1200. 
Water purification system: MILLIPORE, models Milli-Q and 
Milli-RO. 
Tanks for electrophoresis: BIORAD, model Mini-PROTEAN 
3 Cell 
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Tanks for electrotransference: BIORAD, model Mini 
Trans-Blot Cell. 
Power supply for electrophoresis: SIGMA, model PS 250-
2, BIORAD, model 200/2.0 Power Supply. 
Image analysis system: FUJIFILM, modelo LAS-1000 plus. 
H.P.L.C.  
The device used includes: 
-2 pumps: WATERS model 510. 
-injector PHARMACIA LKB, model 2157. 
- UV detector WATERS, model 441, at the constant wave 
length of 365 nm. 
-Computer IBM XT model 286 with integrator –equipment 
control 
-Chromatography column WATERS, model Spherisorb 
aminated, 20 X 0.46 cm and with particle diameter 5 µm  
Microscopes: Zeiss, inverted microscope, Nikon SE 
Hoods: Telstar AV-30/70, Cultair BC 100 
Incubators: Napco 5415 
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Flow citometer: EPICS PROFILE II (Counter Electronics, 
Hialeah, FL, USA) with software E 11/94 version 4.0 EPICS, 
equipped with argon laser
Confocal microscope: Leica TCS-SP2 confocal laser 
scanning unit equipped with argon and helium-neon laser 
beams and attached to a Leica DM1RB inverted microscope.   
Thermo cycler: i Cycler BIO-RAD 
 
1.3. MATERIAL 
1.3.1. Material and reagents for general use 
Protein determinations  
“Bradford Reagent” BIORAD  
“Lowry” reagent, Sigma 
Folin-Ciocalteu’s phenol reagent, 2N, Sigma 
Western Blotts developing 
-“Protoblot Western Blot AP System”, Promega, for the use 
of horse radish peroxidase (HRP) conjugated anti bodies.  
-LumiGLOl® Reagent (Cell Signalling Technologies).    
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Enzymes 
Glutathion-S-transferase (SIGMA). 
Fluorochromes 
-CellTracker green 5-chloromethylfluorescein diacetate 
(CMFDA) (Molecular probes) 
-propidium iodide (PI) (Sigma) 
-MitoTracker Red 580 (Molecular probes) 
-Hoechst 33342 (Sigma) 
-2',7'-dichlorodihydrofluorescein diacetate (2',7'-
dichlorofluorescin diacetate; H2DCFDA) (Molecular probes) 
-Dihydroethidium (Hydroethidine, HE) (Molecular probes) 
Kits 
-Telomerase activity detection kit (Roche) 
-Nuclear Extraction Kit (Active Motif North America) 
-Oxy Blot protein Oxidation Detection Kit (Chemicon 
International) 
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Other chemicals  
Perchloric acid 60% (PCA), sodium acetate, 
baptholphenanthrolinesulfonate (BPDS), N-ethylmaleimide 
(NEM), potasium hydroxide (KOH), 2-[N-
cyclohexylamino]ethanesulfonic acid (CHES), iodoacetic acid, 
meta-cresol purple, 1-fluoro-2, 4-dinitrobenzene (FDNB), 
reduced glutathione (GSH), glutathione ester, glutathione 
disulfide-reduced glutathione (GSSG), γ-Glu-Glu, H2O2, 
potassium phosphate, 1-chloro-2,4-dinitrobenzene (CDNB), 
sodium chloride, ethylenediaminetetraacetic acid (EDTA), 
ethylene glycol tetraacetic acid (EGTA), 3-(N-
morpholino)propanesulfonic acid (MOPS), (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
trishydroxymethylaminomethane (TRIS), glycine, 
acrylamide, bis-acrylamide, acetic acid, sucrose, hydrichloric 
acid (HCl),sodium dodecyl sulfate (SDS), bromophenol blue, 
coomassie brilliant blue (CBB), dimethyl sulfoxide (DMSO), 
2-mercaptoethanol (β-mercaptoethanol), N,N,N’,N’-
tetramethylethylenediamine (TEMED), bovine serum albumin 
(BSA), ammonium persulfate (APS), dithiothreitol (DTT), 
phenylmethylsulphonyl fluoride (PMSF), ethanol, methanol, 
Tween 20, paraformaldehyde, protease inhibitor, phosphate 
buffered saline (PBS), diethil maleate (DEM), buthionine 
sulfoximine (BSO), Carbonyl cyanide m-
chlorophenylhydrazone (CCCP), carbonyl cyanide p-
trifluoromethoxy p henyl hydrazone (FCCP). Los reactivos se 
obtuvieron de las firmas: Sigma-Aldrich Química (Spain), 
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Boehringer Manheim S.A. (Germany), Panreac, Merck 
Biochemica (Germany). 
 
1.3.2. Material and reagents for cell culture 
The sterile material and reagents used in cell culture 
were the following: 
TPP 
Flasks 25cm2, flasks 75cm2, Flasks 150cm2, Tube 
15mL, Tube 50mL, Petri dish 60mm, Pipettes 10mL, Pipettes 
25mL, 6 well plates, 12 well plates, 24 well plates, 
Cryotubes 2mL, Cell scrapers 24cm, Sterile filters 0,22 μm  
Nalgene 
Sterile filters 0,22 μm, cellulose, Sterile filters 0,22 
μm, nylon 
Corning 
Cell Scrapers 25cm 
Nunc 
Cryotubes 1,8mL , LAB-TEK II chambered cover glass 
W/Cover#1,5 borosilicate sterile for confocal microscopy 
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Invitrogen 
Iscove’s modified Dulbecco’s Medium 
(IMDM)+GlutaMAX (L-Alanyl-L-Glutamine), Dulbecco’s 
Modified Eagle’s Medium (4500 mg/L glucose, 4mM L-
glutamine and 110 mg/L sodium pyruvate), (DMEM), 
Trypsin-EDTA (0.05% Trypsin with EDTA 4Na) 1X, Foetal 
Bovine Serum Origin: EU Approved (South American) , PBS 
sterile, liquid, PBS tablets, Fungizone (Amphotericin B) 
Sigma 
DMEM, Penicillin-Streptomycin, Trypsin-EDTA, Poli-L-
lysine, Dimethyl sulfoxide (DMSO) 1L 
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2. METHODS 
 
2.1. DETERMINATION OF THE PROTEIN CONTENT 
OF THE SAMPLES 
2.1.1. Bradford method 
Protocol 
1. Prepare the BSA dilutions for standard curve. Use 
at least 5 known concentrations e.g. 5mg/ml, 2,5 mg/ml, 
1,25 mg/ml, 0,5 mg/ml, 0,25 mg/ml, 0, 125 mg/ml. BSA 
dilutions can be stored at -20ºC for weeks. 
2. Prepare 1:5 water dilution of Bradford reagent for 
all samples and standard curve (at least 5 points), 1 ml per 
sample.  
3. Load microcuvettes with 998μl of Bradford dilution 
and read the absorbance at 595 nm. This value will be used 
as a blanc, and each sample has its own. 
4. Add 2μl of the sample or the known concentration 
of BSA to the cuvette and read the absorbance again.  
 
 
 56  
                                                  III Materials and methods 
Calculations 
Known concentrations of BSA and its ΔAbs (see below) 
are used to built the standard curve where the values of 
sample ΔAbs will be interpolated. The curve equation serves 
to calculate the protein concentration in the sample. 
 
ΔAbs= Abs sample - Abs blanc
 
2.1.2. Lowry method 
Protocol 
1. Reconstitute “Lowry” reagent 
1 vial + 40 ml H2Obidestilled  
“Lowry” reagent can be stored diluted for weeks  
2. Prepare Folin: 18 ml Folin (SIGMA) + 90 ml H2Obidestilled 
3. Prepare the standard curve (see “Bradford” method) and 
the samples in the test tube: 
4. 20 μl sample/BSA + 980 μl H2O bidestilled = 1 ml  
5.  Add Lowry reagent:  
6. 1 ml Lowry + 1 ml sample/BSA = 2 ml (V final) 
7. Prepare the blanc: 1 ml of H2O bidestilled  
8. Incubate in the dark for 20 minutes. 
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9. Add 500 μl of Folin per sample and vortex briefly 
10. Incubate in the dark for another 30 minutes. 
11. Load the sample in the macrocuvette and read the 
absorbance at 660 nm. 
Calculations 
The protein concentrations of the sample are 
calculated in the same way as for Bradford method. 
 
2.2. DETERMINATION OF THE GLUTATHIONE 
LEVEL 
The level of reduced glutathione (GSH) was measured 
spectrophotometrically using the glutathione-S-transferase 
assay, while the determination of total and glutathione 
disulfide-oxidized glutathione (GSSG) was carried out by 
high-performance liquid chromatography.  
Preparation of the acid extract of the cells 
For both techniques, the procedure of obtaining the 
extracts is similar: 
1. Aspirate the cell culture medium. 
2. Wash the cells with the cold PBS (2ml for 25cm2 flasc) 
and aspirate. 
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3. Add directly to the cells: 
• PCA 6%, EDTA 0.2mM for reduced GSH 
• PCA 6%, BPDS 1mM for total glutathione 
• PCA 6%, BPDS 1mM, NEM 20mM 
Not more than 40μl/100000 cells. 
4. Collect the extract with the cell scraper in an eppendorf. 
5. Centrifuge the extracts at 13000 g, for 15 minutes at 
4ºC. 
6. Collect the supernatant – acid extract and measure its 
volume.  
7. Add to the pellet the same volume of 1N (NaOH) and 
incubate the sample in water bath at 50ºC to dissolve the 
proteins.  
Acid extract obtained was used for subsequent 
determination of the reduced GSH/total glutathione/GSSG 
depending on the acid used for the extraction. 
Protein content was determined by Bradford or by 
Lowry method. 
Preparation of the acid extract of the nuclei 
For the determination of the nuclear GSH and GSSG 
level, cell nuclei were isolated and acid extract prepared as 
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described for total cellular extract starting from the step 3. 
Nuclei were isolated by the following procedure: 
1. Aspirate the cell culture medium 
2. Wash the cells with the cold PBS 
3. Add directly to the cells the following buffer (200µl 
of the buffer/1X106cells) 
10 mM Hepes pH 7,9, 10 mM KCl, 1,5 mM MgCl2, 1 
mM DTT, Protease Inhibitor cocktail 
4. Collect into an eppendorf with a cell scraper and 
incubate on ice for 10 min. 
5. Add IGEPAL (NP-40) and vortex 
6. Centrifuge for 30 sec., at 4ºC and 14000 rpm 
7. Discard the supernatant and proceed adding the 
corresponding acid buffers as described previously for the 
intact cells starting from the step 3.  
2.2.1. Glutathione-S-transferase essay for the 
determination of reduced GSH by spectrophotometry 
Preparation of the acid extract 
The preparation of the sample for the determination of 
the reduced glutathione is as described previously. 
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Protocol 
1. Prepare CDNB in ethanol at 2 mg/ml and isolate from 
light. 
2. Put in a micro cuvette: 
3. 80 μl acid extract (supernatant) + 10 μl CDNB + 770 μl 
buffer (KPI 0.2 mM + EDTA 2 mM ph=7, at room 
temperature)  
4. Measure the blanc of the samples at 340 nm. 
5. Add 10 μl of the glutathione-s-transferase (starts the 
enzymatic reaction) on the plastic stick and than to the 
cuvette and remove gently. 
6. Incubate until the reaction reaches its final point (for 45 
min. aprox) and read the absorbance again.  
Calculations 
- Level of GSH by the cell number: 
( )
molesGSHV
V
VblancAbssampleAbs
tvolumeacidextrac
mesamplevolu
cubetteGSHGSH μ=+− *
6.9
 
-Level of GSH by protein content 
 ( )
ml
molesGSH
V
VblancAbssampleAbs
mesamplevolu
cubetteGSHGSH μ=+−
6.9
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2.2.2. Determination of the total glutathione level by 
H.P.L.C. 
The total glutathione level in the cell was measured by the 
H.P.L.C., according to the method of Reed et al. [6] 
Preparation of the acid extract 
The preparation of the sample for the determination of the 
total glutathione is as described previously. 
Samples could be stored at -20º C until derivatization. 
Derivatization of the sample 
1. To 200 µL of the acid supernatant is added 20 µL of the 
internal standard (γ-glutamil-glutamato 1 mM in PCA at 
0.3%) and 20 µL of iodoacetic acid 1 M dissolved in m-cresol  
purple 0.2 mM (pH indicator) 
2. The sample pH is adjusted to 8.5–9 using KOH 3 M CHES 
0.3M buffer and incubated 10 minutes at room temperature 
in the dark. 
3. 400 µL of 1% 1-fluor dinitrobenzene in absolute ethanol 
is added to a sample and is maintained in the dark at 4ºC for 
at least 24h. At this point, samples are stable at 4ºC for 
weeks. 
4. The samples are centrifuged at 15000g for 15 minutes at 
4º C and the dilution that is going to be injected in the HPLC 
is prepared: 50 µL of the supernatant and 270 µL of the 
mixture methanol – water (800:200). 
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Chromatography 
For the analysis of the total glutathione content, 80 µL 
of the sample containing solution is injected in the HPLC. 
Mobile phase contains 2 solvents:  
• Solvent A: is 80% methanol in bi-distilled water. 
• Solvent B: is acetic/acetate buffer 0.5 M in 64% 
methanol.  
The procedure is performed at the constant flow of 1 
ml/minute. The substances of interest are eluted using a 
gradient: 
 - The mobile phase is maintained for 5 minutes at 20% of 
solvent B and 80% of solvent A. 
 - After this period the solvent B concentration starts to 
increase linearly, to reach 99% after 15 minutes.  
 - This concentration of each solvent is maintained from 5-10 
minutes depending on the elution time of the last substance. 
 - Once the last substance of interest is eluted, the column 
has to be re equilibrated. The initial condition of solvents has 
to be reached (20% of B and 80 % of A) and maintained for 
15 minutes. 
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Calculations 
GSH and GSSG concentrations are calculated from a 
chromatogram, on the basis of the known concentration of 
internal standard which has been added to each sample in 
the process of derivatization. The internal standard used is 
γ-glutamil-glutamate, previously calibrated against the 
standards of known concentrations of GSH and GSSG 
determined in the enzymatic reaction. The GSH is calibrated 
by the method based on glutathione s-transferase (see 
above) and for GSSG the enzymatic reaction used involved 
glutathione reductase. 
Total cellular glutathione is calculated as the sum of 
the GSH concentration and double GSSG concentration. 
 [GSH]= Glutation total -(2X GSSG)
 
 
2.3. DETERMINATION OF THE LEVEL OF THE 
OXIDASED GLUTATHIONE (GSSG)  
For GSSG determination the protocol described by 
Asensi and col. [7] was performed. It is based on separation 
of dinitrobenzene derivatives by H.P.L.C. and their detection 
at 365 nm. 
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Preparation of the acid extract 
The samples for the determination of GSSG were 
obtained as described previously. The samples could be 
stored at -20ºC until analysis. 
Derivatization 
1. To 200 µL of the acid supernatant is added 20 µL of the 
internal standard (γ-glutamil-glutamato 1 mM in PCA at 
0.3%) and 20 µL of m-cresol purple 0.2 mM (pH indicator) 
2. The sample pH is adjusted to 8.5–9 using KOH 3 M CHES 
0.3M buffer.  
3. The samples are centrifuged at 15000g for 15 minutes at 
4º C.  
4. 25 µL of the supernatant is mixed with 50µL of 1-fluor 
dinitrobenzene at 1% in absolute ethanol. 
5. The sample is incubated for 45 minutes in dark and is 
desiccated in the speed-vac.  
6. Dried samples can be stored for months at –20ºC until its 
analysis by HPLC. 
7. Just before the injection samples are resuspended in 200 
µl of solvent A. 
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Calculations 
Calculation of the GSSG concentration in the sample is 
done in the function of the calibration of the solutions of the 
standards of known GSSG concentrations against the 
internal standard concentration.  
 
2.4. TELOMERASE ACTIVITY DETECTION  
Sample preparation 
1. Aspirate the cell culture medium. 
2. Wash the cells with the PBS (2ml for 25cm2 flasc) and   
aspirate. 
3. Detach the cells by trypsinization. 
4. Collect the cells with cold PBS to a corning tube. 
Maintain on ice 
5. Centrifuge at 425 g for 6 minutes at 4ºC 
6. Discard the supernatant and resuspend the cells in 1ml of 
cold PBS.  
7. Count the cells and pass an aliquot containing at least 
200000 cells to an eppendorf. 
8. Centrifuge at 425 g for 6 minutes at 4ºC. 
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9. Eliminate the supernatant and store the pellet at –80ºC 
until use. 
The telomerase activity in this work was determined 
by TeloTAGGG Telomerase PCR ELISAPLUS kit – a photometric 
enzyme immunoassay for quantitative determination of 
telomerase activity, utilizing the Telomeric Repeat 
Amplification Protocol.  The test is performed in three steps: 
elongation, PCR, and ELISA. In the first step, telomerase 
from the sample adds telomeric repeats (TTAGGG) to the 3’ 
–end of the biotin-labeled synthetic primers. This elongation 
products, together with the internal standard (IS-provided 
by the kit manufacturer) included in the same reaction 
vessel, are amplified by the PCR reaction. The positive 
control (known concentration of telomerase elongation 
product with 8 telomeric repeats) is included in the kit. The 
samples are split in two aliquots and they are denatured and 
hybridized separately to digoxigenin -labeled-detection 
probes, specific for the telomeric repeats or the internal 
standard, and immobilized via the biotin label to a 
streptavidin-coated microplate. The quantification of the 
amplicons is performed by the detection with an anti-
digoxigenin antibody conjugated to horsradish-peroxidase 
and the sensitive peroxidase substrate. The absorbance is 
read at 450nm and the relative telomerase activity is 
obtained using the following formula: 
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100
/)(
( /) X
AAA
AAARTA
lateISconroltemprlysisbuffeplatecontroltem
sampleISdsampleheattreatesample
−
−=  
 
 2.5. ANALYSIS OF THE PROTEIN EXPRESSION BY 
WESTERN BLOTTING  
2.5.1. Immunoblot analysis of the cell cycle proteins 
Preparation of total cellular protein lysate for western 
blotting  
Lyses buffer is prepared on the day and contains: 
1. TRIS/SDS/Glicerol (3,766ml) 
• 83ml of TRIS (0,927g in 100ml of H2O, ph 6,8) 
• 2g of SDS 
• 10ml of GLICEROL 
(This buffer is kept in the fridge until use.)  
2. Na Ortovanadate 200mM (optional) (40µl)  
3. Protease inhibitor cocktail (Sigma) (40µl) 
Protocol 
1. Cells are washed twice with ice cold PBS, and the remains 
of PBS aspirated 
2. Lysis buffer is added directly to the cells and left on ice 
for 30 min. 
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2304505-7 days
25035096 h
23030072 h
20023022548 h
1307024 h
10090606 h
Primary
neurons3T3
MCF7 +
MCF7 -
Time of
culture
Table II 1. Volumes of lyses buffer (µl) used for protein extraction
3. Lysates were collected with cell scraper to eppendorfs 
and incubated at 90ºC for 10 min. 
4. Samples were kept at -20ºC until use 
Protein concentration was determined by Lowry or Bradford 
method as described previously. 
SDS/PAGE electrophoresis 
Samples were separated by SDS/PAGE electrophoresis 
in polyacrylamide gels with 0,1% of SDS acording to the 
standard protocol. Stacking gel contained 4% 
polyacrylamide in a Tris buffer pH 6,8, while resolving gel 
was prepared as 10-12,5% polycacrylamide in Tris buffer pH 
8,8. The gels were sumerged in the Tris-Glycine buffer (25 
mM Tris, 200 mM Glicina, 0,1% SDS, pH 8,3), and an 
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electric current of the constant voltage (100V) was applied 
across the gel for at least 2h. 
After electrophoresis, the proteins were electroblotted 
to 0.2-µm-pore-size nitrocellulose membrane (Schelider & 
Schuel, USA) by wet blotting method during 2h at 4ºC in 
transfer buffer (25 mM Tris, 192 mM Glicina, Metanol 20% 
v/v, pH 8,3) using Mini-protean II system (Bio-Rad, USA).  
The proteins were visualised by the following 
immunostaining protocol: 
1. Blocking. The membranes were incubated in blocking 
solution [5% (w/v) non-fat dry milk with 0.05% (v/v) Tween 
20], for 1 h at room temperature with orbital shaking. 
2. Immunostaining. Following three washes of 5 minutes 
with TBST [25 mM Tris/HCl (pH 7.5)/0.15 M NaCl/0.1% 
(v/v) Tween 20], blots were incubated with embryonic 
antibodies (table III 2.) in TTBS containing 5% BSA 
overnight at 4ºC or 1h at room temperature. Thereafter, the 
blots were washed again with TBST and further incubated 
with the coresponding  secondary antibody (table III 2.) 
conjugated to horseradish peroxidase (Santa Cruz) for 1h at 
room temperature.  
3. Detection. Finally, blots were washed with TBST and 
detection was carried out using the chemiluminescent 
luminol reagent developed by using the LumiGLOl® reagent 
as specified by the manufacturer (Cell Signaling 
Technologies) and susequently detected by CCD camera. 
 70  
                                                  III Materials and methods 
Digital images created were stored as tif documents. 
Alternativelly, a sensitive sheet of photographic film was 
placed against the membrane, and exposure to the light 
from the reaction created an image of the antibodies bound 
to the blot. The films were scaned using PrestoPage manager 
para EPSON, and stored as digital TIF documents. 
4. Quantification. The intensity of the bands was measured 
by densitometry using the GeneGenius system and the 
GeneTools analysis software (Syngene). 
2.5.2. Immunoblot analysis of the level of 
glutationilation and oxidation of nuclear proteins. 
Preparation of nuclear protein lysate for western 
blotting  
3T3 cells were subjected to nuclear protein extraction, 
following the instructions of the Nuclear Extract Kit (Active 
Motif North America).  
The efficiency of nuclear extraction was determined by 
measuring the relative activity of a cytosolic enzyme, lactate 
dehydrogenase, in nuclei and in whole cell. Nuclear lactate 
deshydrogenase activity was less than 1.2 % of the total 
cellular activity. Nuclear lysates obtained were used for 
determination of protein oxidation and protein 
glutathionation.  
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Determination of nuclear protein oxidation 
To measure the level of nuclear protein oxidation 
nuclear lysates were derivatised, and the western blotting 
was performed according to the recommendation of the 
manufacturer. The level of nuclear protein oxidation was 
determined by the Oxy Blot protein Oxidation Detection Kit 
(Chemicon International) which detects carbonylated 
proteins. 
The oxidative modification of the proteins by the 
action of free radicals and other reactive oxidative species, 
e.g. hydroxynonenal, occur both in pathological and 
physiological processes. As a consequence of these 
modifications, carbonyl groups are introduced in the chains 
of amino acids in a specific manner.  
Carbonyl groups are derivatized to 2,4-
dinitrophenilhydrazone (DNP-hydrazone) by its reaction with 
2,4-dinitrophenilhidrazine (DNPH). The derivatized samples 
are separated by electrophoresis in a acrilamide gel followed 
by western blotting and immunodetection protocols as 
described previously.  
Determination of nuclear protein glutathiolation 
Nuclear lysates were obtained as described previously 
in the absence of reductive agents .  
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Western blotting. 40 µg of samples was loaded and 
electrophoresis procedure was performed as usual. Addition 
of any reducing agents was avoided. Membrane was blocked 
in 5% BSA in TBST for 1h at room temperature, and probed 
against the anti-glutathione antibody at the dilution 1:1000 
over night at 4ºC, and secondary antibody at 1:10 000 for 
1h at room temperature. 
• Embryonic antibody: IgG2a monoclonal mouse antibody 
against glutathione-protein complexes, Virogen, product 
number: 101-A-250.  
• Secondary antibody: goat anti-Mouse  IgG, Calbiochem 
(401215) conjugated to horseradish peroxidase 
Detection procedure was performed using Amersham 
RPN 2106 ECL Western Blotting Detection Reagent. 
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 Table III. 2. Description of antibodies used in western blotting 
procedures
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2.6. FLOW CITOMETRY STUDIES 
In this work flow citometry was used for cell cycle 
study, and apoptosis detection. Fluorochromes were excited 
with an argon laser tuned at 488 nm. Forward-angle and 
right-angle light scattering were measured. Samples were 
acquired for 11000-15000 individual cells.  
2.6.1. Cell cycle 
Cell cycle phases were determined using the 
fluorescent DNA dye propidium iodide (PI) (final 
concentration, 5µg/mL) at 630 nm fluorescence emission. 
The specific union between PI and DNA allows the 
quantification of the DNA content per cell, and thus the 
estimation of the proliferative activity of the cell population, 
apoptosis level and the portion of the dead cells (debris).  
 
 
 
 
 
 
 
Figure XX. Typical DNA content histogram defining the phases 
of cell cycle
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Sample preparation 
1. Collect the cell culture medium to the test tube (on ice) 
and wash the cells twice with PBS, collecting it to the same 
test tube (any floating cells are collected this way)  
2. Add trypsine to the cells (1ml for 25cm2 flask) and 
incubate at 37ºC, 5% CO2 until the cells detach. 
 Maintain on ice: 
3. Collect the detached cells with the ice cold PBS to the 
same test tube. Be sure to collect all the cells. 
4. Centrifuge at 425g for 6 minutes at 4ºC. 
5. Eliminate the supernatant and resuspend the pellet in 
1ml of PBS. 
6. Count the cells. Cell counts of each sample were obtained 
using a conventional Neu-bauer chamber and optical 
inverted microscope. 
7. Put the aliquot with 1x106 cells in the tube for flow 
citometry. 
8. Centrifuge again at 425g for 6 minutes at 4ºC. 
9.  Eliminate the supernatant. 
10. Fix the cells in ice cold ethanol vortexing gently while 
adding 2ml of ethanol drop by drop to 1x106 cells.  
11. Allow the sample to rest at –20ºC, at least over night 
before the staining and flow cytometry analysis.  
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Staining procedure 
1. Warm the PBS to room temperature. 
2. Centrifuge the samples in ethanol at 425g for 6 min at 
room temperature. 
3. Eliminate ethanol carefully and resuspend  each sample 
in 1ml of PBS. 
4. Centrifuge the samples again at 425g for 6 min at room 
temperature. 
5. While centrifuging prepare the staining solution for all the 
samples to be analysed, 1 ml/1X106 cells 
- 50 μl propidium iodide ([1 mg/ml]stock), 
- 25 μl RNAsa ([1 mg/ml]stock), 
- 50 μl 10% IGEPAL (NP 40), 
- 875 μl of pre-warmed PBS 
6. Eliminate the supernatant and resuspend the pellet in 1 
ml of staining solution per 1X106 cells 
7. Incubate for 1h in the dark at room temperature, or 24h 
at 2-4ºC, before flow citometry analysis of the samples. 
Flow citometry analysis of the DNA content in 
the monolayer cell cultures. Modified protocol used for 
embryonic neural culture. 
Prepare hypotonic propidium solution: 
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Sodium citrate-5H2O: 100 mg 
Triton X-100: 100 μl 
Propidium iodide: 5 mg 
H2O bi-distilled: 100 ml 
Maintain in the fridge isolated from the light. Add 
RNAse on the day at the amount of 25 μl per ml of cell nuclei 
suspension. 
Protocol 
1. Collect the cell culture medium containing floating cells 
carefully to avoid detaching of the cells in monolayer and put 
it to the test tube.  
2. Add 2 ml (for 30cm2 Petri dish) of the hypotonic solution 
to the attached cells and maintain on ice. 
3. Centrifuge the floating cells at 900 rpm, for 3 minutes at 
25ºC  
4. Eliminate the supernatant and resuspend the pellet in 
500 μl of hypotonic solution. Add this cell suspension to the 
monolayer prepared for the incubation.  
5. Incubate at 4ºC for 12-24h, making sure that the plates 
are maintained perfectly horizontal. 
6. Resuspend with the Pasteur pipette the nuclei liberated 
by the hypotonic solution.  
7. Filter through the nylon mash (diameter 35-60 μm). 
8. Analyze by the flow citometry immediately   
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2.6.2. Detection of the apoptosis by flow citometry  
In this work the percentage of apoptotic cells in cell 
population was detected by two different approaches: 
 
 
 
 
 
 
 
 
Figure III 1. Schematics of apoptosis detection by DNA content. 
Adapted from www.compucyte.com. 
• presence of fragmented DNA defined by the subG1 
fraction in DNA content histogram obtained by the propidium 
iodide staining (Fig. III 1.) 
• double staining with annexin V, Alexa Fluor ® 488 
conjugate (Molecular probes) that has a high affinity for 
phosphatidyl-serine exposed on the surface of apoptotic cells 
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and PI. The cells are considered apoptotic if they were 
annexin V positive and PI negative. (Fig. III 2.) 
 
 
 
 
 
 
 
Protocol 
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Figure III 2. Schematics of apoptosis measurement by Annexin
V/PI staining. Adapted from www.compucyte.com
1. The cell culture medium and PBS used to wash the 
cells were pulled together to a test tube to collect the 
floating cells. Following trypsinization, cells were centrifuged 
as described before, resuspended in annexin-binding buffer 
(AB, 10mM HEPES, 140mM NaCl, and 2,5mM CaCl2, pH 7,4) 
and counted.  
2. The suspension containing 100000 cells in 100 µl of AB 
was loaded with 4 µl of annexin V and incubated for 10min 
at room temperature in the dark 
3. 10 µl of PI (1mg/ml) was added to cells and incubated for 
another 5 minutes under the same conditions. Finalized the 
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incubation period, 400 µl of AB per sample was added and 
immediately analyzed.  
4. Flow citometry was used to analyze 11000 cells/per 
sample, and it was possible to discriminate between 4 
groups of cells (table III.3.) 
 
 
 
 
 
 
2.7. CONFOCAL MICROSCOPY  
The principle of confocal imaging invented by Marvin 
Minsky, and patented in 1957, is employed in all modern 
confocal microscopes. This technique enables visualization 
deep within both living and fixed cells and tissues. 
In a conventional fluorescence microscope, the entire 
specimen is exposed to light from a light source. This way, 
all parts of the specimen throughout the optical path will be 
excited and the fluorescence from whole sample will be 
detected by a photodetector or a camera. In confocal 
microscopy, the illumination is achieved by scanning one or 
HIGHHIGHLATE 
APOPTOSIS
LOWHIGHEARLY 
APOPTOSIS
HIGHLOWNECROTIC/
DEBRIS
LOWLOWALIVE
PIANNEXIN V
FLUOROCROME INTENSITY
CELL 
STATUS
Table III.3. Apoptosis detection by double staining with annexin v
and PI
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more focused beams of light, usually from a laser, across the 
specimen. The basic key to the confocal approach is the use 
of spatial filtering techniques to eliminate out-of-focus light 
or glare in specimens whose thickness exceeds the 
immediate plane of focus. Confocal microscopy offers the 
ability to control depth of field, elimination or reduction of 
background information away from the focal plane (that 
leads to image degradation), and the capability to collect 
serial of high-resolution images, termed optical sections. 
These images are produced in sequence through relatively 
thick sections or whole-mount specimens. Based on the 
optical section as the basic image unit, data can be collected 
from fixed and stained specimens in single, double, triple, or 
multiple-wavelength illumination modes, and the images 
collected with the various illumination and labeling strategies 
will be in register with each other. The design of 
temperature controlled chambers with the CO2 
suplementation and humidity control makes possible live cell 
imaging and long time-lapse sequences. Digital image 
processing methods applied to sequences of images allow 
obtaining of z-series (used in this work), and subsequent 
reconstruction of three-dimensional representation of 
specimens, as well as the time-sequence presentation of 3D 
data as four-dimensional imaging.  
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2.7.1. Visualisation of the GSH compartmentalization 
by confocal microscopy 
3T3 fibroblasts and MCF7 cells were maintained in 
culture as described previously and plated in 2cm
2
 LAB-TEK 
II chambered cover glass (Nunc) for 5 days, 72h, 48h, 24h, 
12h and 6h before the experiment, so cells in all phases of 
the cell cycle were dyed and analysed on the same day. 
Triple staining was performed: 2µg/ml propidium iodide (PI) 
(Sigma) to identify dead cells, 2µg/ml Hoechst (Sigma) to 
localize nuclei and 5µM CellTracker green 5-
chloromethylfluorescein diacetate (CMFDA) (Molecular 
probes), to detect GSH (specificity 95%). When indicated, 
mitochondria were stained with MitoTracker Red 580. Cells 
were first stained with 5µM CMFDA in cell culture medium for 
30 min., at 37ºC and 5% CO2. After washing with pre-
warmed cell culture medium, cells were left to rest for 30 
min at 37ºC and 5% CO
2
, in cell culture medium or, 
alternatively, were loaded with 250 nM MitoTracker Red 580 
(Molecular Probes). In the last 5 min of incubation 2 µg/ml 
Hoechst and 2 µg/ml PI were added. After incubation with 
the fluorochromes, staining solution was replaced with fresh 
pre-warmed cell culture medium and cells were analysed.  
The excitation wavelengths for fluorochromes were 
488 nm for CMFDA, 543 nm for IP, 364 nm for Hoechst and 
543 nm for MitoTracker Red 580. The emission aperture for 
fluorescence detection were 510-540 nm for CMFDA, 585-
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715 nm for PI, 380-485 for Hoechst and 575-650 nm for 
MitoTracker Red.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III 3. An example of microscopic confocal analysis of the 
intracellular distribution of GSH. Triple staining was performed on 
living 3T3 fibroblasts: Hoechst 33342 to localize nuclei (blue fluorescence, 
a), CMFDA to mark GSH, (green fluorescence, b) and PI to exclude dead 
cells (results not shown). Cells were maintained in the chamber provided 
with 5% CO2 at 37 °C. A representative Z axes series is shown. Each
panel represents one step in the Z-section series obtained beginning from
the nuclear apex (1) and progressing downward in 1 ± 0.2-µm
increments.
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Z-section series obtained beginning from nuclear apex 
and progressing down in 1±0.2µm increments (at least 10 
planes) were converted to maximum projection images to 
avoid subjectivity in the choice of plane to be analyzed (Fig. 
III 3.).  
The distributions of green CMFDA fluorescence (GSH 
levels) and blue Hoechst fluorescence (nuclei localisation) 
were analysed by profile and by area as follows.  
Fluorescence profile analysis. A cross section line of 
200±20µm was drawn through a cell field to compare the 
intensity and distribution of Hoechst (DNA) and CMFDA 
(GSH) fluorescence (Fig. III 4.).  
Fluorescence area analysis. Perimeters were drawn 
around the nucleus (according to the area marked with 
Hoechst) and around the entire cell excluding nucleus area 
(according to transmission image obtained by light 
microscopy) (Fig. III 5.).  
Nucleus/cytoplasm ratio for GSH in every cell analysed was 
established by dividing the mean of green CMFDA 
fluorescence of nuclear area by the mean of CMFDA 
fluorescence in cytoplasmic area. We calculated the 
nucleus/cytoplasm ratio (n/c) using CMFDA fluorescence in 3 
separate experiments (100 cells per condition). 
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Figure III 4. Fluorescence profile analysis. An example of the 
analysis of the fluorescence distribution by obtaining the profile of its 
intensity along the cross section line.
 
 
 
 
 
 
 
 
 
Figure III 5. Fluorescence area analysis. The perimeters were 
drown to define the nuclei stained blue by Hoechst 33342 (green and 
orange lines) and cytoplasmic area according to the transmission 
image (blue and turquoise lines)
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2.8. ATP depletion by mitochondrial uncoupling 
agent. The determination of the ATP level.  
3T3 fibroblasts were plated as usual and incubated for 
30 min-2h with freshly prepared 20µM FCCP (p-
trifluoromethoxy carbonyl cyanide phenyl hydrazone, 
Sigma), loaded with CMFDA, PI and Hoechst and analyzed 
by confocal microscopy as described before.  
The determination of the ATP level 
1. Wash the cells with cold PBS 
2. Add 2% PCA and collect with a cell scraper to an 
eppendorf. 
3. Centrifuge 10 min at 15000 rpm 
3. Collect the supernatant measuring the volume of 
the acid sample (Va). Use the pellet for the protein 
concentration determination, as described for glutathione 
determination. 
4. Neutralize with the KOH using ≈ 20µl of the 
indicator. Measure the volume of the neutralized sample 
(Vn). 
5. Prepare control and the sample for the ATP 
determination: 
Control: 1ml Coctail+1ml H2O 
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Sample: 1ml cocktail+ 0,9ml H2O+0,1ml sample 
Coctail: TRIS 0,1M pH 8 (10ml), MgCl2 0,1M (1ml), 
NADP 1% (1ml), glucose 0,01M (1ml), G6PDH (0,1ml) 
6. Measure the absorbance at 340 nm 
7. Add 10 µl of the hexokinase prepared in SO4(NH4)2 
(450 µl of SO4(NH4)2 and 50 µl of hexokinase). 
8. Measure the absorbance at 340nm at the final point 
of the reaction 
9. Calculate the ATP level in µmols/ml using the 
formula: 
 
levelATP
Va
VnOD =Δ *
1,0
1*
22,6
01,2*
 
 
2.9. GSH depletion by diethyl maleate (DEM) and 
butionine sulfoximine (BSO) 
Cells were plated as usual and after attaching to the 
plate (3-6h) the GSH was depleted. Our model of differential 
GSH depletion included 3T3 fibroblasts treated with: 
• 100 mM diethylmaleate (DEM) that depletes all cellular 
thiols in entire cell, including nuclear GSH  
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• 100mM DEM and 1mM GSH ester that enters the cell and 
protects it efficiently from GSH depletion induced by DEM 
• 10mM BSO that prevents the GSH synthesis in 24h 
affecting mostly cytosolic GSH 
GSH distribution was studied by fluorescence 
determination of its CMFDA conjugate using confocal 
microscopy and cell cycle by flow cytometry. 
 
2.10. Statistical analysis of the results 
The results presented in this thesis are expresed as a 
mean value ± standard deviation, with the number of 
experiments (n) indicated. If the normality of the data was 
confirmed, by Shapiro-Wilk test, for the comparison of two 
groups of the data student t test was used, while when 
comparing 3 and more groups ANOVA was applied. When 
statistical differences were observed, the Tuckey contrast 
was used. When the data did not follow the normal 
distribution, the mean values were compared with a non 
parametric test Kruskal-Wallis. The absence of the difference 
between mean values was considered the null hypothesis, 
and it was rejected when α≤0,05. When the statistical 
significance was confirmed, Mann-Witney test U was 
performed, and values of p<0,05 were accepted as 
significant.  
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I THE RELATIONSHIP BETWEEN GLUTATHIONE LEVELS 
AND TELOMERASE ACTIVITY, AND ITS 
CONSEQUENCES ON CELL PROLIFERATION, A 
UNIVERSAL PHENOMENON.  
1. The peak of GSH precedes the exponential phase of cell 
growth.  
2. GSH as a driving force of cell cycle progression.  
3. The peak of GSH coincides with the peak of telomerase 
activity in three proliferation models 
4. Three different models of cell growth  
 
II NUCLEAR DISTRIBUTION OF GLUTATHIONE AND 
CELL CYCLE 
 
1. The election of the methodology 
2. The cellular distribution of GSH along the cell cycle in 
three models of proliferation 
3. The comprehensive analysis of the nuclear 
compartmentalization of GSH in 3T3 fibroblasts 
 
III THE DEPLETION OF NUCLEAR GLUTATHIONE AND 
THE CELL CYCLE 
 
1. Design and characterization of the model of nuclear GSH 
depletion 
2. Depletion of nuclear GSH impairs cell growth 
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3. Alterations of the cell cycle were induced by depletion of 
the nuclear but not the cytoplasmic GSH  
 
IV SEARCHING FOR THE MECHANISM TO EXPLAIN THE 
NUCLEAR COMPARTIMENTALIZATION OF 
GLUTATHIONE  
 
1. The implication of the active transport or nuclear GSH 
synthesis de novo were not confirmed in our model 
2. Bcl-2 as a potential mediator of the nuclear GSH 
compartmentalization  
3. The importance of Bcl-2 in nuclear compartmentalization 
of GSH and its consequences on the proliferation activity. 
Study in MCF7 cells that over express Bcl-2. 
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I THE RELATIONSHIP BETWEEN GSH LEVELS 
AND TELOMERASE ACTIVITY, AND ITS 
CONSEQUENCES ON CELL PROLIFERATION, A 
UNIVERSAL PHENOMENON. 
1. The peak of GSH precedes the exponential phase of 
cell growth.  
1.1 The study of the GSH level during the cell growth in 3T3 
fibroblasts. 
1.2 The study of the GSH level during the cell growth in 
MCF7 cells. 
1.3 The study of the GSH level during the cell growth in 
embryonic neural culture. 
 
2. GSH as a driving force of cell cycle progression.  
 
2.1 Flow cytometry study of DNA content in 3T3 fibroblasts 
2.2 Flow cytometry study of DNA content in MCF7 cells 
2.3 Flow cytometry study of DNA content in embryonic 
neural culture 
2.4 The expression of proliferation related proteins, Id2 and 
PCNA, as indicators of the exponential phase of cell growth 
in 3T3 fibroblasts 
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2.5 The expression of proliferation related proteins, Id2 and 
PCNA, as indicators of the exponential phase of cell growth 
in MCF7 cells 
2.6 The expression of proliferation related proteins, Id2 and 
PCNA, as indicators of the exponential phase of cell growth 
in embryonic neural culture 
 
3. The peak of GSH coincides with the peak of 
telomerase activity in three proliferation models 
 
3.1 The relationship between GSH level and telomerase 
activity during the growth of 3T3 fibroblasts. 
3.2 The relationship between GSH level and telomerase 
activity during the growth of MCF7 cells. 
3.3 The relationship between GSH level and telomerase 
activity during the growth of embryonic neural culture. 
 
4. Three different models of cell growth 
 
4.1 The rhythm of cell growth is diverse in 3T3 fibroblasts, 
cancer cells and embryonic neural culture.  
4.2 The intensity of cell growth corresponds to the level of 
GSH  
4.3 The profiles of telomerase activity along the cell cycle 
match the variation in GSH level  
4.4 The GSH level correlates with the level of DNA synthesis 
in the three models of cell proliferation, but not with the 
percentage of cells in G2/M phase 
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4.5 The end time point and the cell death is different in the 
three cell lines.
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I THE RELATIONSHIP BETWEEN GSH LEVELS AND 
TELOMERASE ACTIVITY, AND ITS CONSEQUENCES ON 
CELL PROLIFERATION, A UNIVERSAL PHENOMENON. 
Previous research published by our group (1) for the 
first time associated the total cellular GSH level with the 
telomerase activity, offering the possible explanation of the 
effect of the former on the cell cycle progression. That study 
was entirely performed on 3T3 fibroblasts. 
The first objective of the present thesis was to 
investigate and evaluate the mentioned phenomenon in two 
cellular models of different proliferative activity:  
1. MCF7 cells, highly proliferating human mammary 
adenocarcinoma 
2. Embryonic neural culture (ENC) characterised by two 
phases:  
• non differentiated and proliferating until 4th day of 
culture 
• differentiated and very low proliferating, present 
from the 5th day. 
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1. The peak of GSH precedes the exponential phase of 
cell growth.  
1.1 The study of the GSH level during the cell 
growth in 3T3 fibroblasts. 
The GSH level was high at the beginning of culture 
and reached its maximal value at 24h (81,52±19 nmols/mg 
prot.) when the exponential phase of the growth curve 
begun (Fig. 1).  
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Figure 1. GSH level and cell growth in 3T3 fibroblasts during cell 
culture. The left Y axis shows the level of GSH along the cell culture and 
the right Y axis displays the cell number. The cells were plated as usual 
and counted at represented time points. The total cellular concentration 
of GSH was determined spectrophotometrically as described in “Materials 
and Methods”. Data are represented as the mean ± SD of 6-10 different 
experiments. 
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1.2 The study of the GSH level during the cell 
growth in MCF7 cells. 
In MCF7 cells (Fig. 2), our observations were similar: 
in the first 48h of culture the values of GSH were very high, 
with the extreme value at 18h, and then decreased 
progressively. The cell culture grew slowly but steadily, and 
at 24h we could already observe an important increase in 
cell number (p≤0,05 vs. 18h). However, the striking growth 
in this culture was observed after 48h. The cancer cells show 
no contact inhibition, and they continued to grow, still 
duplicating the population between 4th to 7th day of culture 
(2,033±0,133 and 4,336±0,127 X 106 cells, respectively).  
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Figure 2. GSH level and cell growth in MCF7 cells during cell culture.
The left Y axis shows the level of GSH along the cell culture and the right Y axis 
displays the cell number. The cells were plated as usual and counted at 
represented time points. The total cellular concentration of GSH was determined 
spectrophotometrically as described in “Materials and Methods”. Data are 
represented as the mean ± SD of 6-10 different experiments. 
           101 
                                                                         IV Results 
 
The levels of GSH are lower than at the beginning of 
the culture, but still above the maximal value observed in 
3T3 fibroblasts (95,77±0,96 nmols/mg prot.). 
1.3 The study of the GSH level during the cell 
growth in embryonic neural culture. 
Embryonic neural culture (ENC) (Fig. 3) is studied as a 
two phase model in coherence with the development of the 
rat neural system.  
When isolated from the brains of rat foetuses at 14th 
day of gestation, this culture contained highly proliferating 
undifferentiated cells. The cell number increased rapidly and, 
as in 3T3 fibroblasts and MCF7 cells, the growth was 
preceded by an important increase in GSH level (p≤0,01 24h 
vs. 6h), which maintained high plateau values until 72h (no 
significant difference at this time points). 
An important change of the culture was at 96h, when 
the cytosine arabinoside was added to inhibit further glial 
growth (indicated with an arrow in the graph). Proliferating 
cells were eliminated from the plate and remaining culture 
contained mostly differentiated neurons. The remarkable fall 
of the cell number at 5 days of culture reflected the dying off 
of the glial cells. The cell number is maintained until the 7th 
day and then started to decline slowly towards the end of 
the culture. Although the level of GSH was maintained 
almost unchanged for several days (no significant difference 
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starting from 72h), the decrease in GSH observed in this 
phase of culture was significant comparing to the maximum 
reached in the proliferating phase (p≤0,05 48h vs. 7 days of 
culture).  
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Figure 3. GSH level and cell growth in embrionary neuronal 
culture (ENC). The left Y axis shows the level of GSH along the cell 
culture and the right Y axis displays the cell number. The cells were 
plated as usual and counted at represented time points. The total cellular 
concentration of GSH was determined spectrophotometrically as 
described in “Materials and Methods”. Data are represented as the mean 
± SD of 3-5 different experiments. 
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2. GSH as a driving force of cell cycle 
progression.  
 
2.1 Flow cytometry study of DNA content in 3T3 
fibroblasts 
 
The cell cycle study in 3T3 fibroblasts (Fig. 4A) proved 
that at 24h after plating, when GSH was at maximal level, 
the percentage of cells at the S+G2/M phase increased 
significantly (p≤0,05 VS. 6h) and remained elevated until 
72h. Afterwards, the GSH level decreased progressively, 
until 5 days after plating (p≤0,0001 vs. 24, 48 and 72h). 
Consequently, at 72 h or later, cell growth slowed, and 5 
days after plating most of the cells were in the G0/G1 phase 
(results not shown) and the culture was 100% confluent. 
Thorough analysis of the cell cycle data, shows that cell 
division (G2/M) (Fig. 4B) peaked at 24h and started to 
decrease slowly (p≤0,001 vs. 72h). However, the 
percentage of cells in the phase of DNA synthesis (S), after 
the striking boost at 24h (p≤0,0001 vs. 6h) continued to 
increase until 48h (p≤0,05 vs. 24h) and then quickly fell by 
half (Fig. 4C).  
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cell culture. The percentage of cells in the phase of DNA synthesis (S)
Figure 4. GSH level and cell proliferation in 3T3 fibroblasts during 
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(figure A), in mitosis and G2 phase of the cell cycle (M/G2) (figure B), 
and the percentage of cells actively proliferating (S+M/G2) (Figure C) is 
shown on the right y axis. The level of GSH along the cell culture is 
represent at left y axis. Data are expressed as the mean ± SD of 6-10 
different experiments. 
 
2.2 Flow cytometry study of DNA content in 
MCF7 cells 
In our cancer cell model, MCF7 cells, as well as in 3T3 
fibroblasts, high levels of GSH preceded the maximum of cell 
proliferation.  
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Figure 5. GSH level and cell proliferation in MCF7 cells during cell 
culture. The percentage of cells in the phase of DNA synthesis (S) 
(figure A), in mitosis and G2 phase of the cell cycle (M/G2) (figure B), 
and the percentage of cells actively proliferating (S+M/G2) (Figure C) is 
shown on the right y axis. The level of GSH along the cell culture is 
represent at left y axis. Data are expressed as the mean ± SD of 6-10 
different experiments. 
The exponential phase of cell growth, defined by the 
high percentage of cells in S (Fig. 5C) and G2/M (Fig. 5B) 
phase of cell cycle, was extended in MCF7 cells to several 
days. The peak is reached at 24h of culture and the level is 
preserved without significant fluctuations until the 4th day of 
culture, when the decline of proliferation coincided with the 
decrease in GSH level. 
 
2.3 Flow cytometry study of DNA content in 
embryonic neural culture 
 
As expected, during the first 4 days of neural culture, 
when the GSH level is increased, the percentage of cells in S 
and G2/M phase was also high.  
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Figure 6. GSH level and cell proliferation in embrionary neuronal 
culture. The percentage of cells in the phase of DNA synthesis (S) 
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 ur(fig
 
 the
w
 
re
er
e A), in mitosis and G2 phase of the cell cycle (M/G2) (figure B), 
and  percentage of cells actively proliferating (S+M/G2) (Figure C) is 
sho n on the right Y axis. The level of GSH along the cell culture is 
rep sent at left Y axis. Data are expressed as the mean ± SD of 3-5 
diff ent experiments. 
 
Interestingly, the peak of GSH was posterior to the 
time point with the maximal number of dividing cells (Fig. 
6B), but it overlapped with the highest percentage of the 
cells in S phase (Fig. 6C). In the second stage of the culture, 
at 7 and 10 days, although the GSH level shows no 
remarkable fall, the proliferation was almost absent; less 
than 5 % of the cells were dividing and less than 3% were in 
S phase. 
 
 
2.4 The expression of proliferation related proteins, 
Id2 and PCNA, as indicators of the exponential 
phase of cell growth in 3T3 fibroblasts 
 
To ensure that most cells at 24 and 48 h in culture 
were in the S/M+G2 phase of the cell cycle, we studied Id2 
and PCNA expression patterns during cell growth (Fig. 7A-F). 
These proteins are over expressed when cell division is 
active. Indeed, consistent with the evidence derived from 
flow cytometry, the expression of these proteins was high at 
24 and 48h of culture in 3T3 fibroblasts (7A,B) and 
subsequently decreased towards the end of culture. 
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2.5 The expression of proliferation related 
proteins, Id2 and PCNA, as indicators of the 
exponential phase of cell growth in MCF7 cells 
 
In MCF7 cells, the increase in Id2 was initiated as 
early as at 12h, and remained high throughout the culture 
(Fig. 7C), while the important increase in PCNA was 
observed at 48-72h (Fig. 7D).  
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Figure 7. Changes of Id2 and PCNA protein expression during cell 
culture. Upper panels, Western blot analysis of Id2 in 3T3 fibroblasts, 
MCF7 cells and embrionary neuronal culture (ENC). Lower panels, 
Western blot analysis of PCNA expression along the cell cycle of
mentioned cell lines. Representative results from at least 3 experiments 
are shown.
 
2.6 The expression of proliferation related 
proteins, Id2 and PCNA, as indicators of the 
exponential phase of cell growth in embryonic neural 
culture 
The proliferating phase of neural culture, as expected, 
was characterized by high expression of both proteins. The 
deficiency of proliferation in the second phase of cell culture 
was confirmed by the considerable decrease in the 
expression of Id2 and PCNA at 5 and 7 days of culture, 
respectively, while at 10 days the level of both proteins was 
beyond detection (Fig. 7E, F). 
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3. The peak of GSH coincides with the peak of 
telomerase activity in the three proliferation models 
 
3.1 The relationship between GSH level and 
telomerase activity during the growth of 3T3 
fibroblasts. 
The peak of telomerase activity (TA) overlapped with 
the maximal GSH value in the cell culture of 3T3 fibroblasts 
(1) (Fig. 8A). The TA at its maximal value, at 24h, was 3 
times higher comparing to the beginning of the culture (6h) 
(Fig. 8B), and then decreased rapidly and continuously until 
the last time point.  
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Figure 8. GSH level and relative telomerase activity (TA) in 3T3 
fibroblasts during cell culture. The GSH level, presented at left Y 
axis, was measured as described previously and relative telomerase 
activity, at right Y axis, was estimated by TRAP reaction as explained in 
“Materials and Methods”. Data are expressed as the mean ± SD of 6-10 
different experiments (panel A) and as a % of change normalized by the 
starting point of culture (6h) (panel B). 
 
3.2 The relationship between GSH level and 
telomerase activity during the growth of MCF7 cells. 
 In MCF7 cells we observed the same occurrence; the 
high level of GSH was accompanied by the plateau of 
elevated TA (Fig. 9A), and the profile of TA resembled that 
of GSH. The maximal TA increment was more than 200% 
(Fig. 9B), and the decrease was gradual until the end of 
culture. 
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Figure 9. GSH level and relative telomerase activity (TA) in MCF7 
cells during cell culture. The GSH level, presented at left Y axis, was
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measured as described previously and relative telomerase activity, at 
right Y axis, was estimated by TRAP reaction as explained in “Materials 
and Methods”. Data are expressed as the mean ± SD of 6-10 different 
experiments (panel A) and as a % of change normalized by the starting 
point of culture (6h) (panel B). 
 
3.3 The relationship between GSH level and 
telomerase activity during the growth of embryonic 
neural culture. 
 
In the proliferating phase of neural culture the peak of 
GSH matched the maximum of TA, while in differentiated 
culture the steady decrease of GSH was followed by more 
noticeable decline of TA (Fig. 10A). The changes of TA along 
the culture are less prominent than when other two cell  
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types were considered; the maximal increase is of less than 
20% (Fig. 10B). 
 
4. Three different models of cell growth 
 
4.1 The rhythm of cell growth is diverse in 3T3 
fibroblasts, cancer cells and embryonic neural culture.  
Figure 11 displays the differences in proliferation 
curves between the three cellular models under study in the 
present thesis.  
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Figure 10. GSH level and relative telomerase activity (TA) in 
embrionary neural culture. The GSH level, presented at left Y axis, 
was measured as described previously and relative telomerase activity, 
at right Y axis, was estimated by TRAP reaction as explained in 
“Materials and Methods”. Data are expressed as the mean ± SD of 3-5 
different experiments (panel A) and as a % of change normalized by the 
starting point of culture (6h) (panel B). 
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Figure 11. The comparative population curves in different cell 
lines. Cells were cultivated and plated as described in “Materials and 
Methods” and counted at established time points. Demonstrated results 
are the mean ± SD of at 3-10 experiments.
3T3 fibroblasts demonstrated different cell growth 
profile comparing to MCF7 cells. Cancer cells had later 
proliferation onset, but their exponential phase of cell growth 
was elongated and more intense. Probably due to the 
deficiency of contact inhibition, these cells continued to 
divide days after 3T3 fibroblasts have reached confluence 
and consequently entered quiescence. The total cell number 
of MCF cells on the plate, at the final time point, was almost 
twice as high as in the case of 3T3 fibroblasts. Embryonic 
neural culture showed certain proliferating activity limited to 
the first 4 days of culture (see Fig. 6). Afterwards, the 
proliferation was almost absent and the vast majority of the 
cells on the plate were differentiated in to neurons. 
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4.2 The intensity of cell growth corresponds to 
the level of GSH  
 
Figure 12 demonstrate the results of the comparison 
of the GSH levels in the three models of cell proliferation.  
 In MCF7 cells, the peak of GSH was prior (at 18h) to 
the peak of 3T3 fibroblasts (24h of culture) and the value 
was three times higher (256,75±54,80 and 81,52±19 
nmols/mg prot., respectively). When the ENC is concerned, 
the GSH values were higher while the cells were 
proliferating, until 96h of culture, then after, when the 
culture contained mainly differentiated cells.  
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Figure 12 . The comparison of GSH levels along the cell culture in 
diferent cell lines. The total cellular concentration of GSH was 
determined spectrophotometrically as described in “Materials and 
Methods”. Data are represented as the mean ± SD of 3-10 different 
experiments. 
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Beginning from the 7th day the level of GSH was very 
low (28,6±8,64 nmols/mg prot.) and without perceptible 
fluctuations until the end of the culture. 
 
4.3 The profiles of telomerase activity along the 
cell cycle match the variation in GSH level  
 
In MCF7 cells and 3T3 fibroblasts the changes in TA 
along the cell cycle were extraordinary (Fig. 13). 
As described before, in 3T3 fibroblasts a striking 
augmentation of TA activity was accompanied by the 
increase of GSH, and the maximal values of both parameters 
concurred at 24h after plating. Likewise, in MCF7 cells, the 
level of TA doubled in the first 18h of culture, and this 
increase corresponded to the peak of GSH.  
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Figure 13. The comparative rhythm of relative telomerase 
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reaction as explained in “Materials and Methods”. Data are normalized by 
the starting point of culture (6h) and expressed in the % of change as 
mean ± SD (n=3-5).
Interestingly, the augment in TA in MCF7 cells was 
less prominent than in 3T3 fibroblasts, but it endured longer. 
Embryonic neural culture showed more subtle increment, 
two days after plating it increased only 15%. 
 
 4.4 The GSH level correlates with the level of 
DNA synthesis in the three models of cell proliferation, 
but not with the percentage of cells in G2/M phase 
 
The study of the cell cycle by flow cytometry allowed 
us to develop the comparative analysis of the intensity of  
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Figure 14. The comparative levels of the cell proliferating activity 
 
along the cell culture in different cell lines. The percentage of 
actively dividing cells is obtained as a sum of S+M/G2. Data are
expressed as the mean ± SD of 3-10 different experiments. 
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cell proliferation (percentages of the cells in the phases S 
and G2/M) and its possible correlation with GSH levels in 
three cellular models along the cell cycle. 
Surprisingly, the levels of cellular proliferating activity, 
defined by the sum of the cells in S+G2/M phases, 
demonstrated to be higher in 3T3 fibroblasts than in MCF7 
cells (Fig. 14), although in MCF7 cells the higher values were 
sustained for longer time. Consequently, no clear correlation 
between S+G2/M phase and GSH levels could be 
demonstrated in our three models (Fig. 15). 
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Figure 15. The correlation of the levels of cell proliferation and 
GSH levels along the cell cycle in different cell lines. The 
percentage of actively dividing cells is obtained as a sum of S+M/G2. 
GSH measurement was performed by spectrophotometry. Data are 
expressed as the mean ± SD of 3-10 different experiments. 
Separate analysis of the G2/M phase of cell cycle 
showed analogous pattern and the absence of the correlation 
with GSH levels (Fig. 16. and Fig.17). 
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Figure 16. The comparative levels of the cell division along the
cell cycle in different cell lines. The percentage of dividing cells 
(M/G2) was estimated by the flow cytometry analysis of the DNA 
content. Data are expressed as the mean ± SD of 3-10 different 
experiments. 
Figure 17. The correlation of the levels of cell division and GSH 
levels along the cell cycle in different cell lines. The percentage of 
cells in the M/G2 phase was estimated by the flow cytometry analysis of 
the DNA content. GSH measurement was performed by 
spectrophotometry. Data are expressed as the mean ± SD of 3-10 
different experiments. 
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On the contrary, the analysis of the phase of DNA 
synthesis revealed considerable differences (Fig. 18, 19).  
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Figure 18. The comparative levels of DNA synthesis along the cell 
cycle in different cell lines. The percentage of cells in the phase of 
DNA synthesis (S) was estimated by the flow cytometry analysis of the 
DNA content. Data are expressed as the mean ± SD of 3-10 different 
experiments. 
The neural culture was characterized by the low 
percentage of the cells in S phase and low level of GSH, 
while the extremely high GSH level of MCF7 cells was 
accompanied by high level of DNA synthesis. 3T3 cells 
showed medium levels both of GSH and of the quantity of 
cells synthesizing DNA.  
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Figure 19. The correlation of the levels of DNA synthesis and GSH 
levels along the cell cycle in different cell lines. The percentage of 
cells in the phase of DNA synthesis (S) was estimated by the flow 
cytometry analysis of the DNA content. GSH measurement was 
performed by spectrophotometry. Data are expressed as the mean ± SD 
of 3-10 different experiments. 
 
Based on this data, we conclude that there was a 
strong correlation (R2=0,7) of GSH levels and DNA synthesis 
in the comparative study of the three cellular models 
 
4.5 The end time point and the cell death is 
different in three cultures  
 
The 3T3 fibroblasts were studied until reaching 100% 
confluence, which was at 5 days of culture. The longer 
maintenance of the cells in the plate would result in high 
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percentage of dead cells, due to the contact inhibition of cell 
growth.  
MCF7 cells were cultivated up to 7 days of culture, and 
at this time point, were still dividing. Continuation of the 
cultivation would require the refreshing of the medium, 
which was avoided due to the possible consequences on the 
parameters under analysis. 
Embryonic neuronal culture was maintained until 16th 
day (results not shown) with considerable variations in the 
percentage of cell death between experiments. In our study 
we have included neurons only until 10th day when the 
quality of culture was still highly reproducible. 
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Figure 20. The cell death at the final time point of the cell 
culture. The percentage of necrotic and apoptotic cells was estimated by
the flow cytometry analysis of the DNA content. Data are expressed as 
the mean ± SD of 3-10 different experiments. **P≤0,01 and *P≤0,05 
derives from t student analysis of the statistical differences between 3T3 
and  MCF7 cells and 3T3 and ECN, respectively.
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Figure 20 shows the level of cell death at the final 
time point of the culture. The MCF7 cells at 7 days of culture 
were still proliferating and the level of cell death was 
extremely low. 3T3 fibroblasts had reached confluence and 
as they are contact inhibited, some dead cells could be found 
in the culture. Embryonic neuronal culture at advanced time 
point had a higher death rate due to the sensibility to the 
cultivation conditions. 
In conclusion, the comparative study of the GSH level 
and its effect on the cell growth parameters in three models 
of distinct proliferating activity proved the universality of the 
observations displayed previously only for 3T3 fibroblasts: 
the peak of GSH precedes the exponential phase of cell 
growth and coincides with the maximal value of telomerase 
activity. The dependence of the telomerase activity on the 
GSH level drove us to study the possible correlation between 
the DNA synthesis and GSH in our model, and it appears 
that there is direct correlation between the GSH level of the 
cell population and the percentage of the cells in the S 
phase.  
These findings motivated the second goal in our 
research: to study the importance of the nuclear 
compartmentalization of GSH in the cell cycle progression. 
 
1. Borras, C., Esteve, J. M., Vina, J. R., Sastre, J., Vina, J., 
and Pallardo, F. V. (2004) Glutathione regulates 
telomerase activity in 3T3 fibroblasts. J Biol Chem 279, 
34332-34335 
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II NUCLEAR DISTRIBUTION OF GSH AND CELL CYCLE 
 
1. The election of the methodology 
 
2. The cellular distribution of GSH along the cell cycle 
in three models of proliferation 
2.1 The GSH distribution in 3T3 fibroblasts.  
2.2 The GSH distribution in MCF7 cells.  
2.3 The GSH distribution in embryonic neural culture.  
 
3. The comprehensive analysis of the nuclear 
compartmentalization of GSH in 3T3 fibroblasts 
3.1 The GSH is increased in the nucleus when cells 
proliferate, and the level is equal to cytoplasmatic at 
confluence.  
3.2 The quantification of nuclear GSH compartmentalization. 
3.3 The study of the oxidative status of nuclear proteins 
3.3.1. Oxidation of nuclear proteins  
3.3.2. Glutathiolation of nuclear proteins 
3.4 Resolving the limitations of the technique. 
3.4.1 Variations in the relative cellular and nuclear surface 
along the cell cycle. 
3.4.2 The interference of the mitochondrial pool of GSH 
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II NUCLEAR DISTRIBUTION OF GSH AND CELL CYCLE 
 
In view of the results demonstrated previously, we planted a 
question whether nuclear compartmentalization of GSH 
might have a role in the evolution of the cell cycle during the 
early phases of cell culture.  
 
1. The election of the methodology 
Preliminary experiments that were based on classical cell 
fractionation protocols produced unsatisfactory results. The 
nuclear isolation and subsequent determination of total 
glutathione content (GT) and the level of oxidised 
glutathione (GSSG), by H.P.L.C. technique described in 
“Materials and Methods”, revealed not only the substantial 
loss of GT level with repeated washings (Fig. 21 A), but its 
oxidation as well (Fig. 21 B).  
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Figure 21. Determination of the nuclear glutathione level by 
fractionation technique. Total glutathione level (GT) (A) and oxidised 
glutathione level (GSSG) (B) in nmols/mg proteins were determined in 
isolated nuclei by HPLC as described in Materials and methods. 
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Therefore, in this study, a fluorescent confocal microscopy 
was the approach of choice. This non invasive technique 
enables the analysis of the living cells, under normal cell 
cultivation conditions (37ºC, 5% CO2) using vital cellular 
dyes.  
 
2. There is detectable nuclear compartmentalization of 
GSH in early phase of cell culture in three proliferating 
models  
The cell cycle-dependent GSH distribution was studied in 3T3 
fibroblasts, MCF7 cells and embryonic neural culture, at 
three time points: the beginning of culture (6h after plating), 
while proliferating (24h after plating) and at the final point of 
culture (5 days for 3T3, 7 days for MCF7 and 10 days when 
using ENC). The representative experiments are shown on 
the figure 22, 23 and 24, respectively. Cellular glutathione 
distribution is defined by the green CMFDA fluorescence, 
shown on the panels a. The blue staining of the nuclei with 
Hoechst 33342 is shown on the panels b, and transmission 
image is presented on the panels c.   
We perceive that the highest green fluorescence co-
localized with blue fluorescence of nuclei at 6h and 24h in all 
three cultures. To support this observation we quantified the 
intensity of blue and green fluorescence by drawing the 
cross section line (shown in red at panels a) throughout the 
cell field. Panels d show that the nuclei blue staining (blue 
peaks in the graph) co-localized with the green glutathione 
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staining (green peaks in the graph) at the beginning of the 
culture. 
 
 2.1 The GSH distribution in 3T3 fibroblasts.  
The maximum correlation of blue/green fluorescence 
(Fig. 22A and 22B) and highest intensity of green 
fluorescence, i.e. GSH level, was observed at 24 h, in 
accordance with biochemical analysis (Fig. 1).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 22 A. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in 3T3 fibroblasts.
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 Figure 22 B. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in 3T3 fibroblasts. Amplified detail.
 Figure 22. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in 3T3 fibroblasts. 3T3 fibroblasts (22 A and 
22B), were studied at the beginning of culture (6h), during cell growth 
(24h) and at the end of culture (at 5 days). Triple staining was performed 
on living cells: Hoechst 33342 to localize nuclei (blue fluorescence, a), 
CMFDA to mark GSH, (green fluorescence, b), and PI to exclude dead cells 
(results not shown) and cells were maintained in the chamber provided with 
5% CO2 at 37 °C. Histograms (panel d) show the level (axis y) of CMFDA
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and Hoechst fluorescence (green and blue line, respectively) along the
“red” line (axis X) used as quantification tool (shown on panel a) which allows the 
study of the blue/green fluorescence co localization. Panel c shows the images 
obtained by light microscopy. A representative Z axes series of at least 3 
experiments are shown on figure 22 A, and the amplified details (1:4) are 
displayed in figure 22B. 
 
At 5 days in culture, when the cells are confluent, the 
green staining was of lower intensity and homogeneous 
across the plate.  
 
2.2 The GSH distribution in MCF7 cells. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 23A. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in MCF7 cells.
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 Figure 23 B. Microscopic confocal analysis of the nuclear 
 
compartimentation of GSH in MCF7 cells. Amplified detail.
Figure 23. Microscopic confocal analysis of the nuclear 
 
 
 
compartimentation of GSH in MCF7 cells. MCF7 cells were studied at the 
beginning of culture (6h), during cell growth (24h) and at the end of culture 
(at 7days). Triple staining was performed on living cells: Hoechst 33342 to 
localize nuclei (blue fluorescence, a), CMFDA to mark GSH, (green 
fluorescence, b), and PI to exclude dead cells (results not shown) and cells 
were maintained in the chamber provided with 5% CO2 at 37 °C. 
                                                                         IV Results   
 
 
 
 
Histograms (panel d) show the level (axis y) of CMFDA and Hoechst 
fluorescence (green and blue line, respectively) along the “red” line (axis X) 
used as quantification tool (shown on panel a) which allows the study of the 
blue/green fluorescence co localization. Panel c shows the images obtained 
by light microscopy. A representative Z axes series of at least 3 experiments 
are shown on figures 23 A, and the amplified details (1:4) are displayed in 
figure 23B.
2.3 The GSH distribution in embryonic neural 
culture.  
In the proliferative phase of embryonic neural culture, 
at 24h, it was possible to detect the cells with nuclear GSH  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 24A. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in embrionary neuronal culture.
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localization (Fig. 24A, panel a) although the nuclear 
compartmentalization in these cells was not of the same 
level as in other two models.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24B. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in 3T3 fibroblasts. Amplified detail.
 
Figure 24. Microscopic confocal analysis of the nuclear 
compartimentation of GSH in embrionary neuronal culture.
Embrionary culture of neurons (ENC) were studied at the beginning of
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culture (6h), during cell growth (24h) and at the end of culture (10 days). 
Triple staining was performed on living cells: Hoechst 33342 to localize 
nuclei (blue fluorescence, a), CMFDA to mark GSH, (green fluorescence, b), 
and PI to exclude dead cells (results not shown) and cells were maintained 
in the chamber provided with 5% CO2 at 37 °C. Histograms (panel d) show 
the level (axis y) of CMFDA and Hoechst fluorescence (green and blue line, 
respectively) along the “red” line (axis X) used as quantification tool (shown 
on panel a) which allows the study of the blue/green fluorescence co 
localization. Panel c shows the images obtained by light microscopy. A 
representative Z axes series of at least 3 experiments are shown on figures 
24 A, and the amplified details (1:4) are displayed in figure 24B. 
 
On the contrary, in advanced state of culture differentiation 
towards neurons, the cellular distribution of GSH was more 
homogeneous (24 B).  
 
Apparently, while cells are actively proliferating and entering 
the exponential phase of cell growth (24h of culture), the 
GSH level is high and its nuclear compartmentalization could 
be observed. When cells are proliferating more slowly, like 
MCF7 cells at 7 days of culture, or almost not at all, in the 
case of neuronal culture, the GSH level is lower and its 
distribution is uniform across the cell. 
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3. The comprehensive analysis of the nuclear 
compartmentalization of GSH in 3T3 fibroblasts 
For a more extensive analysis of this phenomenon we have 
focused our attention on 3T3 fibroblasts. 
 
3.1 The GSH level is increased in the nucleus when 
cells proliferate, and equal to cytoplasmatic at 
confluence.  
 
The result of detailed confocal microscopy analysis of the 
GSH distribution along the cell cycle is shown in the Fig. 25.  
Six hours after plating, few cells could be seen on the plate. 
The blue staining of the nuclei with Hoechst 33342 is shown 
in panel b, and green (glutathione) staining is shown in 
panel c. Magnified detail of glutathione staining (panel d) 
shows that the highest fluorescence is located in the nucleus. 
A white cross section line (best shown on panel d) was 
drawn throughout the cell field. Panel e displays the 
fluorescence level and distribution along the line. The nuclei 
blue staining (blue peaks in the graph) co-localizes with the 
green glutathione staining (green peaks in the graph) at the 
beginning of the culture. At 12 and 24 h of culture, cells 
continued to populate the plate. Cellular glutathione (CMFDA 
green fluorescence intensity) was maximal at 24 h. Analysis 
of the blue/green fluorescence (Fig. 25 b and d, respectively) 
distribution and intensity showed a maximum correlation of 
blue/green fluorescence at 24 h. When cells were confluent 
after 72 h or 5 days in culture, no correlation among the  
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Figure 25. Confocal microscopic images of 3T3 fibroblasts during cell
growth. Cells were plated in chamber slides 5 days, 72 h, 48 h, 24 h, 12 h, 
and 6 h before the experiment and were stained and analyzed the same
day. Triple staining was performed on living cells: Hoechst 33342 to localize
nuclei, CMFDA to mark GSH, and PI to exclude dead cells. During
microscopic confocal analysis, cells were maintained in the chamber
provided with 5% CO2 at 37 °C. Images veré taken by light microscopy (a) 
and confocal microscopy, as described in “Materials and Methods” to capture 
blue fluorescence of nuclei (b) and by green fluorescence, which marks GSH 
(c), and red fluorescence of dead cells (results not shown). Maximum
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 projection images were analyzed by profile of fluorescence, where a cross-
section white line of 200 ± 20 µm was drawn through a cell field (best 
shown in amplified detail on the d panels) to compare distribution of green
CMFDA fluorescence (levels of GSH) along the line (green area under the 
curves in the e panels) with blue Hoechst fluorescence (nuclei localization) 
(blue area under the curves in the e panels). a.u., arbitrary units.
 
 
 
peaks of green and blue fluorescence could be found. 
The increase over culture time in total cellular staining for 
CMFDA correlated with the peak of glutathione concentration 
(81,52 ± 19 nmols/mg prot.) determined 
spectrophotometrically (see Fig. 1).  As expected, green 
(GSH) fluorescence clearly decreased at 72 h and 5 days in 
culture when cell culture reached confluence, cell-to-cell 
growth inhibition took place, and as a consequence the cell 
population entered quiescence (70–80% G0/G1). At these 
stages no significant difference could be seen between the 
nucleus and cytoplasm, and there was a homogenous green 
(CMFDA) pattern on the plates. Thus, when cells started to 
grow, GSH was located mainly in the cell nucleus. However, 
when cell growth slowed, GSH distribution was homogenous 
throughout the cell. 
 
3.2. The quantification of nuclear GSH 
compartmentalization.  
 
The capacity of the cell to concentrate GSH in the nucleus 
was estimated calculating the nuclear/cytoplasmic ratio, 
after measuring the levels of CMFDA fluorescence of the 
nuclear and cytoplasmatic area in ~100 cells one by one in 
each experiment. The results in Fig. 26 show a distribution 
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pattern where the maximal nuclear/cytoplasmic ratio (4.2 ± 
0.8) was found very early after plating (6 h). Although a 
high nuclear/cytoplasmic ratio for GSH was maintained 
during cell growth, as the culture progressed, a steady 
decrease in the nucleus/cytoplasm ratio was present. Once 
the cells reached confluence and most of them were in the 
G0/G1 phase, the nuclear/cytoplasmic ratio for GSH was 
homogeneous, and no difference could be seen between the 
nucleus and the cytoplasm. 
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Figure 26. Nucleus/cytoplasm GSH ratio obtained by confocal
microscopy. Analysis of the cellular distribution of GSH. Cells were 
plated and stained and images obtained as described previously. To quantify 
the changes in GSH distribution in cells along the cell cycle, cells were 
analyzed by area (as described in Materials and methods). The 
nucleus/cytoplasm ratio for GSH in every cell analyzed was established by 
dividing the mean of green CMFDA fluorescence of the nucleus area by the 
mean of CMFDA fluorescence in the cytoplasm area. Results are mean ±
S.D. for three independent experiments, where 100 cells in at least five 
different fields were analyzed.
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3.3 The study of the oxidative status of nuclear 
proteins 
To elucidate the possible consequences of the high 
glutathione concentration in the nucleus in early phases of 
cell proliferation, we have studied the level of oxidation and 
glutathiolation of nuclear proteins.  
3.3.1. Oxidation of nuclear proteins  
Consequent with the finding that nuclear GSH is high during 
the early phases of cell cycle and low when cells are 
confluent, nuclear oxidized proteins levels are higher during  
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 Figure 27. Oxidized nuclear proteins during cell growth. 3T3 cells 
were subjected to nuclear protein extraction, for the determination of 
protein oxidation. The level of nuclear protein oxidation was determined by 
detecting the carbonylation level with the Oxy Blot protein oxidation 
detection Kit (Chemicon International). Samples were lysed and derivatized, 
and Western blotting was performed according to the recommendation of 
the manufacturer.
 
 
 
 
cell cycle arrest than 6 h after culture (Fig. 27) 
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3.3.2. Glutathiolation of nuclear proteins 
Western blot analysis of nuclear extracts showed the 
differences in the glutathiolation of nuclear proteins (Fig. 
28); it was higher at 6 h after culture, when nuclear 
compartmentalization reached its maximum. As expected, 
when cells reached confluence and nuclear/cytoplasmic 
distribution was homogeneous, glutathiolation of nuclear 
proteins decreases. 
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Figure 28. Glutathiolated nuclear proteins during cell growth. Nuclear 
lysates of 3T3 cells were obtained in the absence of reductive agents. 
Western blotting procedure was performed as described in “Materials and
Methods” and the membrane was probed against anti-glutathione antibody
(1:1000) (Virogen) at 4 °C overnight.
 
 
 
 
3.4 Resolving the limitations of the technique. 
 
3.4.1 Variations in the relative cellular and nuclear surface 
along the cell cycle. 
The confidence of this analysis was questioned by the 
possibility that the difference in the mean fluorescence ratio 
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could be the consequence of the changes in the cellular and 
cell compartments areas along the cell cycle. Figure 29.A 
demonstrate that during proliferation, the cellular and 
nuclear area is bigger than when cells are confluent, so the 
high mean fluorescence of the nuclei at the beginning of the 
culture is not due to underestimation of the nuclear surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2 The interference of the mitochondrial pool of GSH 
 
The mitochondria represent an important pool of GSH and 
their localization in the upper nuclear area at the apex of the 
cell could be mistaken for the nuclear fluorescence.  
To ensure that it is not mitochondrial GSH that was 
responsible for the areas of high CMFDA fluorescence we 
incubated fibroblasts with Hoechst to stain genomic DNA (in 
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Figure 29. Analysis of the changes in cell compartments areas along 
the cell cycle. Cells were plated and stained and images obtained as 
described previously. The area was measured by drawing perimeters around 
the nucleus (A,B), cytoplasm excluding nucleus and whole cell (A) (as 
described in Materials and methods). Results are mean ± S.D. for three 
independent experiments, where 100 cells in at least five different fields 
were analyzed.
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blue), CMFDA for GSH (green), and MitoTracker for 
mitochondrial staining (red) (Fig. 30). A selection of images 
obtained along the z axis starting from the cell apex is shown 
in Fig. 30 (a representative experiment of three). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 30. Cellular distribution of GSH and mitochondria in 3T3 
fibroblasts after 24 h in culture. Cells were grown and stained and 
images obtained as described in “Materials and Methods”. Blue fluorescence 
of nuclei dyed by Hoechst, green fluorescence of CMFDA that marks GSH, 
and fluorescence of MitoTracker Red 580 that stains mitochondria were 
captured by confocal microscopy. Each panel shows the Z-section series.
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 obtained beginning from the nuclear apex and progressing downward in 1 ±
0.2-µm increments.
 
The nuclear shape is clearly visible as is the presence of GSH 
in the nucleus. Mitochondrial distribution was perinuclear, as 
expected. 
 
In conclusion, we have shown that cells need a reduced 
nuclear environment provided by glutathione to proliferate 
(see Fig. 31). Indeed, the nucleus/cytoplasm ratio was high 
several hours after plating.  
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Figure 31. Correlation between nuclear GSH distribution and cell
growth. The number of cells x106 is shown on the right y axis. The 
nucleus/cytoplasm GSH ratio is shown on the left y axis. Data are expressed 
as the mean ± SD of ten different experiments.
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Thus, glutathione translocates to the nucleus before 
exponential cell growth. When cells reached confluence, at 3 
and 5 days after plating, GSH distribution was similar in both 
cell compartments, nucleus and cytoplasm. 
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III THE DEPLETION OF NUCLEAR GSH AND THE CELL 
CYCLE 
 
1. Design and characterization of the model of nuclear 
GSH depletion 
1.1 DEM and BSO have different effect on the level of GSH 
and rhythm of its fluctuations during cell culture 
1.2 DEM but not BSO causes the depletion of nuclear 
glutathione 
1.3 Quantification of the nuclear GSH levels after the 
depletion with DEM and BSO  
 
2. Depletion of nuclear GSH impairs cell growth 
2.1 The rhythm of cell growth change with the nuclear GSH 
depletion (Fig. 35) 
2.2 The difference in cell number along the cell cycle is not 
due to the induction of cell death 
 
3. Alterations of the cell cycle were induced by 
depletion of the nuclear   but not the cytoplasmic GSH  
3.1 Flow cytometry analysis of the consequences of the 
nuclear GSH depletion 
3.2. The effect of nuclear GSH depletion on the cell 
proliferation markers 
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III THE DEPLETION OF NUCLEAR GSH AND THE CELL 
CYCLE 
 
1. Design and characterization of the model of 
the nuclear GSH depletion 
To confirm the importance of nuclear GSH in the onset of cell 
proliferation we have designed a model based on the 
different effects of two depleating agents: diethyl maleate 
(DEM) and buthionine sulfoximine (BSO) on the cellular GSH 
level and distribution. DEM causes direct and instantaneous 
GSH depletion that affects all cell compartments. In 
contrast, BSO induces irreversible inhibition of gamma-
glutamylcystein synthetase, thus gradually decreasing GSH 
level. Moreover, it has been demonstrated that nuclear GSH 
pool remains intact in the treatment with BSO. 
 This model allowed us to explore the differential effects of 
GSH depletion depending on the cell compartment affected. 
 
1.1 DEM and BSO produce different consequences on 
 the level of GSH and rhythm of its fluctuations during 
cell culture 
 The Fig. 32. shows the intensity of the GSH depletion and 
the rhythm of changes in GSH level in the four experimental 
groups included in our model. A clear decrease of GSH levels 
was observed in the cells treated with DEM at 6h of culture, 
while the similar decrease induced by BSO treatment did not 
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occur until 24h of culture (7,28 y 8,10 nmoles/mg prot., 
respectively, no significant difference).  
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Figure 32. The time course analysis of the GSH level after depletion 
with DEM and BSO. The cells were plated as described previously and after 
attaching 100µM DEM, or 10mM BSO, or 100µM DEM+1mM GSH were 
added. The total cellular concentration of GSH was determined 
spectrophotometrically as described in “Materials and Methods”. The results 
are presented as mean ± SD of at least five different experiments. The table 
of p significance derives from double ANOVA test followed by t student.
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The level of GSH in the cells treated with BSO increased 
slowly and steadily, but was maintained significantly inferior 
to other experimental groups, until 5 days of culture when 
the difference was not significant any longer (except vs. 
DEM)  
On the contrary, the level of GSH in the DEM treated cells 
rapidly increased; at 24h was already higher than in the 
case of BSO but still did not reach the level of control (51,96 
nmoles/mg prots. comparing to 90,64, respectively, 
p≤0,018). 
At 48h a rebound effect was observed, which to a lesser 
extent persisted until 72h, and declined significantly at 5 
days of culture. 
The cells simultaneously treated both with DEM and GSH 
ester, displayed similar pattern to the control, with the peak 
at 24h. Therefore, the effect of GSH depletion by DEM was 
completely compensated by the simultaneous addition of 
GSH ester. 
 
1.2 DEM but not BSO causes the depletion of 
nuclear glutathione 
Following the determination of the total cellular GSH 
level we studied the distribution of cellular GSH between the 
cytoplasm and the nucleus of the cells. As could be seen in 
Fig 33. untreated fibroblasts during 24 hours in culture 
showed that GSH (CMFDA staining-green fluorescence) was 
mainly distributed in the cell nucleus since it co-localizes  
with the DNA distribution (Hoechst-blue fluorescence). 
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Figure 33. The confocal microscopy analysis of the GSH distribution 
after its depletion with DEM and BSO. The cells were plated as described 
previously and after attaching, 100µM DEM, or 10mM BSO, or 100µM 
DEM+1mM GSH were added. At 24h after plating the cells were stained as 
described in Materials and Methods and observed by confocal microscopy. Z 
series of at least 8 planes were obtained and maximum projection images 
were created and analysed. The representative experiment is presented. 
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However, cells incubated with 100 µM DEM showed clearly 
lower GSH level and more uniform GSH distribution within 
the cells. Surprisingly, the GSH depleting agent BSO was 
unable to change the distribution of cellular GSH, showing a 
cellular glutathione pattern different that the one shown in 
the DEM-treated cells. GSH was high in the nucleus and low 
in the cytoplasm, like in the control group.  
Thus, each GSH-depleting agent induced different responses 
in the distribution of cellular GSH when fibroblasts were 
proliferating. As expected, co-incubating the cells with 100 
µM DEM and 1mM GSHe showed similar glutathione 
distribution as untreated cells. 
 
1.3 Quantification of the nuclear GSH levels after 
the depletion with DEM and BSO  
 
Measurement of the fluorescence emission in the 
nuclear area (Fig. 34) showed that GSH levels in the nucleus 
of DEM treated cells was significantly lower than in the other 
groups of cells studied, including the BSO treated fibroblasts. 
BSO caused no effect on the nuclear GSH level, and the 
simultaneous administration of GSH ester completely 
abolished the effect of DEM. 
In conclusion, the DEM treatment depletes GSH in the whole 
cell, while BSO shows no effect on the nuclear GSH. 
 
 
 
           155 
                                                                         IV Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Treatment
**
0
50
100
150
200
250
CONTROL DEM 100µM DEM+GSH BSO
C
M
F
D
A
 f
lu
o
re
sc
e
n
ce
 (
A
U
)
C
M
F
D
A
 f
lu
o
re
sc
e
n
ce
 (
A
U
)
 Figure 34. The effect of the depletion with DEM and BSO on  nuclear 
GSH in 3T3 fibroblasts 24h in culture. The maximum projection images 
(as presented in the fig 33) were analysed by area, as described in 
“Materials and Methods”. The results presented are mean ± SD values from 
at least 4 different experiments (50-80 cells per experiment) and the 
statistical significance is expressed as: ** p < 0.01 versus control value.
 
 
 
 
Following the characterization of the model, we proceeded to 
the study of the possible consequences of nuclear GSH 
depletion on cell proliferation.  
 
2. Depletion of nuclear GSH impairs cell growth 
 
2.1 The rhythm of cell growth change with the 
nuclear GSH depletion (Fig. 35) 
Control 3T3 fibroblasts grew slowly during the first 24 
hours in culture and reached exponential phase of cell 
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growth between 24 and 72 hours, when cells reached 
confluence and stopped growing; there were no significant 
difference in cell number comparing to the day 5. 
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Figure 35. Nuclear GSH depletion (treatment with DEM) decreases 
the rate of cell growth in 3T3 fibroblasts. Cells were plated and treated 
as described previously, detached by trypsinization and counted. The 
proliferation curves are created on the bases of the mean results of at least 
5 different experiments.
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Fibroblasts incubated with 10 µM BSO exhibited a 
growth trend similar to controls, with a discrete delay 
detectable only at 24h, and even remained growing for a 
longer time than untreated cells (day 5 of culture). However, 
the cells treated with DEM 100 µM showed a very low 
growing profile. In the first 48h of culture, when the control 
group expands extremely, this cell population showed no 
increase: there was no significant difference in cell number 
from the beginning of culture until 48h later. The visible 
growth occurred between 48 and 72h and remained the 
same until 5 days of culture. The cell number was, at all 
time points, significantly lower (p≤0,001), and at the end of 
the culture this cell population hardly exceeded half of the 
control population (1,46x106 and 2,71x106, respectively). 
When DEM-treated cells were co-incubated with 1mM 
glutathione ethyl ester (GSHe), in order to replenish GSH 
levels, cells grew at a similar rate to controls.  
 
2.2 The difference in cell number along the cell cycle is 
not due to the induction of cell death 
 
The different growing behaviour in the cells with depleted 
nuclear GSH was not due to an increased rate of cell death 
(Fig. 36). Indeed, the percentage of apoptotic and necrotic 
cells remained below 5% throughout the cell culture. Only 
during the fifth day in culture i.e. when control and 
DEM+GSHe treated cells reached confluence, an increase in 
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the number of dead cells was shown, but not in the DEM and 
BSO treated cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
BSO 10µM
DEM 100µM+GSH ester 1mM
DEM 100µM
control
%
 o
f 
d
e
a
d
 c
e
ll
s
0
4
8
12
16
6h 24h 72h 5 days48h
Time of culture
%
 o
f 
d
e
a
d
 c
e
ll
s
%
 o
f 
d
e
a
d
 c
e
ll
s
 
 
 
 
Figure 36. The effect of the GSH depletion on cell death in 3T3 
fibroblasts. The sum of the percentage of apoptotic and necrotic cells along 
the proliferation curve of the 3T3 fibroblasts is shown. The cell death was 
studied by flow citometry analysis of the DNA content, and the results 
presented are mean±SD of at least five different experiments.
 
To summarize, the nuclear GSH depletion (with DEM) 
had severe consequences on the cell growth. On the 
contrary, when only the cytoplasmatic GSH was depleted 
(BSO) no marked differences were observed. 
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3. Alterations of the cell cycle were induced by 
the depletion of the nuclear but not the cytoplasmic 
GSH  
3.1 Flow cytometry analysis of the consequences 
of the nuclear GSH depletion 
Figure 37. shows the differences in the percentage of 
cells in the different phases of the cell cycle during the time 
of culture. 
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Figure 37. The effect of the depletion of the nuclear GSH (treatment 
with DEM) on the cell cycle in 3T3 fibroblasts. Cells were plated and 
treated as described previously. The cell cycle was analysed by flow 
citometry detection of the changes in the DNA content, as described in 
Materials and Methods. The results correspond to mean±SD of at least 5 
different experiments.
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As expected, the percentage of cells in the phases S, 
M and G2 of the cell cycle was higher when cell were 
growing, i.e. at 24h (47,7±9,8%), 48h (40,7±8,2%) and 72 
hours (30,9±6,2%) in culture. However, in those cells that 
were treated with DEM the percentage of cells in either 
proliferation phase S, or G2/M was lower (24-48 hours of 
culture) than in controls (p≤0,001, and p≤0,018, 
respectively). As expected BSO and DEM+GSHe treated cells 
showed results similar to control fibroblasts. 
 
3.2. The effect of nuclear GSH depletion on the 
cell proliferation markers 
 
In order to find a molecular explanation for the 
impairment of the cell cycle caused by the depletion of 
nuclear GSH levels with DEM, we studied the expression of 
the cell cycle-related protein Id-2.  
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Figure 38. The expression of the cell proliferation marker, Id2, after 
the depletion of the nuclear GSH (treatment with DEM). At upper 
panel, Western blot analysis of Id2 in 3T3 fibroblasts at 6, 24, and 72h of 
culture is shown. Lower panel shows the Id2 content [Mean ± SD (n=4)] 
derived from densitometry.
 
Figure 38. shows that Id-2 expression, decreased in 
the DEM, but not in the BSO treated cells or in the 
DEM+GSHe treated cells.  
Thus, depletion of nuclear, but not cytoplasmic 
glutathione levels is able to decrease Id-2 expression, 
impairing cell growth.  
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IV SEARCHING FOR THE MECHANISM TO EXPLAIN THE 
NUCLEAR COMPARTIMENTALIZATION OF 
GLUTATHIONE  
1. The implication of the active transport or nuclear 
GSH synthesis de novo were not confirmed in our 
model 
1.1 The depletion of ATP failed to prevent the nuclear GSH 
compartimentalization. 
1.2 No evidence on the possible nuclear GSH synthesis could 
be discovered 
2. Bcl-2 as a potential mediator of the nuclear GSH 
compartmentalization 
2.1 The elevated nuclear presence of Bcl-2 concurred with 
the high GSH level in the nucleus in 3T3 fibroblasts. 
3. The importance of Bcl-2 in nuclear 
compartmentalization of GSH and its consequences on 
the proliferation activity. Study in MCF7 cells that over 
express Bcl-2. 
3.1 Bcl-2 induces a rapid increase in total cellular GSH level 
soon after cell plating 
3.2 The Bcl-2 could be responsible for an early increase of 
nuclear GSH in MCF7 cells  
3.3 Bcl2 causes augmentation in the maximal TA level which 
is delayed comparing to the peak of GSH level.  
3.4 Bcl-2 had no significant consequences on cell 
proliferation in MCF7 cells 
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IV SEARCHING FOR THE MECHANISM TO EXPLAIN 
NUCLEAR COMPARTIMENTALIZATION OF 
GLUTATHIONE 
One of the important questions that impose itself is the 
possible mechanism implicated in the nuclear 
compartmentalization of GSH.  
 
1. The implication of the active transport or nuclear 
GSH synthesis de novo were not confirmed in our 
model 
 
1.1 The depletion of ATP failed to prevent the 
nuclear GSH compartmentalization. 
 
In order to elucidate the origin of the high nuclear GSH level 
we have considered that the tripeptide could enter the 
nucleus by an active, ATP dependent transport. We 
incubated 3T3 fibroblasts 24h in culture, when the nuclear 
compartmentalization is maximal, with FCCP, a mitochondrial 
uncoupling agent.  
As shown in Fig. 39 A, 20µM FCCP decreased the ATP levels 
in treated cells to 40% of its control. Nevertheless, the 
results shown in Fig. 39 B imply that glutathione 
concentrates in the nucleus by an ATP-independent process, 
because the glutathione distribution was similar in both 
treated and untreated cells. 
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Figure 39. Glutathione distribution after ATP depletion. Cells were
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 incubated for 120 min with 10, 20 and 40 µM FCCP and the level of the ATP 
depletion is shown in the graph A. The results are presented as mean ± SD 
(n=3). The consequences of ATP depletion with 20 µM FCCP on GSH 
distribution are presented in the image B. Blue fluorescence of nuclei dyed 
by Hoechst, green fluorescence of CMFDA that marks GSH, and PI staining 
for dead cells were captured by confocal microscopy as described in 
“Materials and Methods”.
 
 
 
 
1.2 No evidence on the possible nuclear GSH synthesis 
could be discovered 
 
An additional possible explanation for the reported nuclear 
increase in GSH during the early phases of cell cycle would 
be the nuclear GSH synthesis. We studied the presence of 
the enzymes for GSH synthesis GCS and GSH synthetase. 
Fig. 40 shows a lack of expression of the rate-limiting 
enzyme GCS (1) in nuclear extracts, whereas samples from 
whole cells showed a marked expression.  
 
 Cellular Nuclear
mw 6h24h48h120h48h
GCS
 
 
 
 Figure 40. Expression of glutamyl cysteine synthetase (GCS) in 
nuclear and cellular 3T3 fibroblasts extracts. 3T3 cells were subjected 
to nuclear protein extraction, and a Western blotting procedure was 
performed in nuclear lysates. The membrane was probed against anti-GCS 
antibody (1:750) (NeoMarkers, rabbit polyclonal antibody)
 
 
 
 
Thus, under our experimental conditions, the nuclear 
synthesis of GSH seems improbable. 
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2. Bcl-2 as a potential mediator of the nuclear GSH 
compartmentalization in 3T3 fibroblasts. 
 
One of the proposed mechanisms of the entrance of GSH to 
the nucleus involves the transport mediated by Bcl-2, an 
anti-apoptotic protein whose over expression is shown to 
increase nuclear glutathione level (2) 
 
2.1 The elevated nuclear presence of Bcl-2 concurred 
with the high GSH level in the nucleus in 3T3 
fibroblasts. 
 
The presence of Bcl-2 was studied in nuclear extracts of 3T3 
fibroblasts 6, 24, 48h and 5 days in culture (Fig. 41). 
Interestingly, we have found it to express the highest levels 
in early phases of cell culture, at 6h and 24h, and decreases 
starting from 48h of culture. 
 
 6h24h48h120h
Bcl-2 
 
 Figure 41. Expression of Bcl-2 in nuclear extracts of 3T3 fibroblasts.
3T3 cells were subjected to nuclear protein extraction, and a Western 
blotting procedure was performed in nuclear lysates. The membrane was 
probed against anti-bcl2 antibody (1:1000) (rabbit polyclonal IgG, Santa 
Cruz Biotechnology)
 
 
 
 
Our result points to a correlation between the expression of 
Bcl-2 during the cell cycle and the distribution of cellular 
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GSH. When cells are dividing (6 and 24 h of culture), the 
presence of nuclear Bcl-2 is high, but it decreases later (48 h 
and 5 days of culture) when cell growth stops. 
 
3. The importance of Bcl-2 in nuclear 
compartmentalization of GSH and its consequences on 
the proliferation activity. Study in MCF7 cells that over 
express Bcl-2. 
 
 In attempt to elucidate the possible implication of Bcl-2 in 
the nuclear compartimentalization of GSH we have used the 
cell line obtained by the stable transfection of MCF7 cell with 
the oncogen Bcl-2, “MCF7 Bcl-2” cells. 
 
3.1 Bcl-2 induces a rapid increase in total cellular GSH 
level soon after cell plating 
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Figure 42. The effect of bcl-2 on cellular GSH level in MCF7 cells. The 
cells were plated as desribed above and the acid extracts were obtained as 
described in “Materials and Methods”. The total cellular concentration of GSH 
was determined spectrophotometrically as described in “Materials and 
Methods”. The results are presented as mean ± SD of at least five different 
experiments. The table of p significance derives from double ANOVA test 
followed by t student.
 
 
 
 
 
The MCF7 Bcl-2 cells had exceptionally high GSH value at 6h 
of culture (304,93±18,51 nmols/mg prot., p≤0,001 vs. 
MCF7) (Fig. 42). Afterwards, the level of GSH descended 
swiftly and at 18h of culture was already lower than in MCF7 
cells (p≤0,05), which had their maximal GSH value at this 
time point. Total cellular GSH in MCF7 Bcl-2 cells continued 
to decline until 24h when it started to increase again. It 
stayed higher than in wild type MCF7 until the end of the 
culture, but the difference was not significant. 
  
3.2 Bcl-2 could be responsible for an early increase of 
nuclear GSH in MCF7 cells  
 
3.2.1 The confocal microscopy analysis of the nuclear 
compartmentalization of GSH. 
The high level of total cellular and nuclear GSH (green 
CMFDA fluorescence) could be observed in both cells lines, 
particularly before 24h of culture (Fig. 43).  
 170  
                                                                         IV Results   
           171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43. The confocal microscopy study of the effect of bcl-2 on 
the cellular distribution of GSH. MCF7 and MCF7 bcl2 cells were plated
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7days, 72h, 24h, 18h, 12h, and 6h before the experiment as described in 
“Materials and Methods” and analyzed the same day. The staining was 
performed as described previously and the maximum projection images 
derive from 7-10 Z axis planes. The representative experiment is shown.
 
 
 
The nuclear compartmentalization of GSH became 
perceptible starting from 12h in culture in both cell lines. 
Although the level of the fluorescence decreased during the 
cell culture, in coherence with the decreased level of the 
total cellular GSH (obtained by biochemical analysis), the 
level of nuclear GSH compartmentalization seemed 
unchanged until 7 days in culture. Even in the advanced 
culture of cancer cells, some dividing cells with high GSH 
content and its nuclear localization could still be seen on the 
plate. 
 
3.2.2 The quantification of the nuclear CMFDA fluorescence 
level in early phases of cell culture 
At 12h of culture (Fig. 44) MCF7 Bcl-2 cells have reached 
the peak of nuclear GSH (p≤0,01 vs. 6h) and had 
significantly higher level of nuclear GSH than wild type 
(p≤0,05). On the contrary, at 18h of culture, the nuclear 
GSH level in transfected cells already decreases, although 
not significantly, while MCF7 cells reach their maximal 
nuclear GSH value.  
The quantification of the nuclear levels of CMFDA 
fluorescence showed that Bcl-2 might cause the early 
increase of nuclear GSH level in MCF7 cells.  
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Figure 44. The effect of bcl-2 on nuclear GSH level in MCF7 cells The 
maximum projection images (as presented in the fig  ) were analysed by 
area, as described in “Materials and Methods”. The results presented are 
mean values ± SD from 2 different experiments (200-500 cells per 
experiment). The table of p significance derives from double ANOVA test 
followed by t student.
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3.3 Bcl2 causes augmentation in the maximal TA 
level which is delayed comparing to the peak of 
GSH level.  
 
As previously shown (Fig. 9), the peak of telomerase activity 
of MCF7 cells was at 18h and it coincided with the peak of 
GSH. In MCF7 Bcl-2 cells, the peak of TA was at 12h-6h 
earlier comparing to the MCF7 cells (Fig. 45). Moreover, the 
increase comparing to 6h was four fold, and the level was 
more than double of the maximal TA level observed in MCF7 
cells (p≤0,05 vs. MCF7 cells, and vs. 6h).  
However, maximal TA did not coincide with the peak of GSH; 
it was 6h delayed with respect to the maximal GSH value.  
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 Figure 45. The effect of bcl-2 on telomerase activity in MCF7 cells. 
The cells were plated, the samples obtained and the relative telomerase 
activity was measured by TRAP as described in “Materials and Methods”. The 
results are presented as mean ± SD of at least three different experiments 
(A) and as the % of change of TA along the cell cycle normalized by the 
value at the beginning of culture (6h) (B). 
 
 
 
 
 
 
3.4 Bcl-2 had no significant consequences on cell 
proliferation in MCF7 cells 
 
The flow cytometry analysis of the DNA content showed no 
differences between MCF7 and MCF7 Bcl-2 cells (Fig. 46).  
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Figure 46. The effect of the bcl-2 on the cell proliferation in MCF7 
cells. Cells were plated as described and the flow cytometry analysis of the
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 DNA content was performed as explained in “Materials and Methods”. The 
results of cell cycle analysis for DNA synthesis (A), M+G2 phase (B), and 
total cell proliferation activity (S+M/G2) (C) are demonstrated as mean  ±
SD of at least 5 different experiments.
 
 
 
 
The percentage of cells in S phase was higher in transfected 
cells at 6h of culture and again starting from 48h of culture. 
These fluctuations are coherent with the changes in GSH 
level along the cell cycle (Fig. 42), but the differences are 
not statistically significant. 
 
The study of the expression of cell proliferation marker, 
PCNA, confirmed the extended length of exponential growth 
phase of MCF7 cells (high expression 24-72h), but lacked to 
show any significant differences caused by Bcl-2 (Fig. 47) 
 
 6h 24h 48h12h 18h 72h 168h
MCF-7 bcl-2
MCF-7
α-tubulin
 
 
 
 
 
 
 
 Figure 47. The effect of the bcl-2 on the expression of the cell 
proliferation marker, PCNA, along the cell cycle in MCF7 cells. The 
representative experiment (n=3) is shown.
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In conclusion, the peak of telomerase activity (Fig. 45) 
coincides with the peak of nuclear GSH level (Fig. 44) in 
both cell types. Bcl-2 seemed to cause the early increase of 
total cellular GSH level, nuclear GSH level and telomerase 
activity (Fig. 42, 44 and 45, respectively). These values, 
although extremely high, did not persist and seemed to have 
no apparent consequences on the cell growth (Fig. 46).  
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V DISCUSSION 
 
1. Overview of the results 
The present thesis offers an insight in the importance of  
nuclear GSH in cell proliferation.  
The research was performed in three different cellular 
models of diverse proliferating activity: immortalized mouse 
embryonic fibroblasts 3T3, mammary adenocarcinoma cell 
line MCF7 and primary embryonic neuralonal culture. The 
results presented here provide evidence that suggest that 
the relationship between GSH level and telomerase activity, 
previously described by our group for 3T3 fibroblasts is a 
common phenomenon in mammalian cells. Reduced 
glutathione emerged as a driving force of cell cycle 
progression; high level of GSH coincided with the peak of 
telomerase activity and preceded the exponential phase of 
cell growth in all three cell types analyzed. Moreover, the 
comparative studies of three distinct proliferating models 
revealed that the level of GSH corresponded to the intensity 
of the proliferation and clearly correlated with the level of 
DNA synthesis. This finding inspired the focus on the nuclear 
compartmentalization of GSH. Interestingly, nuclear 
localization of GSH was observed before the exponential 
phase of cell growth in all three cell types, while the GSH 
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distribution within the cell was uniform when the cells 
stopped proliferating. Comprehensive analysis of the nuclear 
GSH levels along the cell cycle, and the experiments with the 
depletion of nuclear GSH conducted in 3T3 fibroblasts, 
provided further evidence on crucial importance of nuclear 
GSH for the onset of cell proliferation. In the attempt to 
elucidate the possible mechanism of nuclear GSH 
compartmentalization, we have found no evidence either of 
active GSH transport or of its de novo synthesis in the 
nucleus. The implication of bcl2 in nuclear transport of GSH 
was evaluated in the study of MCF7 cells over-expressing 
this protein. In this model, bcl2 caused an early and striking 
increase of total cellular glutathione, nuclear GSH and 
telomerase activity; unexpectedly, these alterations induced 
no significant effect on cell proliferation. 
In summary, our results reveal the importance of nuclear 
GSH compartmentalization in early phases of cell 
proliferation. This study suggests that the control of the cell 
cycle progression from G1 to S phase is dependent on 
elevated nuclear GSH levels and originates from its influence 
on telomerase activity and DNA synthesis. 
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2. The concurrence of increased levels of total cellular 
glutathione and telomerase activity before the 
exponential phase of cell growth is a common feature 
in the three cell types studied. 
 
2.1. The high level of total cellular glutathione precedes the 
exponential phase of the cell growth. 
The comprehensive comparative study of the relationship 
between GSH and cell cycle progression in three different 
models of cell proliferation, presented in this thesis, gave the 
evidence of the importance of the high GSH levels before the 
beginning of the cell growth. The same pattern was observed 
in all three cell types, with minor differences.    
In 3T3 fibroblasts the GSH level was high at the beginning of 
culture and reached its maximal value at 24h, just before 
the beginning of the exponential phase of the cell growth 
(Fig. 1), remaining decreased while the cells were 
approaching confluency. Our finding supports the study of 
Hutter et al [1] who demonstrated that actively dividing 
normal fibroblasts had a redox potential of -222mV, which 
gradually increased while the population was growing and 
reached maximal level of -188mV when cells were contact 
inhibited. 
In our cancer cell model, MCF7 cells, GSH level 
reached the peak earlier (at 18h) comparing to 3T3 
fibroblasts, and the increased levels were sustained for a 
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longer period of time. In accordance to this, the interval of 
intensive cell growth was also longer in MCF7 cells (Fig. 2), 
and, surprisingly, the beginning of the exponential phase 
was delayed comparing to 3T3 fibroblasts.  
However, in the embryonic neural culture model, we 
could clearly distinguish two growth patterns: 1) the 
prominent cell growth in the beginning of the culture which 
corresponded to the period of the intensive development of 
rat neural system (14-18th day of gestation, see Materials 
and Methods) and 2) the interval after 96h of culture when 
the cell growth was absent since the proliferation of glial 
cells was prevented (cytosine arabinoside was added, as 
described in Materials and Methods) and the culture 
consisted of non-proliferating neurons. Equivalent to the 
other two cell lines, the intensive growth was preceded and 
accompanied by the high GSH level, while the differentiated 
neuronal culture that stopped growing had lower GSH level 
(Fig. 3).  
Thus, our results reveal that, regardless of the cell type 
studied and the proliferating capacity of the cell culture, the 
GSH level is always elevated before the cell growth begins; it 
is maintained during the initiation of the proliferation and 
decreases together with the growth intensity. 
Additionally, the comparative analysis of the intensity of cell 
growth in these three cell lines revealed important 
differences in the profiles of the proliferation curves in these 
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cell types (Fig. 11). 3T3 fibroblasts started growing 
exponentially at 24h, when the GSH concentration was also 
at its maximal level. The growth slowed later and the GSH 
level decreased gradually and the growth slowed as the 
culture progressed to confluence. MCF7 cells showed a 
striking increase in cell number starting from 48h, and 
continued to grow at the same pace until the final time 
point. This could explain the extremely high number of cells 
present at the plate, almost double comparing to 3T3 
fibroblast. 
Regarding embryonic neural culture, due to a very low cell 
number and growth rate the cell growth profile was 
complicated to compare on the same scale with other two 
cell types. 
Interestingly, the comparison of the GSH level 
between three cell lines provides further information that 
suggests the importance of GSH in cell proliferation. The 
GSH concentration in MCF7 cells, despite its prompt 
decrease after 18h, and continuous and gradual decline 
during the exponential phase of the cell growth, was always 
higher than the maximal value determined for 3T3 
fibroblasts (Fig. 12).  In accordance with that, the 
comparison of the GSH level (Fig. 12) of this culture with 
3T3 fibroblasts and MCF7 cells revealed the same pattern as 
the cell growth; the GSH concentration in embryonic neural 
culture is lower than in the other two cell types. 
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Hence, our results indicate that the level of cellular 
GSH in a particular cell line could define its proliferating 
capacity and its variations along the cell culture dictate the 
rhythm of cell proliferation.  
This finding is particularly interesting if we consider 
the importance of aberrant proliferation in various human 
pathophysiological conditions. Cancer, neurodegenerative 
processes, atherosclerosis, aging, hyperplasia induced 
fibrotic responses and wound healing are, basically, altered 
proliferative events, and, interestingly, have been associated 
with the alterations in antioxidant pathways and redox 
regulation [2]. Our results point to reduced glutathione, a 
major intracellular antioxidant, as a central player and an 
indicator of the cellular proliferation state.  
Our results, in general, are in accordance with the 
work of Hutter at al, who have studied the redox potential 
(E) in the normal and malignant cells along the cell cycle.  
The E of normal cells fluctuates during the cell cycle; 
for the proliferation to start it has to decrease at least 30mV 
comparing to its level in the G0 phase (where the cells are 
100% confluent). On the contrary, in cancer cells, the E 
remains low throughout the complete cell cycle, even at a 
high cell density [1]. Our evaluation of the GSH levels along 
the cell cycle in different models indirectly confirms these 
findings (Fig. 12).  
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The work of Hutter et al. was further developed and 
completed by Hoffman et al.[3], who proposed recently a 
novel redox model of cell proliferation. They postulate the 
existence of a redox switch that helps regulate the 
proliferation within normal cells; its absence in cancer cells 
enables the bypass of the restriction point and leads to the 
loss of the control of cell cycle. The authors offer this model 
as a base to understand the aberrant cellular proliferation 
that leads to malignant transformation (Fig V 1.).  
 
 
 
 
 
 
 Hoffman A, Spetner LM, Burke M, 2008
According to “redox model of cell proliferation”, in 
normal cells exist a threshold value (θ) of E≤ 207±11mV 
which initiates the phosphorylation of different regulatory 
proteins associated with different phases of the cell cycle 
and, consequently, cell proliferation. When E>θ cell enters 
G1/G0 phase. However, when cancer cells are concerned, 
           185 
                                                                      V Discussion 
 
 
Hoffman does not take into account the fluctuations in the E 
level. In our hands, the increase in GSH level along the cell 
cycle (before the onset of the proliferation comparing to the 
GSH level at the final time point) is, indeed, less striking 
than in 3T3 fibroblasts; two-fold comparing to four-fold, 
respectively (Fig. 4 and 5, respectively). Moreover, the level 
of GSH in MCF7 cells is significantly higher than in 3T3 
fibroblasts during the entire time of the culture (Fig. 12), so 
cancer cells are, indeed, in a permanent reduced state. 
Nevertheless, the exponential phase of the cell growth in 
MCF7 cells is somewhat delayed comparing to 3T3 
fibroblasts.  
 The author hypothesizes, though, the existence of a 
reductive limit of -260mV which normal cell could not 
survive, but would not jeopardise cancer cell.  
It was proposed previously that the proliferation 
occurs within the range of ROS levels, concentrations above 
or below this range could lead to growth arrest or cell death; 
hence ROS could act like a dual-edged sword [4]. 
Analogically, similar supposition could be made for 
glutathione: MCF7 cells at the beginning of culture are in 
extremely reduced state so it might be necessary for the 
GSH level to decrease to some point before the exponential 
growth could start. So, our results suggest that reductive 
limit for the proliferation onset could be present in cancer 
cells. 
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2.2. Cell cycle is governed by the level of GSH 
The interdependence of the GSH level and cell growth 
intensity was further confirmed by the thorough analysis of 
the phases of the cell proliferation (Fig. 4, 5, and 6) and the   
expression of cell cycle regulatory proteins, such as Id2 and 
PCNA (Fig. 7).  
In 3T3 fibroblasts maximal proliferative activity of the 
cells (S+G2/M), defined by the sum of the percentage of the 
cells in DNA synthesis (S) and the percentage of cells in G2 
phase and mitosis, coincided with the peak of GSH. 
However, when these two phases were analysed separately, 
it appeared that the level of G2/M phase actually coincided 
with high values of GSH during 24-48h of culture, while the 
peak of S phase was delayed comparing to the peak of GSH 
Fig.4). On the other hand, in MCF7 cells, the peak of GSH 
preceded both S phase and G2/M phase maximum (Fig. 5). 
In contrast to 3T3 fibroblasts, the interval of high 
proliferation activity in these cells was prolonged, although 
the level of GSH continued to decrease gradually. It is not 
surprising if we bear in mind that the level of GSH in these 
cells was extremely high comparing to other two cell types 
at all time points of the cell culture. 
In embryonic neural culture, considerable percentage 
of cells were in G2/M phase early in the culture, even before 
GSH level increased (Fig. 6). This culture originates from the 
cerebral cortex of the rat foetuses isolated at 14-15th day of 
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gestation; therefore an important number of dividing cells 
could already be present in the culture. DNA synthesis, like 
in other two cell types, was delayed until the GSH level had 
reached its maximal value. However, the increase of GSH 
level followed by the DNA synthesis could not have led to the 
proliferation onset because the latter was prevented by the 
addition of the cytosine arabinoside. 
Furthermore, when proliferating cells i.e. astrocytes, were 
almost entirely absent in the culture of differentiated 
neurons, the GSH level was lower than in the mixed culture. 
This finding is in accordance with the redox switch theory 
(see above); the differentiated neurons are in G0 phase 
characterized by a less reduced state. E is significantly below 
the threshold value necessary for the new entrance to cell 
cycle and is maintained at the similar level until the dying off 
of the culture. Our results provide the support to previous 
reports that neurons in cultures prepared from the cortex 
contain less glutathione than astroglial cultures from cortex 
[5]. This is due to the inability of neurons to take up cystine 
and, therefore, rely on the presence of cysteine as substrate 
for glutathione synthesis which, again, is provided by 
astrocytes [6]. Nevertheless, the decrease in GSH level was 
not striking and in our hands a 10 days neuronal culture had 
total GSH concentration similar to the previously published 
(36,8±6,6 nmols/mg prot., vs. 40 nmols/mg prot., 
respectively) [7]. In accordance with the findings published 
by [8], GSH content was significantly higher in the G2/M 
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phase compared to G1, suggesting that the cells preparing 
for the cell division and undergoing mitosis are at a more 
reduced state compared to G1 phase. According to this 
study, S phase cells showed an intermediate redox state. 
Our findings not only supports this study, but also places in 
time the high levels of GSH in the cell culture before the 
prevalence of the cells that synthesise DNA. In conclusion, 
our work in three different models of cell proliferation 
provides further evidence in favour of the importance of the 
fluctuations of the cellular redox state in regulating the cell 
cycle. Whether the cell line was primary, immortalized or 
malignant, the high level of cellular GSH was essential 
before the onset of the exponential cell growth. 
2.2.1. Glutathione controls the cell cycle regulatory 
proteins 
2.2.1.1. Id2 as a redox sensitive protein. 
The study of the expression of the Id2 along the cell 
cycle gave further support to this premise. The family of 
helix-loop-helix proteins denominated Id (inhibitor of DNA 
binding or inhibitor of differentiation) was demonstrated to 
be of considerable importance in the regulation of cell 
growth, differentiation and cancer in many mammalian 
tissues [9, 10]. Id2, in particular, was shown to disrupt 
antiproliferative effects of tumour suppressor proteins of the 
Rb family, thus allowing cell cycle progression [11]. Indeed, 
the pattern of the Id2 expression detected by Western 
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blotting (Fig. 7), confirmed the distribution of the phases of 
the cell proliferation detected by flow cytometry. Moreover, 
its level is comparable with the level of GSH: when and while 
GSH level is high the important expression of Id2 could be 
observed, at 24 and 48h in 3T3 fibroblasts, at 12, 18, and 
24h in MCF7 cells and in the early embryonic neural culture. 
This observation is in the line with the proposed redox 
regulation of this protein [12]. In addition, the studies of 
liver regeneration, process that involves DNA synthesis and 
cell proliferation, gave further support to our findings. It was 
demonstrated that when the increase of GSH after partial 
hepatectomy was prevented, the liver regeneration was 
delayed and the total liver amount of the DNA was lower 
than in the control group [13]. Furthermore, an early 
increase in Id2 gene has been demonstrated as well as the 
contribution of Id2 in the control of hepatocyte priming 
through modulation of c-myc expression [14]. All these 
support our notion that Id2 could be an excellent candidate 
as a protein marker of the redox regulation of cell 
proliferation in our models.    
2.2.1.2. PCNA as a possible redox sensor in the onset 
of DNA synthesis  
PCNA, a proliferating cell nuclear antigen, is a central 
protein in both DNA replication and repair. It’s a “sliding 
clamp” that localizes proteins, such as DNA polymerase, to 
DNA and thus enables the correct DNA replication. As 
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expected, this marker of DNA synthesis was up regulated at 
48h in 3T3 fibroblasts, between 24-72h in MCF7 cells and 
before 96h of embryonic neural culture, when the % of cells 
in S phase was shown to be maximal also by flow cytometry. 
The time point characterized by the maximal GSH value 
precedes these intervals, which further confirms our premise 
that the reduced cellular environment is a prerequisite for 
the beginning of the DNA synthesis. 
Replication of mammalian genome starts at thousands 
of origins, called replication foci, which contain PCNA and are 
activated at different times during S phase. The dynamics of 
replication foci is still a matter of debate; there are 
contradictory reports on the organization of the DNA 
replication sites in diverse cell types attributable to the 
differences in the technical approach [15, 16]. According to 
Dimitrova, SD and Berezney, R [17] there is no fundamental 
difference in the spatiotemporal organization of the DNA 
replication in primary, immortalized and malignant 
mammalian cells. On the contrary, Kennedy’s group [16], 
observed different patterns of replication foci in primary 
versus immortalized cell lines, as well as their perinuclear 
localization in the contact-inhibited cells prior to cell cycle 
exit [18]. Another fundamental question was weather the 
replication foci are moving along the DNA in the process of 
the replication, or the DNA is spooling through fixed 
replication factories. It seems that the important body of 
evidence is accumulating supporting the fixed-replication-
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site model [15, 19]. The replication machines bind to DNA, 
but they are also tethered to an underlying framework called 
nuclear matrix or skeleton [19]. Regardless of the 
discrepancies in their findings, all the authors call attention 
to the importance of the preserving nuclear architecture in 
order to guarantee the correct development of the process of 
DNA replication [15, 18, 19]. In addition, it has been shown 
that chromosome territory organization depends on 
association with the nuclear skeleton [19]. More than 20 
years ago, Dijkwell et al. [20] postulated that the 
maintenance of the nuclear matrix, especially nuclear 
lamina, by preserving disulphide bonds depended on the 
level of nuclear thiols. In accordance to this work, Oleinick et 
al. [21] reported that DNA-protein cross links, present at 
basal level as normal associations of chromosomal loops 
with the nuclear matrix proteins, can be increased by 
ionising radiation and removal of intracellular glutathione, 
and decreased by hydroxyl radical scavengers. The 
importance of the GSH in cell proliferation could be 
extrapolated to the safeguarding of the nuclear architecture, 
providing in that way a proper milieu for the DNA replication. 
Our results could provide support to the hypothesis of 
Bellomo et al [22] that reduced nuclear glutathione may 
modulate the structural organization of chromatine. It is 
tempting to speculate that the high nuclear GSH level we 
observed before (late G1 phase) and at the onset of cell 
proliferation (S phase) could provide the redox environment 
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that stimulates chromatin decompaction by reducing 
disulfide bonds.  
2.2.2. GSH is an indicator of cell proliferation potential  
So, if the high level of GSH is crucial for the phase of 
proliferation to take place, the question whether the level of 
GSH defines the proliferation potential of the cell type 
imposes itself. The comparison of the three proliferation 
models yielded the most interesting results and provided 
further evidence in favour of our hypothesis.  
In the comparative study of the interdependence of 
the GSH level and the cell proliferation intensity in the three 
cell types the highest correlation with the level of GSH was 
found for DNA synthesis (R2=0,7) (Fig. 19), but not the cell 
division (G2/M) or total proliferation activity (S+G2/M) (Fig. 
17 and Fig. 15, respectively). 
Surprisingly, 3T3 fibroblasts had more cells in S+G2/M 
and G2/M phase of the cell cycle (Fig. 14. and Fig 16., 
respectively) than MCF7 cells and embryonic neural culture, 
although for shorter period of time. Nevertheless, at the final 
time point the number of MCF7 cells almost doubled the 
number of 3T3 fibroblasts. One possible explanation for this 
apparently contradictory finding we could trace in the very 
nature of malignant cells. According to Green, RD and Evan 
GI [23], cancer originates from a rare coincidence where at 
one cell at the same time arise deregulated cell proliferation 
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and suppressed apoptosis. This is just the case of MCF7 
cells; the cell culture is highly desynchronised, and as a 
consequence, we can detect, at all time points, rather the 
significant proportion of cells in different phases of cell cycle 
than accumulation of the cells in one of the phases, as in 
3T3 fibroblasts.  
Our results showed the strong correlation between the 
level of DNA synthesis and GSH level indicates that high 
concentration of GSH is essential for this process. This result 
is not surprising knowing that the importance of GSH in the 
nucleotide synthesis has been demonstrated long since [24]. 
However, in an early work by Spyrou and Holmgren [25] it 
has been demonstrated that BSO, although it decreased 
glutathione level, did not affect the nucleotide synthesis. On 
the other hand, numerous papers demonstrate that the 
depletion of glutathione does induce growth arrest, in vivo 
as well as in vitro, and hampers DNA synthesis. Thus, the 
potential involvement of the GSH in the very process of the 
DNA replication prompted us to search for its further 
possible function in this process. One important parameter 
of cell proliferation, crucial for the correct and complete 
replication of the DNA, and possibly correlated with 
glutathione level is the telomerase activity. 
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2.3. The relationship between telomerase 
activity and the level of cellular glutathione controls 
the cell cycle progression 
 
The increase of telomerase activity is associated with 
deregulated proliferation in human cancers [26] and is also 
present in highly proliferative germinal cells [27]. On the 
contrary, its decrease, which results in replicative 
senescence, was reported in vitro in growth arrested cells 
[27, 28], and in vivo in syndromes of premature aging, 
endothelial dysfunction and atherosclerosis [29]. 
Interestingly, oxidative stress has been implicated in all 
these pathological conditions [30]. In Warner’s syndrome, 
characterised by adult premature aging, the significant 
alteration of GSSG/GSH ratio, as well as considerable DNA 
damage was demonstrated [31]. In Down’s syndrome, which 
displays some features of accelerated senescence associated 
with telomere shortening [32], a prooxidant state with early 
onset has been demonstrated in vivo [33], as well as in 
several other aging-related genetic diseases [34]. All these 
reports point to an increasing interest in the possibility that 
oxidative stress could induce or accelerate the development 
of replicative senescence [35]. Furthermore, it was 
demonstrated in human vascular endothelial cells and in 
human skin keratinocytes that telomere shortening slows 
down when oxidative stress is suppressed by antioxidants, 
such as vitamin C [36, 37]. So, according to these studies, 
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telomerase activity could be stimulated or preserved by 
reduced environment.  
In the context of our study, it was interesting to 
explore a possibility of redox control of telomerase activity 
by glutathione in the framework of cell cycle progression. 
Our group has previously described the connection between 
GSH level and telomerase activity in 3T3 fibroblasts [12]. 
Telomerase activity is regulated by the changes in 
glutathione redox potential at values comparable to those in 
vivo and changes in telomerase activity are modulated in 
coordination with changes in cell cycle proteins, particularly 
Id2. The rhythm of GSH fluctuations coincided with that of 
the telomerase activity (Fig. 8) and it was proposed that the 
control of the proliferation in 3T3 fibroblasts could be based 
on this relationship. Considering the importance of this 
finding and the possible implications it could have in various 
fields of cell biology, from cancer and development to the 
theory of aging, we have amplified the study to cancer cell 
line, MCF7 and embryonic neural culture.  
It is interesting to find that, in the three different 
models of cell proliferation used in this study, the telomerase 
activity (TA) reaches its maximum at the same time point as 
total cellular GSH concentration and the fluctuations along 
the cell cycle are strikingly similar (Fig. 8., 9., 10.). In MCF7 
cells the peak value of GSH and telomerase activity was 
considerably higher than in 3T3 fibroblasts and embryonic 
neural culture. Moreover, these values increased earlier and 
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were maintained elevated for longer period of time then in 
the case of 3T3 fibroblast where the increase was delayed 
and the peak value was easily distinguishable at 24h. In the 
embryonic neural culture, there was important telomerase 
activity before the peak of GSH was reached (attributable to 
the presence of the proliferating cells in the moment of the 
isolation of the primary culture, as discussed previously), 
and, as expected, it was declining steadily after the 
proliferating cells were eliminated from the plate.  
This new results strongly confirmed the previous 
observations published by our group for immortalized cell 
line, 3T3 fibroblasts [12]. Even more, the fluctuations of 
telomerase activity resemble the fluctuation in cellular redox 
potential that, according to Hoffman et al (Fig. V 1) regulate 
the cell cycle progression. Variations in telomerase activity 
are more prominent in 3T3 fibroblasts than in MCF7 cells, 
and in embryonic neural culture telomerase activity seems 
relatively stable (Fig. III 13.) This further supports our 
premise that reduced glutathione level controls cell cycle 
progression by the regulation of telomerase activity. 
On the contrary, in a recently published research by Perez-
Rivero G et al [38] it has been asserted that it is telomerase 
deficiency that promotes the oxidative stress, due to 
reduced catalase activity, and not the other way around. 
This study was performed on cultured mouse embryonic 
fibroblasts (MEF) and renal cortex isolated from mice lacking 
telomerase activity and showing the signs of premature 
aging. On the other hand, it has been reported that the 
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mouse cells do not show senescence when cultured at a 
physiological oxygen concentration (3%). If mouse cells are 
grown at atmospheric oxygen concentration (20%), which 
provides an additional oxidative stress to the cells, cell 
growth slows after 12–15 population doublings, due to 
accumulated DNA damage [39, 40]; So, it is the oxygen 
sensitivity that could cause replicative senescence and not 
the opposite.  
In addition, as Kurz DJ et al. [29] clearly 
demonstrates in human umbilical vein endothelial cells, 
glutathione-dependent redox homeostasis is a key factor in 
the preservation of telomere function, and mild chronic 
oxidative stress is at the root of the replicative senescence 
caused by the loss of telomere integrity. Their results are 
resumed in Fig V 2. The loss of catalase activity leads to 
accumulation of H2O2 and its translocation to the nucleus, 
where in subsequent Fenton reaction it induces telomere 
damage. This premise has a solid theoretical support; 
guanine rich composition of telomeres makes them several-
fold more susceptible to oxidative stress mediated damage 
than non-telomeric DNA [41].
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In addition, a specific inhibitor of telomerase, 2- [3-
(trifluoromethyl)phenyl]isothiazolin-3-one, reacts with a key 
cysteine residue which in order to guarantee telomerase 
activity must be kept reduced; dithiothreitol reverses this 
inhibition [42]. So, the high glutathione concentration could 
be important on the two levels: to preserve the telomere 
integrity by protecting it directly from oxidative damage, 
and/or to preserve the telomerase activity by maintaining 
the crucial cystein residue in reduced state. These findings 
indicate that the implication of glutathione in the control of 
telomerase activity might be considered as its new role in 
the DNA synthesis, further from previously described in the 
pentose phosphate pathway [24].  
 
           199 
                                                                      V Discussion 
 
 
This finding is particularly significant, as it indicates 
that the telomerase activity is highly sensible to the cellular 
redox state, regardless of the cell type, its inherent 
proliferation capacity or the origin of the cells. It is a 
universal phenomenon which could have important 
implications in the study of various pathophysiological 
processes in which the importance of telomerase has been 
demonstrated, such as aging and cancer.  
Furthermore, in a vigorously developing field of stem 
cell research one of the clear and recognized hazards of cell 
therapy is the subsequent development of cancer. Indeed, 
the epidemiological study in 926 patients that underwent a 
life-saving allogeneic hematopoietic stem cell transplantation 
(allo-HSCT) demonstrated an increased risk of development 
a second solid cancer [43]. Interestingly, the risk was 
significantly higher if the donor was a female. In the light of 
our study, this is of particular importance if we bear in mind 
that, on one side females have longer telomeres than males  
[44] and on the other have less oxidative stress [45]. In 
accordance to this, telomerase activity was proposed as a 
useful marker of non-differentiated, still pluripotent cells 
which, if accidentally implanted, could have malignant 
capacity [46]. It would be interesting to investigate if by 
modulation of glutathione these cells cold be eliminated, and 
thus, this threat could be avoided.  
 
 
 200  
                                                                      V Discussion 
 
 
3. Nuclear compartmentalization of glutathione 
as an important feature of proliferating cell: reduce to 
replicate 
  
The functional compartmentalization is an obvious 
characteristic of eukaryotic cell. The organelles, visible by 
light microscopy, are surrounded by membranes, which, 
although permitting communication, provide unique and 
defined environment in each one, which guarantee its 
accurate function. Probably the most remarkable examples 
of compartmentalization are oxidative phosphorilation in 
mitochondria, protein folding in endoplasmatic reticulum 
and, for the purpose of this study the most interesting of all, 
DNA synthesis.  
It is interesting to note that, when the first two 
organelles are concerned, the dependence of their function 
on the correct GSH level has been thoroughly studied. The 
high intramitochondrial concentration of GSH is maintained 
by an active multicomponent transport system “pumping” 
glutathione from the cytosol into the matrix [47]. On the 
contrary, for the correct folding of proteins into a native 
structure by disulfide bond formation, the GSH level and the 
ratio GSH/GSSG in the endoplasmatic reticulum is 
maintained at extremely low level by the limited 
permeability of the vesicle membrane to GSH [48].  
However, in the case of nuclear compartmentalization of 
glutathione the reports were scarce and contradictory over 
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the years. This could be attributed to two main factors: 
methodological difficulties in measuring nuclear glutathione 
content and the focus of the research generally limited to 
confluent cells.  
 
3.1. Methodological challenge 
 Firstly, it is impossible to determine the nuclear 
concentration of GSH using standard cell fractionation and 
analytical techniques. This point was already addressed in an 
interesintg review by Soederdahl et al [49]). This approach 
in our hands also yielded unsatisfactory results (Fig. III 21).  
In view of this knowledge we opted for confocal 
microscopy, the approach which, although providing the 
huge advantage of the possibility to analyse the nuclear 
glutathione of the living cells, is not without contradictions, 
previous reported. Mercury orange, monochloro bimane, and 
5-chloromethylfluorescein diacetate (CMFDA) are the most 
commonly-used probes for GSH determination, but the 
results obtained by these methods are conflicting. Pioneer 
work by Bellomo et al. [22] using monochlorobimane-GSH 
conjugation demonstrated a 3:1 nucleus: cytoplasm ratio. 
However, a more recent report by Briviva et al. [50] argued 
that the high nuclear fluorescence was due to an influx of 
the fluorescent bimane-GSH adduct into the nucleus. In a 
different approach, Thomas et al. [51] used fractionation 
techniques and flow cytometry with mercury orange; this 
probe readily forms fluorescent adducts with GSH and other 
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non-protein sulphydryls (NPSH), but reacts much more 
slowly with protein sulphydryls. Contrary to previous reports, 
they found lower GSH levels in the nucleus than in the 
cytoplasm: the mean nucleus-cytoplasmic ratio was 0,57± 
0,05. It was postulated the existence of a distinct pool of 
GSH in the nucleus since it was partially resistant to BSO 
depletion compared with the cytoplasm. More recently, 
Söderdahl et al. [49] showed the highest GSH staining in a 
perinuclear mitochondrial-rich compartment and low nuclear 
GSH staining using mercury orange and a specific GSH 
antibody. Finally, Voehringer et al. [52] using CMFDA which 
binds in 95% to GSH, showed that GSH was mainly 
distributed in the cytoplasm although Bcl-2 overexpression 
was able to increase nuclear GSH levels. 
In recent years new methods have become available 
for measuring the nuclear redox state. These have been 
recently reviewed by Hansen, Go and Jones [53]. Two forms 
of the redox blot have been developed to separate nuclear 
proteins on the basis of different charge or mass oxidized. 
Other techniques include antibodies that only bind to the 
oxidized form of the protein [54], and mass spectrometry 
[55]. Alternatively, a redox-sensitive green fluorescent 
proteins (roGFP) have been designed with the hope to be 
used as an indicators of the nuclear redox. Although it is a 
promising step, so far no physiological oxidative treatment 
has been capable of triggering detectable changes in the 
excitation ratios of roGFP. Another method consisting in a 
Western blot technique which separates reduced and 
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oxidized Trx1 in nuclear fractions provide a new means to 
establish the redox state of the nucleus [56]. While this may 
be the way to evaluate nuclear redox state, measurement of 
nuclear GSH concentrations remains limited, and no 
methods are available to measure nuclear GSSG [54]. 
However, a substantial breakthrough seems to emerge in a 
very recent work of Tobias Dick’s group, published in Nature 
Methods (may, 2008) [57]. Acording to this study, the Grx1-
roGFP2 fusion protein allowed dynamic live imaging of the 
glutathione redox potential (E(GSH)) in different cellular 
compartments with high sensitivity and temporal resolution. 
The biosensor detected nanomolar changes in oxidized 
glutathione (GSSG) against a backdrop of millimolar reduced 
glutathione (GSH) on a scale of seconds to minutes. It 
facilitated the observation of redox changes associated with 
growth factor availability, cell density, mitochondrial 
depolarization, respiratory burst activity and immune 
receptor stimulation. 
Our approach was based on determining of the cellular 
distribution of glutathione analyzing alive intact cells under 
the usual conditions of cultivation; at 37ºC, 5% CO2 and in 
cell culture medium. In order to study glutathione 
compartmentalization during cell growth, we used a triple 
staining (CMFDA-Hoescht-propidium iodide) or (CMFDA-
Hoescht-mitotracker) and subsequent analysis by confocal 
microscopy [58].  
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3.2. The dynamic focus of the study 
 
Most, if not all reports share the common insight in the 
nuclear GSH distribution in a static situation. Cells are 
usually studied under steady state conditions i.e. at 
confluence (G0/G1 phase). The nucleus changes 
dramatically during the different phases of the cell cycle. 
Therefore, studies designed to elucidate the nuclear 
compartmentalization of GSH should take into account the 
cell cycle physiology. 
Indeed, if glutathione were necessary for the process 
of DNA synthesis and for regulating the telomerase activity 
and cell cycle proteins, as we believe, than it should be 
present in the nucleus in the key moments of cell 
proliferation.  
Our study of cellular distribution of reduced 
glutathione in the three cell models before, during and after 
the exponential phase of cell growth provided evidence that 
contribute to our assumption (Fig III 22, 23, 24). The finding 
that, the high nuclear GSH level was detected in all three cell 
types at the beginning of culture, and while cells were 
actively proliferating, and, conversely, decreased 
significantly when the pace of the proliferation declined 
points to the role of nuclear glutathione in the onset of cell 
proliferation. In 3T3 fibroblasts, characterized by an early 
exponential phase of cell growth, and in the neural culture, 
which already contained proliferating cells (Fig. III4, and 
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III6, respectively), important nuclear compartimentalization 
of GSH was observed already at 6h of culture and it 
persisted at 24h. On the contrary, in MCF7 cells the maximal 
nuclear compartmentalization of GSH was delayed until 24h 
of culture, as well as the onset of exponential phase of cell 
growth (Fig. III5). The total cellular GSH was decreased at 
this time point, but the nuclear level of GSH was preserved. 
 
In accordance with our premise, at the final time 
point, the nuclear compartmentalization of GSH is almost 
absent from the culture of 3T3 fibroblasts that have reached 
confluence (with less than 2% of the cells in S phase) and in 
differentiated neurons (with almost null proliferation 
activity). On the contrary, in the culture of MCF7 cells, that 
maintained the significant level of DNA synthesis until the 
7th day of culture (Fig. III 18), the nuclear GSH 
compartmentalization was still detectable in some cells.  
Moreover, the detailed study of the nuclear 
compartmentalization of GSH along the cell cycle performed 
in 3T3 fibroblasts showed that GSH co-localized with the 
nuclei at 6, 12, and 24 h after plating. However, when cells 
were confluent, at 3 and 5 days after plating, no differences 
between the nucleus and cytoplasm could be seen (Fig. III 
25). The images obtained at 3 or 5 days in culture are 
similar to those reported previously by Soderdahl et al [49] 
using GSH antibody and mercury orange to study the GSH 
distribution in confluent A-549 cells. Thus, our results may 
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explain the apparent discrepancies in the GSH distribution. It 
is very important to take into account the moment of the cell 
cycle in which glutathione distribution is studied. We show 
here that cells that are preparing to divide have high nuclear 
GSH levels. Quiescent cells have similar (or even lower) GSH 
levels in the nucleus than the cytoplasm. The capacity of the 
cell to concentrate GSH in the nucleus was estimated by the 
nucleus/cytoplasm GSH ratio (Fig. III 26). It is high several 
hours after plating, and it is near one when cells are 
confluent. Thus, glutathione translocates to the nucleus 
before exponential cell growth which assures the reduced 
environment at the onset of cell proliferation.  
Thus our results demonstrate that the cell nucleus suffers 
dramatic changes in its oxidative status and underscore the 
role of nuclear glutathione in the physiology of the cell cycle. 
So, the presence of the high glutathione level in the 
nucleus appears to be a common characteristic of the cells 
that are preparing to divide whilst quiescent and 
differentiated cells have similar GSH levels in the nucleus 
and the cytoplasm. Our findings are in line with several 
other studies aimed to elucidate the fine redox regulatory 
mechanisms that lie behind the correct cell cycle 
progression. Conour et al, suggested that the reduction of 
the intracellular environment as cells progress from G1 to 
G2/M phase, as shown in our study, may protect genomic 
DNA from oxidative damage upon brakedown of the nuclear 
envelope [8]. Indeed, one of the assertions in support of this 
premise derives from the study of oxidative stress related to 
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genotoxicity, recently published by Green RM; oxidative DNA 
modifications displayed a negative linear correlation with 
nuclear GSH. This is of special importance considering the 
report of Menon et al [59] on the necessity of the oxidative 
event in early G1 phase to allow G1-S transition. Even more, 
it has recently been postulated that the restriction of DNA 
synthesis to the reductive phase of the cycle in yeast may be 
an evolutionarily important mechanism for reducing 
oxidative damage to DNA during replication [60], which 
implies the common mechanism of the DNA protection 
during S phase in all eukaryotes.  
 
3.3. Modifications of nuclear proteins along the 
cell cycle  
Various studies have demonstrated that the nucleus is 
more reduced than the cytosol (15mM GSH vs. 11 mM, 
respectively) [22, 61, 62]. An important number of nuclear 
proteins, including transcription factors, require a reduced 
environment to bind to DNA. More than 62 proteins are 
involved directly in transcription, nucleotide metabolism, 
(de)phosphorylation, or (de)ubiquitinylation, which are all 
essential processes for cell cycle progression [8]. For 
instance, it appears that, at the onset of cell proliferation in 
the early G1 phase, an increase of ROS in the cytoplasm is 
necessary for the initiation of the phosphorylation cascade 
mediated by epidermal growth factor (EGF) that, 
subsequently, activates DNA replication and the cell division 
 208  
                                                                      V Discussion 
 
([63]). According to Jang and Surh [64] nuclear GSH may 
act as a transcriptional regulator of NF- B, AP-1, and p53 by 
altering their nuclear redox state. The transcription factor 
NF-κB is an example of distinct redox-sensitive activation 
and DNA binding [53]; it is activated by various physiological 
stimuli known to produce ROS; on the contrary, to permit 
DNA binding, similar to Fos, Jun, and Nrf2, cysteine residue 
within DNA binding domain must be reduced. Both processes 
are guaranteed by the adequate redox state of the cytosolic 
and nuclear environment, respectively (Fig. V 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Hansen, JM, Go YM, Jones DP (2006)
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Toledano et al. [65] found a redox-dependent shift of oxyR-
DNA contacts along genomic DNA, suggesting a mechanism 
for differential promoter selection.  
In addition, the reduced nuclear environment could 
protect oxidant sensitive proteins from oxidation [8] Fig. V 
4.  
Indeed, our study showed lower level of protein 
oxidation in nuclear extracts at 6 and 48h of culture, when 
the nuclear GSH was high, than at confluence, when the 
nuclear GSH level was lower and equal to cytoplasmic (Fig 
III 29.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conour et al., 2004
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Interestingly, the nuclear proteins underwent stronger 
glutathiolation before and at the onset of cell proliferation 
than at quiescence (Fig III 30). It is not surprising if we bear 
in mind that high level of GSH in the nucleus could provide 
protection to the proteins against the oxidative threat 
coming from the cytoplasm at the early phase of cell 
proliferation, and that glutathiolation, as it is a reversible 
modification, could be just the way. On the other hand, 
based on the simplicity of the redox transition from thiol to 
disulfide and on the fact that the reversibility was 
energetically favourable, Cotgrave IA and Gerdes RG [66] 
more than 10 years ago have proposed glutathionilation as a 
posttranscriptional modification with the regulative finality. 
They state that it offers “a strong possibility for transducing 
“oxidative information” from intracellular oxidants via the 
GSH redox buffer to individual proteins containing 
“regulatory thiols”. Also, recently, this posttranslational 
modification was proposed as a likely molecular mechanism 
for redox dependent signalling mediated by GSH [67]. Thus, 
high level of GSH in the nucleus, observed before and at the 
onset of cell proliferation, could provide the “GSH redox 
buffer” necessary for the progressing of oxidant stimulated 
mitogenesis. 
It is encouraging to see that the findings of the 
present study have provided some support to the 
assumption that a dynamic intracellular redox environment 
directs the cell proliferation through redox sensitive cell cycle 
proteins. 
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4. The depletion of nuclear glutathione hampers the 
cell cycle progression 
 
 With the intention of providing further evidence of the 
importance of nuclear GSH in the initiation of cell 
proliferation, we have found ourselves in front of a challenge 
of depleting nuclear glutathione. A number of reports have 
focused on the consequences of the depletion of cellular 
glutathione levels on changes in cellular proliferation [51, 
53]. However, all those reports were performed measuring 
cellular or total glutathione levels, but there is no 
information relating cellular proliferation with nuclear 
glutathione levels. A number of studies have indicated the 
existence of a nuclear GSH pool that resists depletion after 
exposure of cells to BSO (for a review see [51]). BSO 
treatment resulted in the concentration dependent depletion 
of cytoplasmic GSH, while the depletion of mitochondrial and 
nuclear pool of GSH required concentrations higher than 100 
µM, which induced DNA damage [68]. Spyrou and Holmgren  
[25] showed that inhibition of glutathione synthesis by 0.1 
mM BSO was able to decrease GSH synthesis after treatment 
for 12 hours, but GSH-depleted cells grew as well as control 
3T6 cells with no decrease in DNA synthesis.  Thus, 
incubation of cells with low concentration of BSO, although 
decreases glutathione levels, does not change cell 
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proliferation. On the other hand, Thomas et al. [51] showed 
that non toxic concentrations of N-ethyl maleimide or DEM 
decreased the GSH level in the nucleus and cytoplasm to a 
similar extent, whereas the nuclear pool of GSH was much 
more resistant to BSO depletion.  
Based on this findings, we have designed a model to 
study the effects on the cell proliferation parameters caused 
by GSH depletion both in the nucleus and the cytoplasm, 
using 100µM DEM, comparing to the administration of 10 µM 
BSO when nuclear GSH level is preserved. 
 Results presented in Fig. III 32 show that inhibition 
of glutathione levels by BSO is delayed and last for a longer 
time than that induced by DEM; the rebound effect is 
obvious at 48 hours. The striking boost of GSH level 
following the administration of DEM has been observed 
previously in hepatocytes and attributed to a four- to five-
fold increase in gamma glutamyl cysteinyl synthetase RNA 
levels [12]. Similarly, HepG2 cells exposed to DEM 
responded with the fourfold up-regulation of glutathione 
synthase [69] 
The inhibition of glutathione synthesis by BSO induced 
a strong decrease in total GSH levels; however, as reported 
previously by various authors [51, 68, 70] nuclear GSH pool 
was preserved (Fig III 33). By contrast, depletion of 
glutathione levels by DEM induces a marked decrease in 
nuclear glutathione levels (Fig. III 34.).  
The compartmentalization of glutathione depletion 
could explain the observed differences in the inhibition of cell 
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proliferation (Fig. III 35.).  Indeed, our results show that 
inhibition of glutathione levels by DEM strongly impairs cell 
proliferation.  This difference could be due to the fact that 
DEM decreases both nuclear and cytosolic glutathione levels 
in opposition to BSO, which only decreases cytosolic 
glutathione. It is worth mentioning that the impairment of 
cell proliferation could not be attributed to the alkylating 
properties of DEM, since the simultaneous administration of 
GSHe completely prevented it, nor to the toxicity of the 
treatment because the cell death was not significantly 
augmented (Fig III 36.). 
In addition, we have observed the delay in the cell cycle 
progression caused by DEM, when both nuclear and 
cytoplasmic GSH was depleted, which is absent in the 
treatment with BSO when nuclear GSH pool was preserved 
(Fig. III 37). Interestingly, Esposito et al. [71] showed that 
direct administration of DEM on the nuclear extracts of COS7 
cells induces cell cycle arrest. So, it is daring to speculate 
that, despite the depletion of cytoplasmic GSH with DEM 
could not be overlooked, the effect on the cell cycle 
progression could be attributed to the depletion of the 
nuclear GSH. Moreover, as Esposito shows, the depletion of 
nuclear GSH strongly induces a p53-independent 
accumulation of p21, which causes a cell cycle arrest. In our 
study, the expression of cell cycle regulatory protein, 
suggested previously to be under redox control, Id2, was 
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decreased when the level of nuclear GSH was depleted (Fig. 
III 38).  
It has been known that cell proliferation is regulated by a 
variety of mechanisms working to allow the activation and 
repression of growth stimulatory genes, one of them being 
the transcription factors. Previous in vitro reports show that 
the activity of transcription factors is related to its redox 
environment. In addition, change in the redox potential 
could induce variations in the activity of those transcription 
factors. Alterations as small as + 15 mV in the redox 
potential can result in transcription factor translocation and 
activation or deactivation, depending on the direction of the 
redox shift [1, 72, 73] 
 Recently Reddy et al. [74] have shown that Nrf2 
deficiency leads to oxidative stress and DNA lesions, 
accompanied by impairment of cell-cycle progression, mainly 
G(2)/M-phase arrest. Both N-acetylcysteine and glutathione 
(GSH) supplementation ablated the DNA lesions and DNA 
damage-response pathways in Nrf2 (-/-) cells; however only 
GSH could rescue the impaired co-localization of mitosis-
promoting factors and the growth arrest. 
Our results demonstrate for the first time that it is 
nuclear GSH levels, and not total cellular glutathione levels, 
that specifically correlate with cellular proliferation.  
Glutathione is considered essential for survival in mammary 
cells and other eukaryotic cells, but not prokaryotic cells.  
However, although a number of important functions have 
been attributed to GSH, its outstanding role in nucleated, 
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but not in prokaryotic cells, remains unknown.  Our results 
underscore the important role of nuclear glutathione in cell 
physiology and suggest that manipulation of nuclear GSH 
levels could be of paramount importance during 
development and cancer. 
 
 
 
5. The occurrence of the glutathione in the 
nucleus; active transport, de novo synthesis, diffusion 
or something else. 
 
How GSH enters the nucleus and how it is regulated during 
the different phases of the cell cycle is still a matter of 
debate. The regulation of such interactions is also unclear. 
According to Smith and colleagues [75], the possible 
biochemical mechanisms responsible for the turnover of 
nuclear GSH are the following: 1.GSH may be taken up from 
the cytoplasm into the nuclei either passively or through 
energy-dependent processes 2.GSH may be synthesized de 
novo in the nucleus by the enzymes glutamate cysteine 
ligase and GSH synthetase 3.GSH may function to transport 
γ-glu-cys-cys.  
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5.1. ATP dependent sequestration of the GSH to 
the nucleus 
 
The role of ATP-dependent mechanisms in maintaining 
the nuclear/cytoplasmic GSH concentration in hepatocytes 
was demonstrated by Bellomo and co-workers [22]. After 20 
min of incubation with the uncoupler protonophore CCCP the 
nuclear/cytoplasmic GSH gradient disappeared, but the total 
GSH content remain unchanged. This study was questioned 
by Briviba et al [50] because of the use of 
monochlorobimane (BmCl). Despite its high specificity for 
glutathione this fluorochrome was found to be of no value in 
the study of cellular GSH distribution; once GSH-BmCl 
conjugate is formed it demonstrates an increased tendency 
of nuclear compartmentalization. Indeed, in our study using 
CMFDA, we have not found an ATP-dependent mechanism of 
nuclear GSH compartmentalization in 3T3 fibroblasts (Fig. III 
39.). Ho and Guenthner using nuclear fractions concluded 
that GSH is taken up by the nucleus by passive diffusion and 
no evidence for an ATP-dependent mechanism for GSH 
concentration was observed.  
 
 
5.2. Nuclear synthesis of glutathione  
 
Glutamate cysteine ligase (GCL) and GSH synthetase 
activities have been reported in nuclei, and a portion of 4-
8% of cell GSH synthetic activity is considered capable of 
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maintaining nuclear GSH levels Ho and Guenthner. However, 
we could not find GCL expression in nuclei of 3T3 fibroblasts 
(Fig. III 40.) 
In addition as previously reported bso, a specific inhibitor of 
gcl was unable of decreasing nuclear glutathione levels. 
Thus, at least under our experimental conditions, the 
possible “de novo” synthesis of nuclear glutathione seems 
improbable in 3t3 fibroblasts. 
 
 
5.3. GSH enters nucleus via nuclear pores 
 
The nuclear pore complex is the biochemical 
machinery that controls the molecular traffic across the 
nuclear envelope [76, 77]. Ions and small hydrophilic 
molecules, like glutathione, are considered to move by free 
and fast diffusion across the nuclear pore [78]; nevertheless 
ion gradients and transnuclear ATP-dependent membrane 
potential have also been reported [77]. In a series of 
creative experiments published in early 1990ies, Feldherr CM 
and Akin D [79, 80], shown that permeability of nuclear 
envelope and nuclear transport were higher in proliferating 
than in quiescent cells. Reported seven fold reduce in the 
nuclear transport capacity was induced by the alterations in 
the characteristics of the pores and not by the changes 
within the cytoplasm, specifically, the decrease in ATP 
concentration. One pore forming protein that has been 
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brought into the connection to nuclear glutathione content is 
Bcl-2. Voehringer and colleagues [52], showed that over-
expression of Bcl-2 recruits GSH to the nucleus. The 
presence of this protein at the nuclear envelope was 
demonstrated [81] and the association with the nuclear pore 
complexes was suggested. Moreover, Zimmermann et al. 
[82] demonstrated that GSH binds to Bcl-2 in mitochondria, 
providing a molecular basis for its antioxidant function. Thus, 
Bcl-2 located in the mitochondrial membrane introduces GSH 
in the mitochondrial space. We have found that the presence 
of Bcl-2 in the nucleus is higher in proliferating than in 
quiescent 3T3 fibroblasts, i.e. it coincides with the high level 
of glutathione in the nucleus (Fig. III 41) as well as with the 
intense nuclear transport regulated by the nuclear pores. 
Thus, we suggest that during the changes in the nuclear 
membrane that precede the cell division, nuclear Bcl-2 could 
facilitate the translocation of glutathione to the cell nucleus.  
 
6. Contradictory effects of Bcl-2 over-expression 
on the proliferation of MCF7 cells.  
Bcl-2 was first intracellular regulator of apoptosis to 
be discovered [83], and its function in the programmed cell 
death inspired over 20000 reports (medline entry). The 
implication of Bcl-2 in cellular proliferation emerged 
relatively soon afterwards; however, in this context it failed 
to show similar prominence being subject of fewer than 6000 
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reports. Interestingly, while the apoptotic prevention by Bcl-
2 is unanimously documented, its effect on the cell cycle 
progression was a less elucidated issue. When expressed at 
high levels in cells derived from several cancers, Bcl-2 
induced strong growth suppression in some but not in all of 
them [84]. Constitutive expression in HL60 cells showed no 
impact on the proliferation or spontaneous differentiation of 
these cells, but facilitated the latter when it was induced by 
specific agents [85]. In the non tumoral cell line, NIH 3T3 
fibroblasts, it caused delay in response to serum stimulation 
[86]. It has also been shown that its anti-apoptotic function 
can be genetically separated from its inhibitory effect on cell 
proliferation: mutated tyrosine residue at the conserved BH4 
domain did not interfere with apoptosis resistance of the cell 
while it did induce a faster cell cycle re-entering upon serum 
stimulation of quiescent cells [13]. On the other hand, the 
development of Bcl-2 knockout mice revealed the 
importance of this protein in regulation of cellular redox 
potential in the response to oxidative stress. Hockenbary at 
al showed that Bcl-2 was unable to block the generation of 
peroxides; however it did inhibit lipid peroxidation [13]. 
Therefore, the direct antioxidant protection provided by Bcl-
2 occur downstream of mitochondria. Again, it was in the 
context of the process of apoptosis where this finding was 
profoundly studied: Kane et al [46] were the first to show 
that the capacity of Bcl-2 to suppress apoptosis depended on 
the concentration of cellular thiols, i.e. GSH, which was 
 220  
                                                                      V Discussion 
 
always increased when the Bcl-2 was elevated. More studies 
followed supporting this premise demonstrating that the 
depletion of GSH restores apoptotic sensitivity to the cell 
over-expressing Bcl-2 [87]. Therefore, it was suggested that 
Bcl-2 modulated apoptotic sensitivity by means of high 
levels of GSH, downstream of its recognized detoxifying 
function (Paper bcl2 mcf7 ghs depletion cisplatin 2002-3). In 
1999 Voehringer et al [52] demonstrated that the over-
expression of Bcl-2 in HeLa cells, not only increased the total 
cellular glutathione level, but also induced its redistribution 
to the nucleus. The hypothesis emerged that the nuclear 
compartmentalization of GSH, facilitated by Bcl-2, provides 
the nuclear redox environment crucial for “fine-tuning” of 
transcriptional regulation [52]. This premise was encouraged 
by another line of studies revealing the Bcl-2 as a pore 
forming protein and a possible transporter regardless of the 
membrane it is localized on: mitochondrial, endoplasmatic 
reticulum, or nuclear membrane [52, 88, 89]. First reports 
on possible membrane transport function of Bcl-2 date from 
early 1990ies and involved the trafficking of proteins and 
Ca++ across the outer mitochondrial membrane, the 
endoplasmatic reticulum and nuclear envelope. It was 
suggested that proteins of this family could act as adaptor or 
docking proteins, capable of pulling other proteins out from 
the cytosol and/or as a channel proteins integrating into 
membranes [88]. Herrmann et al [89] proposed the role of 
Bcl-2 as a “gatekeeper” which selectively regulates nuclear 
localization of crucial transcription factors such as p53 and 
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NfkB. This model was further developed by the hypothesis of 
Voerhinger [52] (Figure V 5) on the nuclear transport of GSH 
dependent on Bcl-2 by an unidentified mechanism.  
 
 
 
 
 
 
 
 Voehringer DW, 1999
In the framework of our study it was of interest to 
investigate the possible effect of Bcl-2 on the proliferation 
parameters relative to the nuclear GSH level. For this 
endeavour we have compared the nuclear GSH level, 
telomerase activity and cell cycle progression in the milieu 
where only Bcl-2 expression was different. Apoptosis 
resistance and deregulated proliferation are two faces of the 
malignant transformation; the importance of understanding 
its mechanisms in order to design efficient anti cancer 
therapy, could not be underestimated. Therefore, in the 
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present work we gave preference to a cancer cell model 
overexpressing Bcl-2, MCF7 cells, over 3T3 fibroblasts. 
Nevertheless, our group is currently continuing this line of 
research using both 3T3 fibroblasts with the silenced Bcl-2 
gene and its overexpressing counterpart.  
Our results seem to be in concordance with numerous 
reports of the increase in GSH level caused by the 
overexpression of Bcl-2 (for a review see [52, 88]). Indeed, 
in contrast to MCF WT which showed the peak of GSH at 18h 
of culture, MCF7 bcl2 showed a striking and rapid increase of 
total cellular GSH 6h after plating, though followed by an 
immediate decline to a moderate value that was maintained 
till the end of culture (Fig III 42). In addition, the enhanced 
expression of Bcl-2 in the MCF7 cells, which includes the 
elevated presence at the nucleus, caused the increment in 
the levels of nuclear GSH (Fig III 43). This finding is in line 
with the results reported by Voehringer in HeLa cells and 
supports the hypothesis of the implication of nuclear Bcl-2 in 
GSH sequestration into the nucleus. However, this 
observation was limited to one time point; at 18h WT cells 
had more nuclear glutathione. This discrepancy could be 
explained by the changes in nuclear envelope and 
architecture during the cell cycle; Voehringer and coll. 
analysed the cellular GSH distribution at 48h of culture 
without the consideration of the cell cycle phase. 
Interestingly, the Bcl-2 caused the rapid increase in the level 
of GSH; however its nuclear sequestration was delayed. On 
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the contrary, the peak of nuclear GSH in MCF7 WT coincides 
with its maximal cellular level. Thus, if the elevated presence 
of Bcl-2 was not enough to provide the nucleus with more 
GSH although it was available, some other factor might be 
involved in the compartmentalization. One possible 
explanation could be that the relocalization of Bcl-2 from the 
cytoplasm to the nuclear envelope takes time, as previously 
described by Melan M and Sluder G [90]. On the other hand, 
strong intranuclear presence of Bcl-2 in interphase nuclei 
was shown in mammalian cells [91] and it was suggested 
that the intranuclear/perinuclear distribution of Bcl-2 was 
cell cycle dependent. So it is tempting to speculate that the 
presence of Bcl-2 at the nuclear envelope, as a request for 
its transport function, is related to the proliferative phase of 
the cell cycle. Indeed, our results in 3T3 fibroblasts confirm 
this premise: Bcl-2 is strongly present at the nucleus already 
at 6h (Fig III 41.) after plating and the entrance of the 
culture in the exponential phase of cell growth is advanced 
comparing to that of MCF7 cells (Fig. III 11). 
We have found that, as well as GSH level, the level of 
telomerase activity augmented in MCF7 bcl2 cells. This result 
seemed to confirm previous findings of Mandal M and Kumar 
R [92] in HeLa cells and in DiFi cells: overexpresion of Bcl-2 
was accompanied by elevated telomerase activity. On the 
other hand, these authors used subconfluent cell cultures for 
their analysis; although cancer cell lines do not show contact 
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inhibition induced growth arrest, it is expectable that their 
proliferating activity slows as they populate the plate, 
together with telomerase activity (Fig. 45), as shown in our 
model. Our culture could be considered “subconfluent” 5 
days after plating; however, at this point we detected no 
significant differences in the TA between MCF7 Bcl-2 and WT 
cells. Although this report failed to provide any mechanistic 
explanation for the elevation of TA caused by Bcl-2, the 
proposed existence of the threshold level of telomerase 
activity in some cancer cells which could not be surpassed 
even though the Bcl-2 is elevated, is an interesting 
possibility. This might be the case in our cells, except in the 
interval before the proliferating phase, exactly when the 
difference in GSH level was striking. Moreover, in both cell 
types the maximal level of nuclear GSH concurred with the 
peak of telomerase activity; indeed, despite the extremely 
high cellular concentration of GSH in MCF7 Bcl-2 cells at 6h 
of culture the TA showed the increase when the nuclear 
compartmentalization of GSH occurred, i.e. 6h later. 
Therefore, according to our findings, telomerase activity is 
stimulated by the increase in nuclear GSH level, possibly 
caused by Bcl-2 relocation to the nuclear envelope.  
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6.1. The absence of the effect of Bcl-2 over-
expression in MCF7 cells proliferation.  
In the light of our findings, bcl2 induced an increase in 
GSH levels and is present in the nucleus of transfected cells  
but does not interfere with their proliferation.  
6.1.1. Why MCF7 bcl2 cells show no proliferation 
decrease? 
It has been shown previously that Bcl-2 over-
expression was related to decreased proliferation of some 
cancer cell lines both in vitro and tumour growth in vivo [83, 
86]. Unexpectedly, no significant consequences of Bcl-2 
expression on the proliferation could be detected in our cell 
model. The work of Hoethelmans  [93, 94] on the 
importance of various Bcl-2 domains in the influence of Bcl-2 
on GSH level and proliferation activity could explain, at least 
in part, our findings.  
According to this author, bcl2 is cleaved by caspase 3 
at Asp 34 of the loop region, and by unidentified factor X at 
asp 64 (Fig V 6). First cleavage liberates 22kD Bcl-2ΔBH4 
and inhibits the second one that produces 19kD Bcl-2 
protein. Cells that were transfected with a Bcl-2 gene lacking 
BH4 domain showed an increase in GSH level and no decline 
in proliferation activity. Hoethelmans further argues that this 
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domain is crucial for the nuclear translocation of Bcl-2 and 
its impairment of cellular proliferation. 
 
 
 
 
 
 
 
 
 
 
Hoetelmans RWM, Van de Velde CJH, Van Dierendonck JH, 2003 
 Conversely, the 19kD Bcl-2 is found in rapidly 
dividing nuclei, which suggests that ongoing cell proliferation 
requires cleavage of Bcl-2 into a 19kD fragment. In MCF7 
cells caspase-3 is missing [95], therefore in this model, the 
19kD bcl2 would prevail. Even more, authors speculated on 
the possible role of nuclear GSH in stimulating this type of 
cleavage: this would be another mechanism by which the 
nuclear presence of 19kD fragment would be favoured in our 
cell model.  
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In conclusion, despite of the increased expression of 
Bcl-2, proliferation would not be hampered in our cells 
because of the prevalence of 19kD Bcl-2 fragment caused by 
the absence of caspase 3 and increased nuclear GSH.  
6.1.2 Why MCF7 bcl2 cells show no proliferation 
increase? 
MCF7 Bcl-2 cells show the increase in total cellular 
GSH level and its nuclear compartmentalization and 
augmented telomerase activity; unexpectedly, they do not 
proliferate more then their WT counterpart.  
This apparent paradox could be explained within the 
proposed model of the redox control of cell proliferation 
discussed previously (Fig V 1). To clarify the delay in the 
onset of exponential phase of cell growth in MCF7 cells, 
despite the presence of the high level of GSH, comparing to 
3T3 fibroblasts where it coincides with the GSH maximum, 
we suggested the existence of the “reductive proliferation 
limit”. This is a hypothetical hyper-reduced state when the 
cell, due to the extremely high GSH level, diminishes the 
ROS, even those necessary for the signalling in mitogen 
stimulation of cell proliferation. Thus, the cell proliferation is 
impaired due to the absence of the oxidative stimulus. In our 
model, MCF7 bcl2 cells accumulated GSH in the nucleus at 
12h of culture, and MCF7 WT later, at 18h of culture, which 
is explained by the increased availability of GSH and 
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overexpression of Bcl-2. However, S+G2/M maximum is not 
reached until 24h of culture in both cell types, when the 
nuclear GSH level, and telomerase activity, decreased to a 
similar value. Thus, MCF7 WT have met the nuclear 
reductive limit, and further decrease of nuclear redox 
potential induced by over-expression of bcl2 confers no 
proliferative advantage.  
 
7. Human pathologies possibly associated to 
nuclear glutathione. 
 
A number of pathophysiological situations show the 
importance of nuclear GSH. Atzori et al. [96] showed 
variations in the amount and redox state of cellular thiols, 
particularly reduced glutathione, supporting a role for thiols 
in the regulation of growth and differentiation of human 
bronchial epithelial cells. In another example, depletion of 
nuclear GSH to 50-60% of initial values prior to irradiation 
(400 cGy) resulted in nuclear DNA fragmentation and 
apoptosis. These findings call attention to nuclear GSH as a 
determinant of intrinsic radiosensitivity of cells, suggesting 
that GSH plays a critical protective role in maintaining 
nuclear functional integrity [97].  
Thalidomide produces human birth defects, mainly 
limb reduction malformations (phocomielia) [98]. A rat is 
proved to be thalidomide-resistant and rabbit thalidomide-
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sensitive species; molecular base of this difference towards 
thalidomide treatment was studied in limb bud cells [99]. 
Confocal microscopy revealed that glutathione distribution 
(determined by CMFDA staining) was different in both cell 
types. Thalidomide induced cytosolic GSH depletion in both 
cell lines, however, nuclear GSH levels remained high in the 
rat thalidomide resistant cells but not in the rabbit 
thalidomide sensitive cells. Thus, it is tempting to speculate 
that a redox shift in the nucleus may result in the 
misregulation of interactions between transcription factors 
and DNA, causing defective growth and development. 
Interestingly, nowadays thalidomide is used in clinical 
practice as an inhibitor of angiogenesis and tumour growth.  
Traditionally, GSH has been associated with increased 
resistance to radiation and xenobiotics [75, 97, 99-101]. Our 
study of the importance of the level of nuclear GSH 
compartmentalization for the onset of proliferation [12, 58] 
opens a series of new possible implications of nuclear GSH in 
human pathologies.  
 
 
8. Suggested role of glutathione in the nucleus: 
an epigenetic perspective 
 
  Protection of the cellular integrity is the issue of 
maintaining the nuclear homeostasis. Hence, the importance 
of nuclear glutathione in the cellular defence from reactive 
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oxygen species (ROS) or xenobiotics should be comparable 
to the one of cytoplasm and mitochondria. Precisely, the 
production of glutathione has been biochemically linked to 
cofactors influencing epigenetic processes, because the 
biosynthesis of this molecule is directly related to the S-
adenosylmethionine (SAM) pathway and SAM is the source 
of the methyl groups used for the methylation of DNA and 
histones [102]. 
Histone modifications are involved in regulating gene 
expression. The pattern of histone posttranslational 
modifications (PTMs) has prompted the “histone code 
hypotesis”, which suggested that PTMs might affect the 
structure of chromatin or modify distinct binding regions of 
transcriptional factors [103, 104]. Chromatin can be divided 
into two distinct states: euchromatin, which is an unpacked 
permissive for transcription state and heterochromatin, 
characterized by having a repressive DNA conformation and 
structure. Furthermore, heterochromatin has two additional 
states: constitutive, generally silenced and facultative, which 
is silenced in some circumstances.  
Well established in the literature, but relatively 
underappreciated, is the fact that most members of the 
histone H3 family contain one or more cysteine(s) (Cys110 
in H3.1, H3.2 and H3.3 and one additional Cys96 in H3.1) in 
their protein core. This feature is a hallmark property of 
histone H3. The other histone proteins H2A, H2B and H4 do 
not have cysteine. As we have mentioned above, cysteine 
plays a specialized role in the function of proteins. The redox 
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behaviour–formation of disulfide bridges, sulphenic acid 
formation, glutathiolation, are all modifications associated 
with the alterations of redox environment [105]. Although 
the extent to which the nucleus contains an oxidizing or 
reducing environment is not well established, redox sensing 
mechanisms appear to play important roles in the nucleus. 
Hake and co-workers suggest the importance of clarifying 
the extension of H3 oxidation/reduction in vivo and 
understand the role of the Cys110 and Cys96, in the special 
case of H3.1, during the chromatin compactation process 
[106]. Furthermore, Hake proposes that histone H3 variants 
play a major role in cell differentiation and cell lineage 
restriction. With all these propositions Hake and co-workers 
proposed “the H3 barcode hypothesis”. The unique cysteines 
in H3 variants might be important for nucleosomal and 
chromatin higher-order structures, through distinct intra- or 
inter-molecular disulphide bridges. Early studies developed 
by Allfrey et al. showed the distinct reactivity of H3 cysteines 
against sulfhydryl reagents in oxidative conditions. Cysteines 
were exposed in euchromatin regions and could form 
disulfide bonds with these reagents. In heterocromatin, 
cysteine residues did not react with the reagents, indicating 
that these cysteins are more buried [107]. In 1980, Lewis 
and Chiu showed that disulfide formation in Cys96 and 110 
by sulfhydryl reagents destabilized the histone core [108]. 
Consequently, our finding that the pattern and level of 
glutathiolation of nuclear proteins change during the cell 
 232  
                                                                      V Discussion 
 
cycle could confirm the possible implication of this 
modification in the control of chromatin structure dynamics 
[58]. 
How the H3 barcode and the histone code are 
connected or how different H3 variants become associated 
with distinct PTMs remains unresolved. A possible answer is 
that the distinct H3 isoforms, would control the precise 
folding of chromatin to make these fibers suitable substrates 
for the appropriate enzymes that introduce the PTMs. 
Another open question is how do the distinct H3 variants 
regulate the nucleosome stability? We propose that the 
glutathiolation of histone H3 cysteine residues could be a 
feasible answer to the regulation of chromatin conformation 
and compaction. Therefore, this modification would be a link 
in the regulation of all these phenomena. 
If H3 glutathiolation occurs, do these changes take 
place during cell cycle? How could this modification affect 
the histone code (PTM’s) and the histone H3 barcode during 
cell cycle?  
Clearly, many questions remain unanswered, the regulation 
of the epigenetic process and its association with the gene 
expression during cell cycle or in the physiopathology of 
different diseases. Disruption of the balance of epigenetic 
networks can cause several major pathologies, including 
cancer, syndromes involving chromosomal instabilities, and 
mental retardation [109].  
 Thus, new approaches on the regulation of the 
epigenetic forces that control the package and un-package of 
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nuclear DNA during the different phases of the cell cycle 
could be envisaged. The information provided in the present 
thesis suggests an important role of nuclear glutathione as a 
key regulator of cell proliferation.  
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VI CONCLUSIONS 
 
1. The level of cellular glutathione in the particular cell 
line could define its proliferating capacity. Its variations 
along the cell culture dictate the rhythm of cell 
proliferation, possibly by the modulation of redox 
sensitive cell cycle regulatory proteins 
 
2. The telomerase activity is highly sensible to the 
cellular redox state, regardless of the cell type, its 
inherent proliferation capacity or the origin of the cells. 
The dependence of the cell cycle progression on the level 
of glutathione could be attributed, at least in part, to its 
modulation of telomerase activity  
 
3. The nuclear compartmentalization of glutathione is a 
prerequisite for the onset of the exponential phase of the 
cell growth. The redox state of nuclear proteins, defined 
by the glutathiolation and oxidation, varies significantly 
with the cell proliferation activity. 
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4. The depletion of nuclear glutathione severely impairs 
the cell cycle progression 
 
5. During the changes in the nuclear membrane that 
precede the cell division, nuclear Bcl-2 could facilitate the 
translocation of glutathione to the cell nucleus. The 
overexpression of bcl-2 induced an early increase of the 
total glutathione level, telomerase activity and nuclear 
GSH compartmentalization. 
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1. Introducción  
El glutatión reducido (GSH) es uno de los antioxidantes 
endógenos más importantes en las células. Por su propiedad 
de mantener estado redox (tioles/disúlfidos) de la célula, 
ocupa un lugar central en el control de muchos procesos 
celulares. Es imprescindible en la síntesis de proteínas (1), 
juega un papel crucial en la defensa celular frente a estrés 
oxidativo y xenobioticos (2) y en la regulación de la muerte 
celular programada (3) y el ciclo celular (4). Esa gran 
diversidad de procesos vitales dependientes del glutatión y 
realizados en diferentes orgánulos de la célula implica la 
necesidad de su compartimentación y existencia de 
mecanismos que controlarían su concentración y 
garantizarían el ambiente adecuado en cada compartimiento. 
Integridad celular se defiende en el núcleo, en su “software” 
- el acido desoxiribonucleico (ADN) que controla los procesos 
celulares atreves de la regulación de la expresión génica. El 
papel protector del glutatión sobre el ADN (5), y su 
implicación en numerosos procesos que tienen lugar en el 
núcleo, sobre todo la síntesis de ADN  (6) y en el 
mantenimiento de organización del matriz nuclear (7) han 
sido claramente demostrados. Sin embargo, sobre la 
concentración del glutatión en el núcleo y su regulación se 
sabe relativamente poco. Eso se debe a dos factores 
principales. El primero es metodológico: es imposible 
determinar la concentración del GSH nuclear usando clásicos 
métodos de fraccionamiento celular (para la revisión ver 
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Söderdahl et al. (8)). El segundo factor es el enfoque: el 
GSH nuclear se estudiaba, por lo general, en las células 
confluentes (en la fase G0/G1) lo que se aproxima a la 
situación in situ, es decir, en el tejido las células están 
diferenciadas, han salido del ciclo celular, y confluentes.  El 
núcleo cambia dramáticamente durante las diferentes fases 
del ciclo celular, por lo tanto los estudios de la 
compartimentación nuclear del GSH tienen que tener en 
cuenta esta dinámica celular. 
El objetivo de la presente tesis es investigar la importancia 
del nivel de GSH y su  distribución celular, especialmente la 
compartimentación nuclear, en la proliferación celular y 
posibles mecanismos involucrados en el control del dicho 
fenómeno.  
 
2. Resultados  
Hemos estudiado los cambios en la compartimentación 
nuclear de GSH en diferentes fases del ciclo celular. 24h 
después de la siembra, los fibroblastos 3T3 empiezan a 
crecer exponencialmente (Fig. 1); a las 24 y 48h después de 
la siembra el porcentaje de las células en la fase S+M/G2 
aumenta significativamente (41% y 35%, respectivamente). 
A las 72h y mas tarde, crecimiento celular es menos intenso 
y a los 6 días en cultivo células llegan a confluencia, 
caracterizada por la mayoría de las células (81%) en la fase 
G0/G1.   
La concentración del GSH celular total era máxima a las 24h 
de cultivo (20 nmoles/106 célula) (Fig. 2A), cuando un alto  
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Figura 1. Curva de crecimiento y proliferación celular 
en los fibroblastos 3T3
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porcentaje de células (41%) estaba a punto de entrar en 
mitosis o ya en la división celular. Sin embargo, cuando las 
células llegaron a confluencia (día 6) y mayoría de las 
células eran quiescentes, la concentración de GSH tenia un 
nivel bajo  (11 nmoles/106 células).  
 
Figura 2a. Concentración total del GSH en el cultivo 
de los fibroblastos 3T3
A
Tiempo de cultivo (h)
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Hemos determinado el ratio GSH/GSSG en las células a lo 
largo del ciclo celular y encontramos que no cambiaba 
significativamente (Fig. 2B). 
 
Figura 2b. El ratio de GSH/GSSG celular en el 
crecimiento de los fibroblastos 3T3
B
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A la luz de estos resultados, nos planteamos si la 
compartimentación nuclear del GSH podría tener un papel en 
la progresión del ciclo celular durante las fases tempranas 
del cultivo celular. Figura 3. muestra la distribución celular 
del GSH dependiente del ciclo celular en los fibroblastos 3T3.  
Seis horas después de la siembra, se ven pocas células en la 
placa (Fig. 3ª y 3b). Los núcleos teñidos en azul con el 
Hoechst 33342 aparecen en el panel b y la distribución del 
glutatión definida por la fluorescencia verde del CMFDA se ve 
en el panel c. Un detalle (aumentado) representado en el 
panel d facilita la visualización de la compartimentación 
nuclear del glutatión. La línea blanca que se observa en las 
fotos es la herramienta de cuantificación del software (que 
apoya el microscopio confocal) que permite la medición del  
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nivel de fluorescencia. Los histogramas en el panel e son 
producto de la comparación de los niveles de fluorescencia 
verde, que nos da la distribución del GSH y la fluorescencia 
azul, que nos da la localización de los núcleos. Los picos 
6h
12h
24h
48h
72h
ías
GSH
núcleos
GSH
núcleos
Fl
uo
re
sc
en
ci
a 
(U
A
)
Fl
uo
re
sc
en
ci
a 
(U
A
)
Fl
uo
re
sc
en
ci
a 
(U
A
)
Fl
uo
re
sc
en
ci
a 
(U
A
)
Fl
uo
re
sc
en
ci
a 
(U
A
)
Fl
uo
re
sc
en
ci
a 
(U
A
)
Figura 3. Distribución intercelular del GSH en los fibroblastos 
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azules coinciden con los verdes al principio del cultivo, existe 
una importante  compartimentación nuclear del GSH. A las 
12 y 24h la población celular sigue creciendo. El GSH celular 
(intensidad de la fluorescencia verde) era máximo a las 24h. 
El análisis de la intensidad y la distribución de la 
fluorescencia azul/verde (Fig. 3b y 3d, respectivamente) 
muestra máxima correlación a las 24h. Cuando las células 
llegaron a confluencia, a las 72h y 6 días en cultivo, los picos 
de GSH ya no coincidían con los núcleos celulares. 
La variación en los niveles de GSH  a lo largo del ciclo celular 
definida por espectrofotometría (Fig. 2a) coincide con la 
variación del nivel total de fluorescencia verde en la 
población celular (Fig. 3c). Como se esperaba, la 
fluorescencia verde del GSH baja claramente a las 72h y 5 
días en cultivo, cuando las células llegan a la confluencia, 
ocurre inhibición por contacto y como consecuencia, la 
población celular entra en la quiescencia (70-80% de células 
en la fase G0/G1). En esta fase, no se observaba diferencia 
en la fluorescencia verde entre el núcleo y el citoplasma de 
las células: la distribución del GSH era homogénea en la 
población celular. 
Por lo tanto, cuando las células empiezan a crecer, el GSH 
estaba localizado predominantemente en el núcleo de las 
células. Sin embargo, cuando el crecimiento celular se ha 
disminuido, la distribución celular del GSH era homogénea. 
La capacidad de la célula de concentrar el GSH en el núcleo 
se ha estimado midiendo el ratio núcleo/citoplasma de la 
fluorescencia verde de CMFDA. Se han comparado los 
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niveles de la fluorescencia verde proveniente del área 
nuclear definida con el teñido azul de Hoechst y el área 
celular visualizada por contraste de fases (panel 3a), célula 
por célula, en 100 células por cada experimento y condición.  
Los resultados en la figura 4 muestran un patrón de 
distribución donde el ratio máximo de núcleo/citoplasma 
(4.2 ± 0.8) se alcanza muy temprano después de la siembra 
(a las 6h). Aunque el alto nivel del ratio núcleo/citoplasma 
se haya mantenido durante el crecimiento exponencial de la 
población celular, se observaba una persistente caída en la 
compartimentación nuclear del GSH a o largo de la 
progresión del ciclo celular. 
 
Figura 4. El ratio nuclear/citoplasmático del GSH en el
crecimiento de los fibroblastos 3T3
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Una vez las células llegaron a la confluencia,  la mayoría en 
la fase G0/G1, el ratio núcleo/citoplasma era cercano a uno, 
es decir, la distribución celular del GSH era homogenea. 
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Para confirmar las fases del ciclo celular obtenidas  en base 
al análisis del contenido de ADN (fluorescencia de ioduro de 
propidio) por citometria de flujo, hemos estudiado los 
patrones de expresión de la proteína Id2 y p107. Estas 
proteínas se sobreexpresan cuando se activan la 
proliferación y división celular. Los resultados en la figura 5. 
muestran la marcada expresión de estas proteínas a las 24 y 
48h de cultivo, que baja significativamente a partir de las 
72h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figura 5. Expresión de las proteínas del ciclo celular
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Las áreas de alta fluorescencia del CMFDA no provenían del 
GSH mitocondrial.  Lo demostramos en los experimentos de 
triple teñido en los que marcamos el ADN celular con 
Hoechst (en azul), el GSH con CMFDA (en verde) y las 
mitocondrias con MitoTracker (en rojo).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figura 6.- Fibroblastos 3T3 24h en cultivo. Estudio 
de la distribución intercelular del GSH y mitocondrias 
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En la figura 6. está representada una serie de imágenes 
obtenida a lo largo del eje Z, desde el ápice celular hasta el 
fondo. La forma de los núcleos se ve claramente y se 
muestra de nuevo que coincide con el máximo brillo de la 
fluorescencia verde del CMFDA en el centro de la célula. La 
distribución mitocondrial era periférica. 
Intentamos, también, elucidar los mecanismos incluidos en 
la compartimentación del GSH; dado que no esta muy claro 
si el GSH se mueve entre el citoplasma  y el núcleo por 
difusión o hay un transporte activo y un transportador 
dependiente del ATP.  
En los fibroblastos 3T3 24h en cultivo, en el momento de 
máxima compartimentación nuclear del GSH, usamos un 
desacoplante mitocondrial FCCP 20µM para disminuir la 
síntesis de ATP y estudiamos el efecto producido en la 
compartimentación del GSH.  
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 Figura 7. Distribución de GSH después de la 
depleción de ATP con FCCP 
 
Los niveles de ATP, determinados bioquímicamente, en las 
células tratadas bajaron un 40% respecto de su control. Sin 
embargo, por microscopía confocal no se han observado 
cambios en la distribución celular del GSH; su 
compartimentación nuclear y mitocondrial no ha sido 
afectada por la depleción del ATP. 
Los resultados presentados en la fig.7 sugieren que la 
concentración del GSH en el núcleo no depende del ATP, 
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porque la distribución era similar en las células tratadas con 
FCCP y las células control.  
Una posible explicación para el aumento de la concentración 
del GSH en el núcleo antes de la proliferación celular podría 
ser su síntesis de novo. Estudiamos la presencia de una 
enzima imprescindible para la síntesis de GSH, la glutatión 
cistein sintetasa (GCS) en los extractos nucleares. Fig. 8A 
muestra la ausencia de la expresión de la enzima GCS en los 
extractos nucleares, mientras se observa su clara presencia 
en el extracto celular. Por lo tanto, bajo nuestras condiciones 
experimentales, la síntesis nuclear del GSH no parece 
probable. 
 
Figura 8. Expresión de la γ-glutamylcysteine
sintetasa y Bcl-2 en los fibroblastos 3T3
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Uno de los mecanismos sugeridos por los cuales el GSH 
podría entrar en el núcleo era el transporte mediado por la 
bcl-2, una proteína anti-apoptotica cuya sobreexpresión 
aumenta el glutatión nuclear (9).  
A lo largo de la curva de proliferación de los fibroblastos 3T3 
estudiamos la distribución nuclear del bcl-2 mediante la 
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técnica de Western blotting en los extractos nucleares de las 
células 6, 24, 48, 72h y 5 días en cultivo.  
La distribución celular del bcl-2 variaba con la fase del ciclo 
celular. La máxima presencia del bcl-2 en el núcleo se 
encuentra a las 6h y 24h de cultivo, antes de la 
proliferación, y baja a partir de las 48h de cultivo.  
Para elucidar las posibles consecuencias de la alta 
concentración de GSH en el núcleo, estudiamos el nivel de 
oxidación y la glutatiónilación en las proteínas nucleares. En 
la figura 9. se observa un aumento en la oxidación de las 
proteínas nucleares, en las fases tardías del cultivo celular, 
cuando el bajo nivel del crecimiento esta acompañado por un 
nivel del GSH nuclear bajo. A las 6h de cultivo, cuando el 
ratio del GSH núcleo/citoplasma es máximo, hay muchas 
menos proteínas oxidadas en el núcleo.  
 
Figura 9. El nivel de oxidación de las proteínas 
nucleares en los fibroblastos 3T3
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El estudio por Western blotting de la glutatiónilacion de las 
proteínas nucleares muestra diferencias relacionadas con el 
nivel de la compartimentación nuclear del GSH y la 
proliferación (Fig.10). A las 6h del cultivo había más 
glutatiónilación de las proteínas nucleares que cuando las 
células llegaron a la confluencia y la distribución del GSH era 
homogénea. 
 
Figura 10. Glutationilación de las proteínas nucleares 
en los fibroblastos 3T3
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Para confirmar la importancia del GSH nuclear en la 
transición de las células de la fase G1 a la fase S y M/G2 del 
ciclo celular, usamos un modelo diferencial que se 
fundamentaba en la depleción del GSH: con dietilmaleato 
(DEM), que afecta a todos los tioles por toda la célula y con 
BSO que previene la síntesis del GSH pero no afecta el pool 
nuclear. Incluimos un grupo control en el que los efectos de 
la depleción con DEM se compensaban con la administración 
simultanea del GSH ester. Estudiamos los efectos 
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diferenciales en la proliferación dependiendo del 
compartimiento celular afectado por la depleción del GSH. 
 
 
Figura 12. Depleción del GSH en el cultivo de los 
fibroblastos 3T3. Concentración celular
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La figura 12. muestra el grado de depleción y ritmo de 
cambios de los niveles de GSH total celular en los 4 grupos 
experimentales de nuestro modelo. Se observa una clara 
bajada del nivel del GSH en las células tratadas con DEM, ya 
a las 6h de cultivo, mientras el tratamiento con BSO tenia un 
retraso de unas 24h para bajar el GSH a un nivel parecido ( 
7,28 y 8,10 nmoles/mg prot., respectivamente). El nivel de 
GSH en las células tratadas con BSO subía lentamente pero 
en general se mantiene significativamente mas bajo 
comparando con otros grupos experimentales, hasta los 5 
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días de cultivo cuando la diferencia ya no es 
estadísticamente significativa, excepto en el caso de DEM. El 
nivel de GSH en las células tratadas con DEM subía 
rápidamente; a las 24h era más alto que en las células 
tratadas con BSO pero todavía no llegaba al nivel del control 
(51,96 nmoles/mg prots. comparado con 90,64, 
respectivamente, p≤0,001). A las 48h se observa un efecto 
rebote, previamente demostrado en diferentes tipos 
celulares, que en menor medida persiste a las 72h para caer 
significativamente a los 5 días del cultivo. Las células 
tratadas simultáneamente con DEM y GSH ester muestran el 
mismo patrón que el control, con el pico a las 24h, y la 
diferencia en los niveles de GSH a lo largo del ciclo celular 
entre estos dos grupos nunca llega a ser significativa.  
Estudios de la distribución del GSH por microscopia confocal 
en nuestro modelo, 24h en cultivo, muestran una clara 
compartimentación nuclear en las células control que con el 
tratamiento con DEM disminuye significativamente (Fig. 13). 
Sin embargo, el BSO no era capaz de afectar la distribución 
del GSH, el pool nuclear del GSH se ha conservado en estas 
células y el patrón era bastante parecido al del control.  
La cuantificación del nivel de la fluorescencia verde del 
CMFDA como la medida del nivel de GSH apoya esta 
observación (Fig.14). Los niveles de GSH nuclear en las 
células tratadas con DEM son significativamente más bajos 
que en otros grupos experimentales. El BSO no ha causado 
la depleción del GSH nuclear y la administración simultanea 
del GSH ester suprime completamente el efecto del DEM,  
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 Figura 13. Depleción del GSH y su 
compartimentación intercelular en los fibroblastos 
3T3 24h en cultivo 
 
 
siendo el nivel de GSH  en el núcleo similar al control. Por lo 
tanto, el DEM depleciona el GSH en toda la célula, tanto en 
el núcleo como en el citoplasma, mientras el BSO no 
muestra efecto sobre el GSH nuclear. 
Las consecuencias en la proliferación celular de la depleción 
del GSH nuclear y celular (DEM) comparadas con las 
observadas por la depleción del GSH citoplasmático mientras 
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el nuclear se mantiene (BSO) han sido objeto de nuestro 
estudio.  
La figura 15. muestra el ritmo de crecimiento celular en 4 
grupos experimentales. Como habíamos demostrado 
anteriormente, los fibroblastos 3T3 crecen despacio en las 
primeras horas de cultivo, para llegar al crecimiento 
exponencial entre 24-48h después de la siembra. A las 72h 
llegan a la confluencia y el crecimiento se para. Los 
fibroblastos incubados con BSO muestran un perfil de 
crecimiento similar al de control, con un pequeño retraso a 
las 24h (p≤0,05), y continúan creciendo hasta los 5 días de 
cultivo.  
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Sin embargo, los fibroblastos tratados con DEM se 
caracterizan por un patrón de crecimiento muy diferente. En 
las primeras 48h de cultivo, la población celular casi no 
aumenta: no existe diferencia significativa entre el número 
de células a las 6h y 2 días después. El crecimiento 
importante de estas células ocurre entre 48 y 72h y se 
mantiene en el mismo nivel hasta los 5 días de cultivo. El 
numero de células es en todo momento significativamente 
mas bajo que en el control (p≤0,001) y al final del cultivo 
había casi dos veces menos células en este grupo que en el 
control (1,46x106 y 2,71x106, respectivamente). Las células 
tratadas simultáneamente con DEM y GSH ester crecían al 
mismo ritmo que las células control. Consecuentemente, la 
depleción del GSH nuclear afectaba gravemente el 
crecimiento del cultivo celular, sin embargo, cuando solo el 
GSH citoplasmático estaba deplecionado no había diferencias 
marcadas en el ritmo de crecimiento de las células 3T3.  
 
 
 
 
 
 
 
 
 
 
 
Figura 16. El efecto de la depleción del GSH nuclear 
en la muerte celular en los fibroblastos 3T3
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La muerte celular se mantuvo por debajo del 5% a lo largo 
del ciclo (Fig. 16), para subir a los 5 días en los grupos 
control y BSO debido a la muerte celular inducida por la 
confluencia completa de las células e inhibición por contacto. 
En ningún momento se encontró un aumento importante en 
el grupo tratado con DEM, por lo tanto la diferencia en el 
numero de células en este grupo comparado con los demás 
no se debería a la muerte celular sino a un retraso en el 
crecimiento de la población celular.  
El estudio del ciclo celular de los 4 grupos 
experimentales, presentado en la figura 17, nos proporciona 
las pruebas de esta suposición. En el grupo control el 
porcentaje de células en las fases que definen la 
proliferación celular, S - síntesis de ADN y M/G2-división 
celular, es alto entre las 24 y 72h de cultivo (47,7±9,8% a 
las 24h).  
 
Figura 17. El efecto de la depleción del GSH nuclear 
en el ciclo celular. 
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Antes y después de esta fase exponencial de 
crecimiento, a las 6h y 5 días de cultivo, respectivamente, la 
mayoría de las células esta en la fase G0/G1. Sin embargo, 
las células tratadas con DEM se mantienen en la fase G0/G1 
hasta después de 48h, y el porcentaje de células en la fase 
S+M/G2 se mantiene bajo (35,1±7,8%) a lo largo del 
experimento. Como era de esperar, las células tratadas con 
BSO y con el DEM y GSH ester simultáneamente, muestran 
niveles de proliferación similares al control. La confirmación 
de estos resultados la encontramos en el estudio de la 
expresión de las proteínas relacionadas con la proliferación 
celular, concretamente el Id2. 
 
Figura 18. Expresión de las proteínas del ciclo 
celular después de la depleción del GSH nuclear
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 La Figura 18. presenta los resultados de un experimento 
representativo que indican una disminución de la expresión 
de esta proteína, comparando con el control, en las células 
tratadas con DEM, pero esto no ocurre con BSO ni con la 
combinación del DEM y GSH ester. El nivel de expresión de 
esta proteína solo se iguala al control a los 5 días, donde las 
células control son confluentes y ya no proliferan más. De 
esta manera hemos vuelto a demostrar que la depleción del 
GSH nuclear induce una disminución de la proliferación 
celular. 
En la continuación de nuestro trabajo nos ha 
interesado evaluar la universalidad de nuestra hipótesis 
sobre la importancia del nivel de GSH y su 
compartimentación nuclear para la proliferación celular. 
Hemos elegido dos tipos celulares provenientes de diferentes 
especies y con un nivel de proliferación muy distinto. Las 
células de cancer MCF7 provienen de un adenocarcinoma 
mamario de una mujer caucasiana de 67 años. Es una línea 
celular establecida que se caracteriza por un nivel de 
proliferación muy alto. Por otro lado, el cultivo embrionario 
de neuronas de rata, nos ha ofrecido la posibilidad de 
realizar un estudio comparativo considerando estas células 
como un control negativo. La figura 19. muestra diferentes 
ritmos de proliferación de estos 3 tipos celulares. Los 
fibroblastos 3T3 muestran el perfil de crecimiento celular, 
analizado previamente, distinto a las células MCF7. Las 
células de cáncer de mama empiezan a crecer mas tarde que 
los fibroblastos pero tiene una fase exponencial de  
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crecimiento mas larga y mas intensa que las 3T3. Dado que 
no muestran la inhibición por contacto, después de 7 días de 
cultivo esta población celular seguía creciendo. El cultivo 
embrionario de rata muestra cierta actividad proliferativa 
con un suave aumento hacia el cuarto día de cultivo. En este 
periodo en el cultivo están presentes las células que 
originaran diferentes tipos celulares del sistema nervioso. A 
partir del cuarto día de cultivo se añade el citosin para 
eliminar las células que proliferaban, con lo cual en la placa 
se mantenían solo las células que se diferenciarían en 
neuronas (con un máximo de 3% de astrocitos restantes) 
(10), caracterizadas por un nivel de proliferación 
extremadamente bajo.  
FIGURA 19. Curvas de proliferación comparativas de 
diferentes tipos celulares
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El estudio comparativo del nivel de GSH a lo largo del 
ciclo celular es acorde con las observaciones previamente 
expuestas para los fibroblastos 3T3. En las células de cáncer 
de mama, MCF7, el pico de GSH es anterior, a las 18h, 
comparado con los fibroblastos 3T3 (24h de cultivo), y el 
valor máximo es 3 veces mas alto (256,75±54,80 y 
80,22±22,80 nmoles/mg prot, respectivamente). Por el 
contrario, las neuronas no muestran un pico claro del nivel 
de GSH, aunque se puede observar una meseta con el nivel 
mas alto de GSH en primeros 4 días durante la “fase 
proliferativa” del cultivo. A partir del séptimo día de cultivo 
primario de neuronas se percibe un nivel de GSH bajo y sin 
variaciones significativas (27,0±2,7 nmoles/mg prot) hasta 
16 días cuando el cultivo empieza a morirse.  
 
 
0
50
100
150
200
250
300
0 2 4 6 8 10 12 14 16
tiempo de cultivo (días)
G
SH
 [n
m
ol
es
/m
g 
pr
ot
]
cultivo primario de neuronas fibroblastos 3T3 MCF7
Figura 20. Comparación de los niveles de GSH 
celular total en diferentes tipos celulares
G
SH
 [n
m
ol
es
/m
g 
pr
ot
]
 
 
 
 
 
 
 
 
 
 
 
 
 268  
                          VII  Resumen de los resultados y discusión  
El análisis del ciclo celular por citometria de flujo nos 
ha permitido realizar un estudio de correlación entre el 
porcentaje de células en la fase de  síntesis de ADN en una 
población celular y el nivel de GSH. Se ha mostrado que en 
la población de neuronas caracterizada por un nivel de GSH 
bajo hay muy pocas células que se encuentran en esta fase 
de ciclo celular, mientras una tasa alta de proliferación de 
las células de cáncer de mama esta acompañada por un 
nivel de GSH extremadamente alto. Las 3T3 tienen unos 
valores medios tanto en la proliferación como en el nivel de 
GSH celular.  
 
cultivo primario neuronas 
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nuestro grupo en los fibroblastos 3T3 es la actividad de la 
telomerasa (4). El pico de GSH total celular coincide con el 
pico de la actividad de telomerasa a las 24h del cultivo y 
precede a la fase exponencial del crecimiento. El perfil de la 
actividad de la telomerasa a lo largo del ciclo celular en las 
células MCF7 y el cultivo primario de neuronas se ha 
manifestado coherente con lo que se ha mostrado 
previamente (4) para los fibroblastos 3T3 (Figura 22).  
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Los cambios en la actividad de la telomerasa en las 
células MCF7 son extremos, en las primeros 18h se triplica, 
en los fibroblastos 3T3 llega solo a duplicarse a las 24h, 
mientras que en el cultivo primario de neuronas se observa 
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un incremento mucho mas sutil (46%) a los 3 días de 
cultivo. Los marcadores de la fase de proliferación del ciclo 
celular, id2 y PCNA (proliferating cell nuclear antigen) se han 
estudiado en los 3 tipos celulares. En las células MCF7 el 
PCNA aumenta a partir de las 72h, lo que marca el principio 
de la fase exponencial del crecimiento en estas células. En 
neuronas, el nivel de PCNA es alto en los primeros días de 
cultivo y disminuye considerablemente a los 7 días.  Hacia 
los 16 días del cultivo sigue disminuyendo hasta niveles 
difícilmente detectables.  
 
Figura 23. Estudio comparativo de la expresión de 
las proteínas relacionadas con la proliferación en 
diferentes tipos celulares
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De la misma manera que en los fibroblastos 3T3 se ha 
estudiado la distribución celular del GSH a lo largo del ciclo 
celular (Fig. 24) en las células MCF7 (Fig. 24 A) y en el 
cultivo primario de neuronas (Fig. 24 B). En las células de  
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 Figura 24. Compartimentación intercelular de GSH 
en la proliferación de las células 
cáncer de mama se observa una marcada 
compartimentación nuclear del GSH a partir de las 24h de 
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cultivo y se mantiene, en algunas células, hasta los 7 días de 
cultivo. En la fase proliferativa del cultivo primario se pueden 
detectar algunas células con glutatión en el núcleo. Como 
era de esperar en el cultivo primario de neuronas, después 
del día 4 cuando en la placa quedan solo las células 
diferenciadas en neuronas, se observa una distribución 
homogénea del GSH.  
 
3. Discusión 
Los  resultados presentados demuestran que en los 
fibroblastos 3T3 hay concentración del GSH en el núcleo en 
los primeros 24h del cultivo, justo antes de que se dispare el 
crecimiento celular. A las 72h y 5 días de cultivo cuando la 
actividad de la telomerasa y el nivel de GSH total 
disminuyen, las células llegan a la confluencia y entran en 
quiescencia, se aprecia una distribución uniforme. 
Las imagines obtenidas a los 3 y 5 días de cultivo son 
similares a las publicados previamente por Söderdahl et al. 
(8). Es muy importante considerar el momento del ciclo 
celular a la hora de estudiar la distribución del GSH y su 
compartimentación nuclear. Nosotros mostramos que las 
células que se preparan para la división tienen niveles de 
GSH en el núcleo altos. Las células quiescentes se 
caracterizan por un nivel del GSH nuclear muy parecido al 
del citoplasma (Fig. 3).  
La disponibilidad del GSH en los compartimentos celulares 
esta definida por un equilibrio complejo entre la utilización, 
el transporte, la síntesis, la glutationilación de las proteínas 
           273 
                          VII  Resumen de los resultados y discusión  
 
y la reducción de GSSG. La regulación de estos procesos a 
nivel nuclear no esta clara. Según Smith et al. (11) posibles 
mecanismos bioquímicos involucrados en el recambio 
nuclear del GSH son:  
1. GSH entra al núcleo desde el citoplasma de manera 
pasiva o mediante un proceso dependiente de la energía.  
2. podría existir una síntesis nuclear de GSH mediante las 
enzimas γ-glutatmil cistein ligasa y GSH sintetasa.  
3. GSH podría funcionar como trasportador del γ-Glu-Cys-
Cys.  
Ho and Guenthner (12), en su estudio en los núcleos 
aislados del hígado, concluyeron que el GSH entraba al 
núcleo por difusión pasiva y no mediante un proceso 
dependiente del ATP. Según esta investigación, alrededor del 
4-8% de la actividad de las enzimas de síntesis de GSH se 
ha encontrado en el núcleo, manteniendo así los niveles 
nucleares del GSH. 
En los fibroblastos 3T3 no encontramos la evidencia del 
trasporte activo del GSH (Fig. 7) ni detectamos la presencia 
de la γ-glutamil-cistein-sintetasa en el núcleo (Fig. 8A). 
Diferentes autores señalan la importancia del oncogen 
humano bcl-2 en el posible trasporte del GSH a través de la 
membrana nuclear. En varios estudios se demuestra que la 
sobreexpresión de dicho oncogen conlleva un aumento en la 
concentración del GSH en el núcleo (9, 13, 14). Por otro 
lado, se ha mostrado la relación entre el bcl-2 y los poros 
nucleares (15)  
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Por lo tanto, nosotros proponemos que durante los cambios 
en la membrana nuclear que preceden la división celular, el 
bcl-2 nuclear podría actuar como transportador selectivo de 
algunos compuestos, entre ellos glutatión, hacia el interior 
del núcleo celular.  
Un gran número de situaciones patofisiológicas desvela la 
importancia del GSH nuclear. Atzori et al. (16), demuestran 
la importancia de la cantidad y el estado redox de los tioles 
celulares, especialmente el GSH, para la proliferación y 
diferenciación de las células bronquiales epiteliales en 
humanos. Por otro lado se revela la importancia del glutatión 
nuclear en la protección del ADN, el mantenimiento de la 
integridad funcional del núcleo y en la determinación de 
sensibilidad intrínseca de las células a la radiación (17). 
Hansen et al (18), sugieren que el cambio del estado redox 
del núcleo puede resultar en la desregulación de las 
interacciones entre el ADN y los factores de trascripción lo 
que puede llevar al trastornos en el crecimiento y desarrollo.  
Un número importante de proteínas nucleares, incluyendo 
los factores de trascripción, requiere de un ambiente 
reducido para poder unirse al ADN. Según  Jang y Surh (19), 
el GSH nuclear podría actuar como regulador de la 
trascripción controlada por NFkB, AP-1 y p53, alterando su 
estado redox en el núcleo.  
La importancia del GSH nuclear para la transición de los 
fibroblastos 3T3 de la fase G1 a la fase S y M/G2 del ciclo 
celular ha sido investigada en estudios en un modelo 
diferencial de la depleción del GSH. Usando las propiedades 
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del DEM, que depleciona todos los tioles en toda la célula, y 
el BSO, que disminuye la síntesis de GSH y su concentración 
en citoplasma, pero no afecta el pool nuclear de GSH, 
pudimos confirmar que la depleción del GSH nuclear 
afectaba gravemente a la proliferación celular. Mientras el 
pool nuclear del GSH se mantenía, no se observaban 
cambios en la proliferación celular. Por lo tanto, el GSH 
nuclear es el que regula el crecimiento de la población 
celular y el ritmo del ciclo celular. 
 En nuestro modelo cancerígeno, así como en los fibroblastos 
3T3, hemos demostrado nuevamente la importancia de la 
compartimentación nuclear del GSH en la preparación de las 
células para la fase exponencial de crecimiento.  
En las células de cáncer de mama, MCF7, mediante 
microscopía confocal, observamos una importante 
compartimentación de GSH en el núcleo a partir de 24h de 
cultivo. En las células MCF7 este nivel máximo esta 
retrasado comparando con los fibroblastos 3T3, al igual que 
la fase exponencial de crecimiento: en los fibroblastos es 
entre las 24h y 48h de cultivo, mientras que en las MCF7 es 
entre las 48h y 72h de cultivo. La fase exponencial de 
crecimiento de las MCF7 era más larga y el número de 
células mayor. 
 El nivel del GSH celular total y la actividad de la telomerasa 
en las células MCF7 eran significativamente más altos y 
estaban adelantados comparando con los picos 
correspondientes en los fibroblastos 3T3 y el cultivo primario 
de neuronas.  
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Nuestros resultados muestran que el nivel de GSH, su 
compartimentación nuclear y la actividad de la telomerasa 
en las células MCF7 eran elevados justo antes de que se 
dispare su proliferación. En el caso del cultivo primario de 
neuronas, cuya tasa de proliferación es insignificante, los 
niveles del GSH y telomerasa eran muy bajos y estaban 
acompañados por una distribución homogénea del GSH en la 
célula.  
 
En el trabajo de investigación aquí presentado se ha 
demostrado la gran importancia del nivel de GSH y su 
compartimentación nuclear para el inicio de la proliferación 
celular. El fenómeno parece universal, confirmado en 
cultivos celulares provenientes de diferentes especies y con 
distintos niveles de proliferación.   
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VIII CONCLUSIONES 
 
1. El nivel de glutation celular en una línea celular puede 
determinar su capacidad proliferativa. La variación del 
nivel del glutation durante el cultivo celular impone el 
ritmo de la proliferación celular, posiblemente vía la 
modulación de las proteínas reguladoras del ciclo celular 
sensibles al estado redox.  
 
2. La actividad de la telomerasa es altamente sensible al 
estado redox de la célula, independientemente del tipo 
celular, su inherente capacidad proliferativa o la especie 
de la que procede el cultivo celular. El vínculo entre la 
progresión del ciclo celular y el nivel de glutation se 
podría atribuir, por lo menos en parte, a la modulación de 
la actividad telomerasa. 
 
3. La compartimentación nuclear del glutation es 
imprescindible en el principio de la fase exponencial del 
crecimiento celular. El estado redox de las proteínas 
nucleares, definido por su glutationilacion y oxidación, 
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varía significativamente con la actividad proliferativa de 
las células. 
 
4.  La depleción del glutation nuclear interfiere 
gravemente con la progresión del ciclo celular.  
 
5. Durante los cambios en la membrana nuclear que 
preceden la división celular, el Bcl-2 nuclear podría 
facilitar la translocacion del glutation al núcleo. La sobre 
expresión del Bcl-2 induce el incremento del nivel del 
glutation celular, de la actividad telomerasa y de la 
compartimentación nuclear del GSH.  
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